
<html lang="en"     class="pb-page"  data-request-id="327d980a-1799-4016-901a-76940b5d6150"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-14;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.9b00537"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases" /></meta><meta name="dc.Creator" content="Xiaodong  Dou" /></meta><meta name="dc.Creator" content="Huixia  Huang" /></meta><meta name="dc.Creator" content="Yibo  Li" /></meta><meta name="dc.Creator" content="Lan  Jiang" /></meta><meta name="dc.Creator" content="Yanxing  Wang" /></meta><meta name="dc.Creator" content="Hongwei  Jin" /></meta><meta name="dc.Creator" content="Ning  Jiao" /></meta><meta name="dc.Creator" content="Lihe  Zhang" /></meta><meta name="dc.Creator" content="Liangren  Zhang" /></meta><meta name="dc.Creator" content="Zhenming  Liu" /></meta><meta name="dc.Description" content="Alzheimer’s disease (AD) is one of the most challenging diseases around the world with no effective clinical treatment. Previous studies have suggested c-Jun N-terminal kinase 3 (JNK3) as an attrac..." /></meta><meta name="Description" content="Alzheimer’s disease (AD) is one of the most challenging diseases around the world with no effective clinical treatment. Previous studies have suggested c-Jun N-terminal kinase 3 (JNK3) as an attrac..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 3, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00537" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00537" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00537" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00537" /></link>
        
    
    

<title>Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00537" /></meta><meta property="og:title" content="Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0018.jpeg" /></meta><meta property="og:description" content="Alzheimer’s disease (AD) is one of the most challenging diseases around the world with no effective clinical treatment. Previous studies have suggested c-Jun N-terminal kinase 3 (JNK3) as an attractive therapeutic target for AD. Herein, we report 3-substituted indolin-2-one derivatives as the first isoform-selective JNK3 inhibitors by multistage screening. In this study, comparative structure-based virtual screening was performed, and J30-8 was identified with a half-maximal inhibitory concentration of 40 nM, which exhibited over 2500-fold isoform selectivity and marked kinome-wide selectivity. Further study indicated that 1 μM J30-8 exhibited neuroprotective activity in vitro so as to alleviate the spatial memory impairment in vivo through reducing plaque burden and inhibiting the phosphorylation of JNKs, Aβ precursor protein, and Tau protein. All of these indicated J30-8 as proved isoform-selective JNK3 inhibitors that might serve as a useful tool for further JNK3 studies with AD as well as for the development of JNK3 inhibitors for the potential treatment of neurodegenerative diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00537"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00537">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00537&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00537&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00537&amp;href=/doi/10.1021/acs.jmedchem.9b00537" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6645-6664</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00447" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00611" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xiaodong Dou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaodong Dou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaodong++Dou">Xiaodong Dou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4064-1051" title="Orcid link">http://orcid.org/0000-0002-4064-1051</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Huixia Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Huixia Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Huixia++Huang">Huixia Huang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yibo Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yibo Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yibo++Li">Yibo Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lan Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lan Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lan++Jiang">Lan Jiang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yanxing Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yanxing Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yanxing++Wang">Yanxing Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hongwei Jin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongwei Jin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongwei++Jin">Hongwei Jin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ning Jiao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ning Jiao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Jiao">Ning Jiao</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0290-9034" title="Orcid link">http://orcid.org/0000-0003-0290-9034</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lihe Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lihe Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lihe++Zhang">Lihe Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Liangren Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Liangren Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#533f3a323d3421363d1331393e267d3637267d303d"><span class="__cf_email__" data-cfemail="a9c5c0c8c7cedbccc7e9cbc3c4dc87cccddc87cac7">[email protected]</span></a> (L.Z.).</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Liangren++Zhang">Liangren Zhang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Zhenming Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhenming Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#374d5a5b5e4277555d5a4219525342195459"><span class="__cf_email__" data-cfemail="0b716667627e4b6961667e256e6f7e256865">[email protected]</span></a> (Z.L.).</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhenming++Liu">Zhenming Liu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8993-4015" title="Orcid link">http://orcid.org/0000-0002-8993-4015</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00537&amp;href=/doi/10.1021%2Facs.jmedchem.9b00537" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6645–6664</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 3, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 March 2019</li><li><span class="item_label"><b>Published</b> online</span>3 July 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 July 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00537" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00537</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6645%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiaodong%2BDou%252C%2BHuixia%2BHuang%252C%2BYibo%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D14%26contentID%3Dacs.jmedchem.9b00537%26title%3DMultistage%2BScreening%2BReveals%2B3-Substituted%2BIndolin-2-one%2BDerivatives%2Bas%2BNovel%2Band%2BIsoform-Selective%2Bc-Jun%2BN-terminal%2BKinase%2B3%2B%2528JNK3%2529%2BInhibitors%253A%2BImplications%2Bto%2BDrug%2BDiscovery%2Bfor%2BPotential%2BTreatment%2Bof%2BNeurodegenerative%2BDiseases%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6664%26publicationDate%3DJuly%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00537"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2059</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00537" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiaodong&quot;,&quot;last_name&quot;:&quot;Dou&quot;},{&quot;first_name&quot;:&quot;Huixia&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Yibo&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Lan&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Yanxing&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Hongwei&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Jiao&quot;},{&quot;first_name&quot;:&quot;Lihe&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Liangren&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Zhenming&quot;,&quot;last_name&quot;:&quot;Liu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;6645-6664&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00537&quot;},&quot;abstract&quot;:&quot;Alzheimer’s disease (AD) is one of the most challenging diseases around the world with no effective clinical treatment. Previous studies have suggested c-Jun N-terminal kinase 3 (JNK3) as an attractive therapeutic target for AD. Herein, we report 3-substituted indolin-2-one derivatives as the first isoform-selective JNK3 inhibitors by multistage screening. In this study, comparative structure-based virtual screening was performed, and J30-8 was identified with a half-maximal inhibitory concentration of 40 nM, which exhibited over 2500-fold isoform selectivity and marked kinome-wide selectivity. Further study indicated that 1 μM J30-8 exhibited neuroprotective activity in vitro so as to alleviate the spatial memory impairment in vivo through reducing plaque burden and inhibiting the phosphorylation of JNKs, Aβ precursor protein, and Tau protein. All of these indicated J30-8 as proved isoform-selective JNK3 inhibitors that might serve as a useful tool for further JNK3 studies with AD as well as for the developm&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00537&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00537" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00537&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00537" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00537&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00537" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00537&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00537&amp;href=/doi/10.1021/acs.jmedchem.9b00537" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00537" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00537" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (13 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00537%26sid%3Dliteratum%253Aachs%26pmid%3D31268308%26genre%3Darticle%26aulast%3DDou%26date%3D2019%26atitle%3DMultistage%2BScreening%2BReveals%2B3-Substituted%2BIndolin-2-one%2BDerivatives%2Bas%2BNovel%2Band%2BIsoform-Selective%2Bc-Jun%2BN-terminal%2BKinase%2B3%2B%2528JNK3%2529%2BInhibitors%253A%2BImplications%2Bto%2BDrug%2BDiscovery%2Bfor%2BPotential%2BTreatment%2Bof%2BNeurodegenerative%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D14%26spage%3D6645%26epage%3D6664%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/jmcmar.2019.62.issue-14/20190725/jmcmar.2019.62.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Alzheimer’s disease (AD) is one of the most challenging diseases around the world with no effective clinical treatment. Previous studies have suggested c-Jun N-terminal kinase 3 (JNK3) as an attractive therapeutic target for AD. Herein, we report 3-substituted indolin-2-one derivatives as the first isoform-selective JNK3 inhibitors by multistage screening. In this study, comparative structure-based virtual screening was performed, and <b>J30-8</b> was identified with a half-maximal inhibitory concentration of 40 nM, which exhibited over 2500-fold isoform selectivity and marked kinome-wide selectivity. Further study indicated that 1 μM <b>J30-8</b> exhibited neuroprotective activity in vitro so as to alleviate the spatial memory impairment in vivo through reducing plaque burden and inhibiting the phosphorylation of JNKs, Aβ precursor protein, and Tau protein. All of these indicated <b>J30-8</b> as proved isoform-selective JNK3 inhibitors that might serve as a useful tool for further JNK3 studies with AD as well as for the development of JNK3 inhibitors for the potential treatment of neurodegenerative diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the main form of dementia that has become the fourth leading killer of the elderly after cardiovascular disease and cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Clinically, AD is characterized by memory loss, language decline, and other serious disorders of cognitive abilities.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> According to the World Alzheimer Report in 2018, an estimated 50 million people are living with AD or some form of dementia.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> To date, although new anti-AD drugs have made some progress, there are only five drugs, including four cholinesterase inhibitors and one <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor antagonist, approved by the U.S. Food and Drug Administration.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> However, clinical studies have shown that these drugs have limited effect in improving the AD-related cognitive deficits and do not delay the progression of disease.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a> Recently, Geng and co-workers have reported a marine-derived oligosaccharide, <b>GV-971</b>, which showed statistically marked improvements in the cognition of AD patients in a phase III study at the conference on clinical trials in alzheimer’s disease.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Therefore, it is an urgent clinical need to develop novel therapies, delay the progression, and modify the underlying pathophysiology of AD.</div><div class="NLM_p">c-Jun N-terminal kinases (JNKs), as serine/threonine kinases, belong to the mitogen-activated protein kinase (MAPK) family.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The JNKs can be activated by many stimulating factors such as cytokines, growth factors, oxidative stress, or amyloid β (Aβ) -protein peptides, affecting the life process of apoptosis, immune response, and autophagy.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> There are three genes, namely, <i>jnk1</i>, <i>jnk2</i>, and <i>jnk3</i>, encoded for 10 different splice forms of JNK.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Among them, JNK1 and JNK2 are spliced into four variants (JNK1/2-α1, -α2, -β1, and -β2) and JNK3 is spliced into two variants (JNK3-α1 and -α2).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Although JNK1 and JNK2 are ubiquitously expressed, JNK3 is mainly expressed in the brain and to a lesser extent in the heart and the testis.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Recent studies have shown that JNK3 is the primary kinase that is responsible for phosphorylating Aβ precursor protein (APP) at the position of Thr668, leading to accelerating the formation of the Aβ product levels and subsequent senile plaques.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> In postmortem cortical tissues, JNK3 is markedly activated in human AD patients and a familial AD mouse model.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The deletion of JNK3 results in dramatical decrease of Aβ deposition level.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Moreover, JNK3 expression exists in Tau protein polymer and therefore affects the stability of cytoskeleton, leading to apoptosis.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> JNK3 also directly regulates the formation of neurofibrillary tangle (NFT) by phosphorylating Tau protein, and this pathological change is positively correlated with neuron loss and cognitive impairment.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Owing to the selective tissue distribution of JNK3 in the brain, the findings that JNK3 deletion or inhibition exhibited amelioration of neurodegeneration in animal models of AD make JNK3 an attractive therapeutic target for AD.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26">(22−26)</a></div><div class="NLM_p">Currently, a number of pan-JNK inhibitors have been discovered and two molecules are going through clinical trials (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref10 ref27'); return false;" href="javascript:void(0);" class="ref ref10 ref27">(10,27)</a> Even so, there is no JNK inhibitor on the market yet. <b>SP600125</b> (<b>1</b>) is the first reported pan-JNK inhibitor and can reverse Alzheimer’s disease phenotype in homozygous APPswe/PS1dE9 double-transgenic mice through reducing the formation of senile plaques and neurofibrillary tangle and improving AD-related cognitive deficits.<a onclick="showRef(event, 'ref22 ref28'); return false;" href="javascript:void(0);" class="ref ref22 ref28">(22,28)</a> Although <b>SP600125</b> has poor kinase selectivity, it is still a reference compound commonly used in research.<a onclick="showRef(event, 'ref25 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref25 ref29 ref30 ref31">(25,29−31)</a><b>AS-602801</b> (<b>2</b>) is in phase II study for the treatment of inflammatory endometriosis.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32−34)</a><b>Tanzisertib</b> (<b>3</b>) is a potent inhibitor of pan-JNK for the treatment of discoid lupus erythematosus and idiopathic pulmonary fibrosis but was terminated in phase II clinical trials with no specific reasons reported.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Compound <b>4</b>, an aminopyrazole derivative, was reported as an isoform-selective JNK3 inhibitor. Compound <b>4</b> exhibited over 50-fold isoform selectivity against JNK1, but the selectivity to JNK2 was not satisfied with only 1.51-fold JNK2/JNK3 isoform selectivity.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> To the best of our knowledge, most of the known molecules are pan-JNK inhibitors without isoform selectivity, due to the highly conserved adenosine 5′-triphosphate (ATP)-binding sites of the three isoforms.<a onclick="showRef(event, 'ref10 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref10 ref38 ref39">(10,38,39)</a> Due to the lack of isoform-selective JNK3 inhibitors, it is not conducive to the study of the relationship between the progression of AD and the isoforms of JNKs.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Thus, the discovery of more potent and isoform-selective JNK3 inhibitors contributes to understanding the mechanism and drug discovery of AD.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of representative JNK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Virtual screening (VS) has become an effective tool for lead compounds identification and drug discovery.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> Herein, we report a successful case of comparative structure-based VS, structure–activity relationship (SAR) study driven by similarity screening, and multistage evaluation to discover novel isoform-selective JNK3 inhibitors. Among the identified hits, compound <b>J30-8</b> with indolin-2-one core exhibited JNK3 with a half-maximal inhibitory concentration (IC<sub>50</sub>) value of 40 nM, which shows 2500-fold isoform selectivity against JNK1α1 and JNK2α2 and excellent kinome-wide selectivity against screened 398 kinases. Further pharmacological and mechanism experiments revealed that <b>J30-8</b> had a marked neuroprotective effect against Aβ<sub>25–35</sub>-induced cell death in vitro and dramatically alleviated the spatial memory impairment through reducing the accumulation of Aβ and the phosphorylation of Tau protein in vivo. The pharmacokinetic and brain penetration studies indicated that <b>J30-8</b> exhibited high effective plasma exposure and a certain amount of intracerebral distribution. Finally, the binding modes of these scaffolds were investigated by molecular docking and molecular dynamics (MD) simulations for further structural optimization.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Model Building and Structure-Based Virtual Screening</h3><div class="NLM_p">As drawn in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, more than 40 JNK3 crystal structures have been reported in the Protein Data Bank (PDB, <a href="https://www.rcsb.org/" class="extLink">https://www.rcsb.org/</a>). To identify suitable crystal structures for the following structure-based virtual screening, we first constructed an unbiased benchmarking data set specialized for JNK3, containing 21 active ligands (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Figure S1</a> in the Supporting Information) and 1024 decoys generated by “MUBD-DECOYMAKER” previously developed by our group,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> to evaluate the selected JNK3 crystal structures. Then, the quality of the aforementioned data set was validated by six physicochemical properties, including <i>A</i> log <i>P</i>, molecular weight, number of hydrogen-bond donors, number of hydrogen-bond acceptors, number of rotatable bonds, and net formal charge. The results indicated that the physicochemical properties of the active ligands and decoys maintained a good similarity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B), which meant that the unbiased benchmarking data set was able to evaluate the JNK3 crystal structure models.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. JNK3 inhibitors identification. (A) General workflow. (B) Physicochemical properties distribution curves for all active ligands and decoys in JNK3 benchmarking data set. (C) Receiver operating characteristic (ROC) curves of the eight evaluated JNK3 docking models. (D) Enrichment factor (EF) results obtained for docking studies of unbiased benchmarking data set into JNK3 crystal complexes, including PDB entries: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMV">1PMV</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P33">2P33</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ZDU">2ZDU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CGF">3CGF</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FV8">3FV8</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTI">3TTI</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y46">4Y46</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As for JNK3 crystal structures, 15 representative JNK3 complexes were selected according to the diversity and activity of the ligands from their corresponding crystal structures (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Table S1</a> in the Supporting Information) and cross-docking was used to verify the docking reproducibility for the original binding modes of active ligands. The results showed that eight of them (PDB entries: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMV">1PMV</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P33">2P33</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ZDU">2ZDU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CGF">3CGF</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FV8">3FV8</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTI">3TTI</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y46">4Y46</a>) seemed to provide good overall performance according to the root-mean-square deviation (RMSD) values and docking scores (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Tables S2 and S3</a> in the Supporting Information). Among them, two crystal structures (PDB entries: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P33">2P33</a>) showed excellent docking reproducibility with the lowest average RMSD value equal to 3.03 Å and the best average docking score value equal to −9.3 kcal/mol. These eight crystal structures were thus applied to screen the aforesaid unbiased benchmarking data set.</div><div class="NLM_p">As drawn in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C, the receiver operating characteristic (ROC) curves demonstrated that two crystal structures (PDB entries: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTI">3TTI</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>) were basically above others, whose areas under the ROC (AUC) curves were 0.87 and 0.89, respectively (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Table S4</a>). In general, only top 1% ranked results of the virtual screening are retained for further selection; thus, the enrichment efficacy at the level of top 1% is more important for the validation study.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Table S4</a>, the EF<sub>1%</sub> values of the crystal structures (PDB entries: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTI">3TTI</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>) were 30 and 25, respectively, which were remarkably better than those of the other six docking complexes. Based on the aforementioned data, two crystal structures (PDB entries: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTI">3TTI</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>) were selected as the initial templates for the following structure-based VS.</div><div class="NLM_p last">As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, approximately 300 000 compounds from SPECS chemical library and Chinese National Compound Library of Peking University (PKU-CNCL) were docked into crystal structures (PDB entries: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P33">2P33</a>) using Glide molecular docking module. The top-ranked 1% results based on scoring, about 3000 compounds each crystal structures, were retained. Then, those interacted with residue Met149, a key residue in the hinge domain for the binding affinity of JNK3, were kept through the PoseFilter module in the Maestro platform. Finally, 600 compounds were clustered into 50 categories based on ECFP_6 fingerprint. Totally 62 predicted candidates were selected with visual inspection and purchased (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Table S5</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Seven Novel JNK3 Inhibitors Were Identified</h3><div class="NLM_p">A total of 62 compounds were evaluated through radiometric assays, and seven compounds, <b>J14</b>, <b>J24</b>, <b>J29</b>, <b>J30</b>, <b>J46</b>, <b>J48</b>, and <b>J49</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A), exhibited over 50% inhibition of JNK3 at the concentration of 10 μM (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Table S5</a>, hit rate = 11.3%). All of the active compounds have passed the pan assay interference compounds (PAINS) test by PAINS-remover.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Further IC<sub>50</sub> assays indicated that the seven identified compounds exhibited satisfactory enzymatic inhibition, with IC<sub>50</sub> values ranging from 0.25 to 14.19 μM (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">S2</a>). Among them, three compounds, <b>J29</b>, <b>J30</b>, and <b>J46</b>, had the IC<sub>50</sub> values of 0.62, 0.59, and 0.25 μM, respectively. Further isoform-selective assays showed that these three compounds had the JNK1α1 and JNK2α2 IC<sub>50</sub> values higher than 100 μM with selectivities of JNK3/JNK1α1 and JNK3/JNK2α2 over 160-fold (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B), respectively, suggesting these compounds showed excellent selectivity to the other isoforms of JNKs.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Chemical structures of the seven identified JNK3 inhibitors. (B) Enzymatic activity and representative molecular properties of identified JNK3 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Besides, the representative physicochemical properties of the seven identified JNK3 inhibitors were calculated by Pipeline Pilot 8.5, and the results indicated that these compounds displayed desirable physicochemical properties, except for the <i>A</i> log <i>P</i> of compound <b>J48</b>, just a little over 5.00 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). The results of predicted brain–blood partition coefficient demonstrated that identified inhibitors exhibited satisfactory blood–brain barrier (BBB) permeability with the ADMET_BBB_Level below 3, except for compound <b>J49</b>, outside the confidence area of the regression model.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The Tanimoto coefficients of each identified inhibitors to each known JNK3 inhibitor in the CHEMBL database (version 24, <a href="https://www.ebi.ac.uk/chembl/" class="extLink">https://www.ebi.ac.uk/chembl/</a>) were calculated based on ECFP_6 fingerprints and showed no similarity to any known JNK3 inhibitor with the Tanimoto coefficient below 0.22. All of these indicated that the identified molecules expanded the chemical space of JNK3 inhibitors and provided a good starting point for further chemical modifications, especially the compounds <b>J29</b>, <b>J30</b>, and <b>J46</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Similarity Searching and Preliminary Structure–Activity Relationships (SARs) Study</h3><div class="NLM_p">To study the SARs of these new scaffolds and find more potent inhibitors, derivatization modification and synthesis were necessary, but it would cost a lot of time. Fortunately, 22 analogues of compounds <b>J29</b> and <b>J30</b> and 15 analogues of compounds <b>J46</b> were captured in the SPECS chemical library and PKU-CNCL databases through two-dimensional (2D) similarity searching based on the Tanimoto coefficient of ECFP_6 fingerprints.</div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> (for dose dependency curves, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Figure S3</a>), replacement of the 3-chloro-2-methylphenylamino of <b>J29</b> with a carbonyl group (<b>J30-1</b>) led to a significant loss of JNK3 inhibition. The replacement of the naphthyl group of <b>J30</b> with a 3-chloro-2-methylphenyl group (<b>J30-12</b>) slightly improved inhibitory activity. Then, replacement of the 3-chloro-2-methylphenyl group of <b>J29</b> or the naphthyl group of <b>J30</b> with a phenyl group (<b>J30-10</b>), p-substituted phenyl groups (<b>J30-2</b>, <b>J30-3</b>, <b>J30-5</b>, <b>J30-6</b>, <b>J30-7</b>, <b>J30-11</b>, <b>J30-13</b>, and <b>J30-16</b>), a phenyl group with electron-withdrawing substitution (<b>J30-15</b>), or a morpholine ring (<b>J30-9</b>) led to a decrease of potency. These results revealed that the phenyl ring of <b>J29</b> could be modified with small hydrophobic groups substitution, especially halogen replacement, in the ortho/meta-position. The bromine/chlorine/fluorine atom substitution at the C-5 position of the indol-2-one core (<b>J30</b>, <b>J30-8</b>, <b>J30-12</b>, and <b>J30-14</b>) was essential for maintaining or enhancing activity. Among them, the 5-fluorine-substituted compound <b>J30-8</b>, with an IC<sub>50</sub> value of 0.04 μM, displayed more than 15-fold improvement of inhibitory potency compared to <b>J29</b>. However, replacement of the 5-bromine atom on the indol-2-one core of <b>J29</b> with methyl or ethyl group (<b>J30-17</b>, <b>J30-18</b>, and <b>J30-19</b>) led to the loss of potency, suggesting that the C-5 position of the indol-2-one core was suitable for a halogen replacement. The substitutions at the C-7 or N-1 position of the indol-2-one core (<b>J30-20</b>, <b>J30-21</b>, and <b>J30-22</b>) led to a significant loss of activity, indicating that the C-7 or N-1 position of the indol-2-one core could not be substituted. Besides, the predicted brain–blood partition coefficients of 3-substituted indolin-2-one derivatives indicated that most of the compounds have satisfactory blood–brain barrier permeability with the ADMET_BBB_Level below 3, except for compound <b>J30-13</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzymatic Activity and Chemical Structures of the 22 Analogues of Compounds <b>J29</b> and <b>J30</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0014.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0015.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data are presented as geometric mean values of at least two independent runs.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Molecular weight.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Predicted octanol/water partition coefficient using Pipeline Pilot 8.5.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Log of brain/blood partition coefficient (Log BB); 0: very high, 1: high, 2: medium, 3: low, 4: undefined.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> (for dose dependency curves, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Figure S3</a>), replacement of the naphthyl group of <b>J46</b> with a smaller aromatic ring, including a phenyl group (<b>J46-1</b>), para-substituted phenyl group (<b>J46-2</b> and <b>J46-3</b>), furan ring (<b>J46-4</b>), and thiophene ring (<b>J46-5</b>) led to a significant loss of JNK3 inhibition. We proposed that smaller substituents would reduce the hydrophobic interaction formed by the naphthyl group of <b>J46</b>. Thus, the naphthyl group was important for JNK3 inhibitory activity. Furthermore, replacement of the nitrogen atom to oxygen atom in the lactam of the quinoxaline core (<b>J46-6</b>–<b>10</b>) did not improve the inhibitory activity, which meant that the NH in the lactam might provide hydrogen-bond donor comparing with the oxygen atom. In addition, substitutions at the C-6 or C-7 position of the quinoxaline core (<b>J46-11</b>–<b>15</b>) led to a decrease of potency. Furthermore, three active compounds, <b>J46</b>, <b>J46-1</b>, and J<b>46-2</b>, showed satisfactory blood–brain barrier permeability with the ADMET_BBB_Level below 3.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Enzymatic Activity and Chemical Structures of the 15 Analogues of Compound <b>J46</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0016.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0017.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Data are presented as geometric mean values of at least two independent runs.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Molecular weight.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Predicted octanol/water partition coefficient using Pipeline Pilot 8.5.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Log of brain/blood partition coefficient (Log BB); 0: very high, 1: high, 2: medium, 3: low, 4: undefined.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Not determined.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Isoform and Kinome-Wide Selectivity Study</h3><div class="NLM_p">To verify the isoform selectivity and kinome-wide selectivity of the identified JNK3 inhibitors, compounds <b>J30-8</b> and <b>J46</b> were synthesized (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A).<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> The structures of <b>J30-8</b> and <b>J46</b> were characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and high-resolution mass spectrometry (HRMS) experiments as single substances. The double bond of <b>J46</b> has cis–trans isomerism and the cis structure can form an intramolecular hydrogen bond with low-energy and stable structure.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The following isoform selectivity assays indicated that compound <b>J30-8</b> showed no inhibition against JNK1α1 and JNK2α2 (IC<sub>50</sub> > 100 μM) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) and showed higher than 2500-fold isoform selectivity against JNK1α1 and JNK2α2 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). Additionally, compound <b>J46</b> exhibited no inhibition to JNK1α1 at 100 μM and 40% inhibition to JNK2α2 at 30 μM, which meant that there were some differences between the scaffolds of <b>J30-8</b> and <b>J46</b> in the isoform selectivity of JNK2α2. Further kinases panel selectivity study revealed that compound <b>J30-8</b> only inhibited Abl (h), Abl (Q252H) (h), Abl (Y253F) (h), and Yes (h) with the IC<sub>50</sub> values of 13.93, 8.00, 10.99, and 7.70 μM, respectively. At the same time, compound <b>J46</b> inhibited DDR1 (h), EGFR (L858R) (h), and EGFR (T790M, L858R) (h) with the IC<sub>50</sub> values of 0.16, 4.50, and 0.37 μM (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C,D and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Table S6</a>), respectively. To sum up, the two promising JNK3 inhibitors, <b>J30-8</b> and <b>J46</b>, demonstrated excellent isoform selectivity and kinome-wide selectivity and deserved further optimization study. In addition, <b>J30-8</b> had better isoform selectivity and kinome-wide selectivity than <b>J46</b>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Synthesis of compounds <b>J30-8</b> and <b>J46</b>. ODPA = <i>o</i>-phenylenediamine. (B) Dose dependency inhibition of compounds <b>J30-8</b> and <b>J46</b> against JNKs. Mean values ± standard error (SE) of duplicate. (C) Kinome-wide selectivity for <b>J30-8</b> and <b>J46</b> represented on a kinome phylogenetic tree. Each inhibitor was screened against 398 kinases at 10 or 1 μM. Kinases more than 50% inhibitions are depicted. (D) IC<sub>50</sub> values of <b>J30-8</b> and <b>J46</b> against kinases. IC<sub>50</sub> values are reported as means ± SE of duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound <b>J30-8</b> Treatment Demonstrated Marked Neuroprotection Effect in Vitro</h3><div class="NLM_p">Three compounds <b>J30-8</b>, <b>J30-12</b>, and <b>J46</b>, with good JNK3 inhibitory activities, were further evaluated for their neuroprotection activity against Aβ<sub>25–35</sub>-induced cellular toxicity in SH-SY5Y cells. <b>LiCl</b>, a potential therapeutic drug for AD, was tested as a reference.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The results showed that Aβ<sub>25–35</sub> induced 20–30% SH-SY5Y cell death at the concentration of 20 μM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, <i>p</i> < 0.01) and 10 mM <b>LiCl</b> exhibited efficient neuroprotective activity on SH-SY5Y cells (<i>p</i> < 0.05). For indol-2-one scaffold, 10 μM compound <b>J30-8</b> showed comparable neuroprotective activity with 10 mM <b>LiCl</b>, and 1 μM <b>J30-8</b> also showed considerable neuroprotective activity (<i>p</i> < 0.05). For quinoxaline scaffold, compound <b>J46</b> did not have neuroprotective activity at the concentration of 10 or 1 μM, which might be related to the physicochemical properties and the cellular membrane permeability of compound <b>J46</b>. Besides, compounds <b>J30-8</b> and <b>J46</b> had no effect on SH-SY5Y cells proliferation and <b>LiCl</b> could promote cell proliferation at the testing concentrations (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Protective effects of JNK3 inhibitors against Aβ<sub>25–35</sub>-induced cell death in SH-SY5Y cells. (B) Effects on cell proliferation of JNK3 inhibitors in SH-SY5Y cells. Data are presented as mean ± SE (<i>n</i> = 3). <sup>##</sup><i>p</i> < 0.01, Aβ<sub>25–35</sub> group compared to vehicle group; * <i>p</i> < 0.05, ** <i>p</i> < 0.01, test groups compared to the Aβ<sub>25–35</sub> group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Compound <b>J30-8</b> Treatment Could Improve Learning and Memory Abilities in APPswe/PS1dE9 Mice</h3><div class="NLM_p">Encouraged by the excellent neuroprotective activity of compound <b>J30-8</b> in vitro, we set out to test the behavioral effects of <b>J30-8</b> in homozygous APPswe/PS1dE9 double-transgenic mice model. <b>SP600125</b>, reportedly reversing AD phenotypes to normal level in vivo, was selected as the positive control.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> As indicated in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A, no significant differences in the body weights were observed among four groups of mice. Moreover, <b>J30-8</b> or <b>SP600125</b> treatment significantly alleviated the spatial learning impairment, for shorter escape latency and traveled distance in the positioning navigation experiments (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,C), and also longer time spent in the target quadrant during the probe trial (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D,E) compared to the vehicle-treated mice (<i>p</i> < 0.01). Besides, the time spent in the target quadrant of <b>J30-8</b> (30 mg/kg) group was significantly longer than that in the <b>SP600125</b> (30 mg/kg) group (<i>p</i> < 0.01) in the probe trials. Further visual platform trails indicated that there was no significant difference in the swimming speed and the time to reach the target among the four groups of mice (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>F,G), suggesting that the differences in the behavioral parameters were mainly attributable to differences in learning and memory abilities of the mice. In the step-through passive avoidance tasks (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>H), there was no significant difference in the latency of each group in the acquisition phase, while in the memory retention test phase (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>I), the retention latencies of <b>SP600125</b> and <b>J30-8</b> treatment were significantly higher than that of the vehicle-treated group (<i>p</i> < 0.01). Besides, the <b>J30-8</b> (30 mg/kg) group had a significantly longer retention latency than the <b>SP600125</b> (30 mg/kg) group (<i>p</i> < 0.01). Collectively, the behavioral indexes of mice in the <b>J30-8</b> groups and the <b>SP600125</b> groups were significantly improved compared to those of the vehicle-treated group, and the effect of <b>J30-8</b> (30 mg/kg) group was better than that of the <b>SP600125</b> (30 mg/kg) group.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Behavioral effects of <b>J30-8</b> in homozygous APPswe/PS1dE9 double-transgenic mice model. (A) Effect of compounds <b>J30-8</b> and <b>SP600125</b> on the weight of the mice. (B) Escape latency and (C) exploration distance in the positioning navigation experiments. (E) Representative searching swimming paths by rats in different groups and (E) total time of stay in the target quadrant (%) in the probe trials. (F) Swimming time to target quadrant and (G) swimming speed to target quadrant in the visual platform trails. (H) Acquisition latency and (I) retention latency during the step-through passive avoidance tasks. Data were presented as mean ± SD (<i>n</i> = 8). * <i>p</i> < 0.05, ** <i>p</i> < 0.01 vs vehicle group; <sup>#</sup><i>p</i> < 0.05, <sup>##</sup><i>p</i> < 0.01 vs <b>SP600125</b> (30 mg/kg) group. SP = <b>SP600125</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound <b>J30-8</b> Treatment Reduced the Diffuse and Fibrillar Aβ Plaques in the Cortex and Hippocampus</h3><div class="NLM_p">Aimed to reveal the mechanism of behavioral improvement, the brain Aβ deposition was analyzed by immunofluorescence assays. The results showed that the number of diffuse and fibrillar plaques as well as the percentage of area occupied by diffuse and fibrillar plaques in the cortex (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B, <i>p</i> < 0.01) and hippocampus (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C,D, <i>p</i> < 0.05) markedly decreased in the <b>SP600125</b>- and <b>J30-8</b>-treated mice compared to the vehicle-treated mice. Besides, the inhibitory effect of the <b>J30-8</b> (30 mg/kg) group was rather better than that of the <b>SP600125</b> (30 mg/kg) group in diffuse plaques (<i>p</i> < 0.05) and fibrillar plaques (<i>p</i> < 0.05). Thus, our findings demonstrated that compound <b>J30-8</b> can dose-dependently reduce the number of diffuse and fibrillar Aβ plaques and the proportion of plaques in the cerebral cortex and hippocampus, and the inhibitory effect of <b>J30-8</b> (30 mg/kg) was better than that of <b>SP600125</b> (30 mg/kg), which was consistent with the JNK3 inhibitory activity and the aforementioned phenotype results.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compounds <b>J30-8</b> and <b>SP600125</b> on the number of diffuse plaques, percent of diffuse plaques (A), number of fibrillar plaques, percent of fibrillar plaques (B) in cortex from mice in the indicated groups, and number of diffuse plaques, percent of diffuse plaques (C), number of fibrillar plaques, percent of fibrillar plaques (D) in hippocampus from mice in the indicated groups. The results are presented as mean ± SD (<i>n</i> = 6). Scale bar, 300 μm. ** <i>p</i> < 0.01 vs vehicle group; <sup>#</sup><i>p</i> < 0.05, <sup>##</sup><i>p</i> < 0.01 vs <b>SP600125</b> (30 mg/kg) group. SP = <b>SP600125</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Compound <b>J30-8</b> Treatment Inhibited the Phosphorylation of JNK, APP, and Tau Protein in the Cortex and Hippocampus</h3><div class="NLM_p">The western blotting assays were used to verify whether the aforesaid phenotype and mechanism were caused by the inhibition of JNK3, APP, and Tau protein phosphorylation (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A,B). The results indicated that the phosphorylation levels of JNK, APP (Thr668), Tau (Ser235), and Tau (Thr205) in the cortex and hippocampus were dramatically decreased in the <b>SP600125</b> (30 mg/kg) and <b>J30-8</b> (30 mg/kg) groups compared to those in the vehicle-treated group (see <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C–F, <i>p</i> < 0.001, respectively). Besides, compared to <b>SP600125</b> (30 mg/kg) treatment, <b>J30-8</b> (30 mg/kg) treatment significantly downregulated the phosphorylation levels of JNKs (hippocampus, <i>p</i> < 0.01), APP (Thr668) (<i>p</i> < 0.01), Tau (Ser235) (hippocampus, <i>p</i> < 0.01), and Tau (Thr205) (cortex, <i>p</i> < 0.001; hippocampus, <i>p</i> < 0.01). Furthermore, the expressions of sAPPα, a metabolite of α-secretase, were markedly increased (<i>p</i> < 0.001) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>G), and the expressions of sAPPβ, a metabolite of β-secretase, were significantly decreased (<i>p</i> < 0.001) after treated with <b>J30-8</b> and <b>SP600125</b>, and <b>J30-8</b> could more effectively transform sAPPβ to sAPPα than <b>SP600125</b> at the same dose (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>H). To sum up, specific inhibition of JNK activation by <b>J30-8</b> treatment could reduce the phosphorylation levels of APP and Tau protein and transform sAPPβ to sAPPα, leading to effectively rescue cognitive impairments.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of <b>J30-8</b> and <b>SP60015</b> treatments on the phosphorylation levels of JNK, APP, Tau protein, and the sAPPα, sAPPβ expressions in the cortex (A) and hippocampus (B) of mice from indicated groups. Representative bands are shown. Densitometric quantification of protein band optical densities for Phos-JNK expression (C), Phos-APP (Thr668) expression (D), Phos-Tau (Ser235) expression (E), Phos-Tau (Thr205) expression (F), sAPPα expression (G), and sAPPβ expression (H). The results are presented as mean ± SD (<i>n</i> = 8). * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 vs vehicle group. <sup>#</sup><i>p</i> < 0.05, <sup>##</sup><i>p</i> < 0.01, <sup>###</sup><i>p</i> < 0.001 vs <b>SP600125</b> (30 mg/kg) group. SP = <b>SP600125</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharmacokinetic and Brain Penetration Study of <b>J30-8</b> and <b>SP600125</b> in the Appswe/PS1dE9 Mice</h3><div class="NLM_p">To determine the pharmacokinetic profiles of <b>J30-8</b> and <b>SP600125</b>, these compounds were intravenously (i.v.) and intraperitoneally (i.p.) injected into the APPswe/PS1dE9 mice with single and multiple doses, respectively. The results indicated that the pharmacokinetic behaviors of <b>J30-8</b> and <b>SP600125</b> for the i.v. (3 mg/kg) and i.p. (30 mg/kg) administration conformed to the two-compartment model (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">S4</a>). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <b>J30-8</b> and <b>SP600125</b> showed similar mean retention times (MRTs) in the administration doses of 3 mg/kg (i.v.). Furthermore, <b>J30-8</b> was rapidly distributed (<i>t</i><sub>1/2(α)</sub> = 0.34 h) and slowly eliminated (<i>t</i><sub>1/2(β)</sub> = 16.11 h) in the administration dose of 30 mg/kg (i.p.), while <b>SP600125</b> was rapidly distributed (<i>t</i><sub>1/2(α)</sub> = 0.21 h) and eliminated (<i>t</i><sub>1/2(β)</sub> = 1.23 h) in vivo. Notably, the plasma concentrations of <b>J30-8</b> and <b>SP600125</b> at 24 h after i.p. (30 mg/kg) administrations were 41 and 22 ng/mL, respectively (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), which were higher than the IC<sub>50</sub> values of JNK3 for two compounds (<b>J30-8</b> is 15 ng/mL and <b>SP600125</b> is 20 ng/mL). It was consistent with the results of the pharmacodynamic experiment and might result in the better pharmacology efficacy of <b>J30-8</b> than <b>SP600125</b> in the administration doses of 30 mg/kg (i.p.). Besides, both compounds had high effective plasma exposure with high maximum concentrations (<i>C</i><sub>max</sub>) and areas under the curve (AUC) in the administration doses of 3 mg/kg (i.v.) and 30 mg/kg (i.p.), respectively. The clearance of <b>SP600125</b> was similar to that of <b>J30</b> and both in an acceptable range. Two compounds also showed good bioavailability, and <b>J30-8</b> (<i>F</i> = 90.53%) showed higher bioavailability than <b>SP600125</b> (<i>F</i> = 81.53%). Additionally, there was no obvious accumulation after multiple-dose administration of <b>J30-8</b> and <b>SP600125</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Table S7</a>).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Plasma concentration–time profiles for <b>J30-8</b> (A) and <b>SP600125</b> (B) intraperitoneal administration (30 mg/kg) in homozygous APPswe/PS1dE9 double-transgenic mice (<i>n</i> = 6, respectively).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Parameters of <b>J30-8</b> and <b>SP600125</b> in Homozygous APPswe/PS1dE9 Double-Transgenic Mice Plasma after Single-Dose Intravenous and Intraperitoneal Administrations<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">single-dose administration</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center" char="±">3 mg/kg (i.v./<b>J30-8</b>)</th><th class="colsep0 rowsep0" align="center" char="±">30 mg/kg (i.p./<b>J30-8</b>)</th><th class="colsep0 rowsep0" align="center" char="±">3 mg/kg (i.v./<b>SP600125</b>)</th><th class="colsep0 rowsep0" align="center" char="±">30 mg/kg (i.p./<b>SP600125</b>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2(α)</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±">0.35 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">0.34 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">0.14 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.21 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2(β)</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±">8.83 ± 4.41</td><td class="colsep0 rowsep0" align="char" char="±">16.11 ± 17.71</td><td class="colsep0 rowsep0" align="char" char="±">1.14 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">1.23 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">0.40 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">0.35 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="char" char="±">4545.84 ± 3388.10</td><td class="colsep0 rowsep0" align="char" char="±">19 186.99 ± 5279.86</td><td class="colsep0 rowsep0" align="char" char="±">6587.76 ± 1424.77</td><td class="colsep0 rowsep0" align="char" char="±">23 268.02 ± 2880.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (ng h/mL)</td><td class="colsep0 rowsep0" align="char" char="±">2117.98 ± 367.63</td><td class="colsep0 rowsep0" align="char" char="±">19 174.39 ± 2586.19</td><td class="colsep0 rowsep0" align="char" char="±">2684.13 ± 99.46</td><td class="colsep0 rowsep0" align="char" char="±">21 884.14 ± 2898.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT (h)</td><td class="colsep0 rowsep0" align="char" char="±">1.61 ± 0.71</td><td class="colsep0 rowsep0" align="char" char="±">2.78 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">1.02 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">2.07 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (L/(h kg))</td><td class="colsep0 rowsep0" align="char" char="±">1.45 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">1.59 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">1.12 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">1.39 ± 0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i></td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center" char="±">90.53%</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center" char="±">81.53%</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Each measurement was repeated six times (<i>n</i> = 6).</p></div></div></div><div class="NLM_p">To investigate the BBB penetration of <b>J30-8</b> and <b>SP600125</b>, the compounds were intraperitoneally injected into Appswe/PS1dE9 mice at 30 mg/kg with a single dose, and its plasma and brain concentrations were measured at 0.5, 2, and 8 h postadministration, respectively. The results indicated that both <b>J30-8</b> and <b>J46</b> showed a certain amount of intracerebral distribution (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), and the BBB permeability of <b>J30-8</b> was higher than that of <b>SP600125</b>, which might be the basis for the better efficacy of <b>J30-8</b>. Notably, the average brain concentration of <b>J30-8</b> was higher than 30 ng/g at 0.5, 2, and 8 h after the administration, which was higher than the JNK3 IC<sub>50</sub> value of <b>J30-8</b> (15 ng/g, calculated by supposing the concentration of tested buffer as 1 g/mL), consistent with the pharmacodynamic results.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Plasma and Brain Concentrations of <b>J30-8</b> and <b>SP600125</b> in Homozygous APPswe/PS1dE9 Double-Transgenic Mice at 0.5, 2, and 8 h after 30 mg/kg i.p. Administration<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center">time point (h)</th><th class="colsep0 rowsep0" align="center" char="±">average conc. in plasma (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">average conc. in brain (ng/g)</th><th class="colsep0 rowsep0" align="center" char="±">average brain/plasma ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left"><b>J30-8</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char="±">20 620.74 ± 2367.89</td><td class="colsep0 rowsep0" align="char" char="±">51.37 ± 5.37</td><td class="colsep0 rowsep0" align="char" char="±">0.0024 ± 0.0001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char="±">1202.41 ± 375.09</td><td class="colsep0 rowsep0" align="char" char="±">157.6 ± 36.28</td><td class="colsep0 rowsep0" align="char" char="±">0.1345 ± 0.0217</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="char" char="±">78.11 ± 16.89</td><td class="colsep0 rowsep0" align="char" char="±">30.66 ± 3.11</td><td class="colsep0 rowsep0" align="char" char="±">0.3999 ± 0.0544</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left"><b>SP600125</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char="±">18 450.37 ± 1927.94</td><td class="colsep0 rowsep0" align="char" char="±">42.29 ± 4.83</td><td class="colsep0 rowsep0" align="char" char="±">0.0022 ± 0.0002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char="±">3613.6 ± 959.77</td><td class="colsep0 rowsep0" align="char" char="±">93.46 ± 11.97</td><td class="colsep0 rowsep0" align="char" char="±">0.0265 ± 0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="char" char="±">155.32 ± 73.13</td><td class="colsep0 rowsep0" align="char" char="±">19.96 ± 2.68</td><td class="colsep0 rowsep0" align="char" char="±">0.1418 ± 0.0427</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Each measurement was repeated three times (<i>n</i> = 3).</p></div></div></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Binding Modes and Isoform Selectivity Analysis</h3><div class="NLM_p">To explain the SARs of two new chemical scaffolds, two representative compounds <b>J30-8</b> and <b>J46</b> were docked into the ATP-binding site of JNK3 (PBD entries: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WHZ">4WHZ</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>).<a onclick="showRef(event, 'ref37 ref52'); return false;" href="javascript:void(0);" class="ref ref37 ref52">(37,52)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A, the indolin-2-one moiety of <b>J30-8</b> was located at the hinge region of JNK3 and its hydrogen atom of NH and oxygen atom of carbonyl formed two hydrogen bonds to the backbone carbonyl and NH of Met149, suggesting that the lactam in indol-2-one played a key role in achieving promising inhibitory activity against JNK3. Besides, the thiazol-4-one scaffold had a hydrophobic interaction with Val78, Ala91, Met146, Val196, and Leu206, and the 2-chlorophenyl group of <b>J30-8</b> was deeply buried in the hydrophobic region I (HR I) formed by Ala91, Ile92, Lys93, Ile124, Leu126, Leu144, Val145, Met146, and Leu206 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Figure S5A</a>). In addition, the 4-position of the 2-chlorophenyl group was close to the Leu144 of JNK3 with a distance of 3.9 Å between two carbon atoms and could not be substituted by any group. The binding mode of compound <b>J46</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B) was similar to that of <b>J30-8</b>, and the lactam in the quinoxaline core of <b>J46</b> interacted with the JNK3 hinge region via two hydrogen bonds with Met149. There was also an intramolecular hydrogen bond and the HR I was occupied by naphthyl group in <b>J46</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Figure S5B</a>), and any group substitution in the 4-position of naphthyl group would clash with Leu144, leading to the decrease of inhibition. To summarize, these findings well consist of the results of the aforesaid SARs study, and the occupation of HR I pocket was of great necessity.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Predicted binding modes of compounds <b>J30-8</b> (A) and <b>J46</b> (B). Superimposition of the crystal structures of JNK3 (PDB IDs: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WHZ">4WHZ</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>, gray), JNK1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PZE">3PZE</a>, light blue), and JNK2 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7O">3E7O</a>, yellow) with compounds <b>J30-8</b> (C) and <b>J46</b> (D). Hydrogen bonds are represented by the yellow lines. HR I = hydrophobic region I. Images depicting the proposed binding modes were generated using PyMOL software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate the high selectivities of compounds <b>J30-8</b> and <b>J46</b> to the other isoforms of JNK, the JNK1 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PZE">3PZE</a>) and JNK2 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7O">3E7O</a>) crystal structures were superimposed to the crystal structure of JNK3.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a> As drawn in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C,D, the methylthio group of Met108 of JNK1 or JNK2 was located at the center of HR I pocket and had a collision with the 2-chlorophenyl group of <b>J30-8</b> and the naphthyl group of <b>J46</b>, which led to the loss of inhibitory activity to JNK1α1 and JNK2α2. Notably, the HR I pocket was also called selectivity pocket for achieving the selectivity to other kinases in the MAPK family.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Our findings first demonstrate that the occupation of HR I pocket can achieve isoform selectivity for JNK3 against two other isoforms.</div><div class="NLM_p">Aimed to explain the marked kinome-wide selectivity of <b>J30-8</b>, we compared the binding modes of <b>J30-8</b> and <b>sunitinib</b>, a multitarget kinase inhibitor with oxindole structure.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> As drawn in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A,B, the hydrogen bonds were flipped in the hinge region between the binding modes of <b>J30-8</b> in JNK3 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WHZ">4WHZ</a>) and <b>sunitinib</b> in vascular endothelial growth factor receptor (VEGFR) (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AGD">4AGD</a>),<a onclick="showRef(event, 'ref37 ref55'); return false;" href="javascript:void(0);" class="ref ref37 ref55">(37,55)</a> which led to the 2-chlorophenyl group of <b>J30-8</b> deeply buried in the HR I. For <b>sunitinib</b> was a multitarget kinase inhibitor, we proposed that the reverse of the binding modes of oxindole might make the marked kinome-wide selectivity of <b>J30-8</b>.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Superimposition of the binding modes of <b>J30-8</b> (pink) in JNK3 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WHZ">4WHZ</a>, gray) and <b>sunitinib</b> (yellow) in VEGFR (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AGD">4AGD</a>) with (A) or without (B) protein ribbons. Hydrogen bonds are represented by the yellow lines. HR I = hydrophobic region I. The images depict the proposed binding modes generated using PyMOL software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To verify the binding modes of <b>J30-8</b> and <b>J46</b> in a dynamic condition, 50 ns MD simulations were performed with Desmond software.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Both of the complexes were stable after 30 ns simulations (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Figure S6</a>), and then the last 20 ns trajectories were extracted and analyzed. The results of MD were well consistent with the docking results and the binding patterns of two compounds did not change. For compound <b>J30-8</b> (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>A,C), two hydrogen bonds formed by the lactam and the hinge region Met149 existed during 99 and 67% of the simulation time, respectively, indicating that the lactam of indolin-2-one could be modified to form more stable hydrogen-bond interaction, especially the carbonyl group. The hydrophilic side of thiazol-4-one formed three hydrogen bonds with Gln75 and Asn152 and a water bridge with Lys93 occupying 80, 18, 29, and 14% of the simulation time, indicating that the interactions of the hydrophilic side were weak and unstable. The 2-chlorophenyl group was well embedded in the HR I pocket and provided selectivity to other isoforms of JNK. For compound <b>J46</b> (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>B,D), the quinoxaline formed two hydrogen bonds with the Met149 over 95% of the simulation time, suggesting that the quinoxaline was a good chemical scaffold for JNK3 inhibitors. Interestingly, the naphthyl group formed π-cation interaction with the Lys93 during 57% of the simulation time, which could explain the fact that the replacement of the naphthyl group led to a significant loss of JNK3 inhibitory activity. Overall, these findings guide us to well understand the SARs of these new scaffolds and seek more optimal JNK3 inhibitors in the future.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Protein–ligand contacts histogram <b>J30-8</b> (A) and <b>J46</b> (B) and corresponding 2D diagram <b>J30-8</b> (C) and <b>J46</b> (D) predicted through MD simulations; percentage suggests that for X% of the simulation time, the specific interaction is maintained.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the current work, we constructed an unbiased benchmarking data set for JNK3 and discovered two suitable crystal complexes for structure-based VS. Then, several new scaffold inhibitors of JNK3 were identified, and three compounds, <b>J29</b>, <b>J30</b>, and <b>J46</b>, showed JNK3 IC<sub>50</sub> values at the nanomolar level. Further optimization based on the structural scaffolds of these compounds led to the discovery of compound <b>J30-8</b> with the JNK3 IC<sub>50</sub> value of 40 nM, exhibiting over 2500-fold isoform selectivity against the JNK1α1 and JNK2α2 and excellent kinome-wide selectivity against screened 398 kinases. Besides, compound <b>J30-8</b> showed comparable neuroprotective activity with <b>LiCl</b> in vitro and dramatically improved learning and memory abilities in the APPswe/PS1dE9 mice. Further mechanism study indicated that <b>J30-8</b> could markedly reduce the diffuse and fibrillar Aβ plaques through inhibiting the phosphorylation of JNK, APP, and Tau protein in the cortex and hippocampus. The pharmacokinetic brain penetration studies showed that <b>J30-8</b> exhibited high effective plasma exposure and a certain amount of intracerebral distribution, and it was consistent with the pharmacodynamic results. Therefore, <b>J30-8</b>, as the first proved isoform-selective JNK3 inhibitor with neuroprotective activity in vitro and anti-AD efficacy in vivo, might serve as a useful tool for further JNK3 studies with AD and also the development of JNK3 inhibitors for the potential treatment of neurodegenerative diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83840" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83840" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Construction of Unbiased Benchmarking Data Set</h3><div class="NLM_p last">The unbiased benchmarking data set used to evaluate the performance of structure-based VS was constructed through “MUBD-DECOYMAKER” previously developed by our research group.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> MUBD-DECOYMAKER is a ligand filter and decoy generation tool, and it can ensure the diversity of ligands and maintain the physicochemical properties similar and chemical topology dissimilar between ligands and decoys, providing unbiased test sets for the model validation in virtual screening. According to the protocol, including (1) analogues excluding strategy, (2) physicochemical properties-based filtering strategy, and (3) topology-based filtering strategy, 91 active ligands were collected from the ChEMBL database and literature with the JNK3 IC<sub>50</sub> value lower than 10 nM first.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Then, analogues were excluded, reducing the amount of selected active ligands to 21 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Figure S1</a>). Following, 474 inactive ligands were gathered from the ChEMBL database and literature with the JNK3 IC<sub>50</sub> value higher than 10 000 nM, and 205 inactive ligands were retained after the same process. For each selected active ligands, 39 decoys were selected from the ZINC database (<a href="http://www.zinc.org/" class="extLink">http://www.zinc.org/</a>)<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> after the filter process of MUBD-DECOYMAKER, ensuring the similarity of six physiochemical properties (molecular weight, formal charge, hydrogen-bond donors/acceptors, rotatable bonds, and AlogP) but structural dissimilarity (Tanimoto coefficient < 0.75). Finally, the unbiased benchmarking data set specialized for JNK3 inhibitors was constituted by 21 active ligands and 1024 decoys.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Preparation of Ligands and Crystal Structures</h3><div class="NLM_p">All of the chemicals in unbiased benchmarking data set and screening databases were processed using the LigPrep module in Schrödinger 10.2 software (Schrödinger, LLC, NY).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Epik module in Schrödinger<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> was used to generate the ionized states and tautomers/stereoisomers at pH = 7.0 ± 2.0. The original chiralities were preserved for JNK3 inhibitors with known three-dimensional (3D) structures, and different combinations of chiralities were generated for the decoys without 3D structures. The maximum number of stereoisomers for each decoy was set to 32 and the low-energy ring conformation was set to 1. The OPLS3 force field was adopted to perform energy minimization.</div><div class="NLM_p last">The crystallographic structures of the JNK3 in complex with inhibitors were retrieved from the RCSB Protein Data Bank (PDB), and crystal structures with incomplete ATP binding site were removed, such as incomplete G-loop. Then, a total of 28 JNK3 crystal structures, including PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1JNK">1JNK</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMN">1PMN</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMU">1PMU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMV">1PMV</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2O0U">2O0U</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P33">2P33</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2R9S">2R9S</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ZDT">2ZDT</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ZDU">2ZDU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CGF">3CGF</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CGO">3CGO</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FV8">3FV8</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KVX">3KVX</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OXI">3OXI</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PTG">3PTG</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTI">3TTI</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTJ">3TTJ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KKE">4KKE</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KKH">4KKH</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4V">4W4V</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4X">4W4X</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4Y">4W4Y</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WHZ">4WHZ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X21">4X21</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y5H">4Y5H</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y46">4Y46</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z9L">4Z9L</a>, were prepared by the Protein Preparation Wizard module. Proteins were assigned bond orders, added hydrogens, protonated, removed all crystallographic water molecules, and restrained minimization until the root-mean-square deviation (RMSD) lower than 0.3 Å based on the OPLS3 force field.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Structure-Based Virtual Screening</h3><div class="NLM_p">The above-mentioned 28 crystal structures of human JNK3 were grouped into 12 categories according to the similarity of ligands (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Table S1</a>). Then, 12 representative crystal structures were selected from the corresponding category based on the activity and diversity of the ligands, which were further subjected to cross-docking using Xglide from the Schrödinger script center.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> For each selected JNK3 crystal structure, the ligand was extracted from the complex and then docked into the ATP-binding sites of 12 crystal structures. The binding pockets with the size of 10 Å × 10 Å × 10 Å were defined for each JNK3 complex and centered at the centroid of associated co-crystallized ligands. The “extra precision (XP)” was ticked and all of the remaining parameters for Xglide were kept as default values. Next, eight JNK3 complexes with better RMSD and docking score were used to screen the unbiased benchmarking data set specialized for JNK3 inhibitors. The performances of the eight JNK3 complexes to enrich active compounds were evaluated and compared using enrichment factors study, which was a small retrospective study conducted to investigate the ability of docking model to distinguish between active ligands and inactive compounds (decoys). The receiver operating characteristic (ROC) curves were prepared by plotting the true-positive rate against the false-positive rate, and the corresponding area under the curve (AUC) values were calculated. The enrichment factors (EFs) were computed according to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a><span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_m001.gif" alt="" id="_i23" /></img><span class="labelSpan">(1)</span></span>where (<i>N</i><sub>experimental</sub>) is the number of experimentally found active structures in the top <i>x</i>% of the sorted test set and (<i>N</i><sub>active</sub>) is the total number of active structures in the test set.</div><div class="NLM_p last">Approximately 300 000 compounds from the SPECS chemical library and PKU-CNCL database were docked into two JNK3 crystal structures (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TT">3TT</a>I and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>), and three predicted binding poses were generated for each compound. Then, top-ranked 3000 compounds scored by the XP scoring function of Glide were retained and 1526 compounds appeared in the docking result of two JNK3 crystal structures were selected for binding pose filter to ensure at least one hydrogen bond with residue Met149. The remaining compounds were structurally clustered into 50 clusters based on the Tanimoto coefficients computed using the ECFP_6 fingerprint. Then, one or two compounds were chosen in each cluster according to the docking score and the diversity of structure. Finally, 62 candidates were purchased and evaluated using a radiometric protein kinase assay.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Similarity Search</h3><div class="NLM_p last">Pipeline Pilot 8.5 of Accelrys was used to perform all of the similarity searches.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The fingerprint ECFP_6 was generated for each structure, and similarities were calculated using the Tanimoto coefficient. Then, 22 analogues of compounds <b>J29</b> and <b>J30</b> and 15 analogues of compounds <b>J46</b> were identified and purchased for biological evaluation.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Molecular Dynamics Simulations</h3><div class="NLM_p last">Following molecular docking, independent 50 ns MD simulations were performed for compounds <b>J30-8</b> and <b>J46</b> ligand–protein complex using the Desmond software.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Na<sup>+</sup> and Cl<sup>–</sup> ions were added at the physiological concentration of 0.15 M to ensure the overall neutrality of the systems. Simulations were conducted with an OPLS3 force field and a TIP3P explicit solvent model. The final size of the solvated system was close to ∼50 000 atoms. We chose a 4.8 ps recording interval, and the NPT ensemble was employed with temperature fixed at 300 K and pressure at 1.01 bar. The integration time step was set at 2 fs. The model systems were relaxed using a six-step default protocol implemented in Desmond and utilized to prepare systems for production quality simulation. Default settings were used for all other parameters. The simulation interaction diagram analysis tool was used to monitor energetics, RMSD fluctuations, hydrogen-bond distances, angles, and van der Waals interactions over the simulation trajectories.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Compound Synthesis and Characterization</h3><div class="NLM_p last">The screened compounds were purchased from SPECS database (<a href="http://www.specs.net" class="extLink">http://www.specs.net</a>) or PKU-CNCL (<a href="http://www.pkucncl.com/" class="extLink">http://www.pkucncl.com/</a>). The purities of all purchased and synthesized compounds are more than 95% by high-performance liquid chromatography (HPLC). For the chemical synthesis study, synthesis reagents and solvents were obtained from J&K Chemical (Beijing, China) and used without further purification. Characterizations of compounds <b>J30-8</b> and <b>J46</b> are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">Supporting Information</a>. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on Bruker (400 MHz) instruments, using dimethyl sulfoxide (DMSO)-<i>d</i><sub>6</sub> as solvents. High-resolution mass spectra were recorded on a Bruker Apex IV FTMS mass spectrometer using electrospray ionization (ESI).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedures for Preparation of <b>J30-8</b><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></h3><div class="NLM_p">A solution of 1-(2-chlorophenyl)thiourea (10.0 mmol, 1.86 g), chloroacetic acid (10.0 mmol, 945 mg), 5-fluoroindoline-2,3-dione (10.0 mmol, 1.65 g), and sodium acetate (10.0 mmol, 820 mg) in acetic acid (100 mL) was stirred under reflux for 4 h. The mixture was cooled to room temperature, and the reddish brown precipitate was filtered off. The residue was washed with acetic acid (20 mL), water (20 mL), ethanol (20 mL), and diethyl ether (20 mL) in sequence and then recrystallized from a mixture solvent of dimethylformamide (DMF)/ethanol (20:1).</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-((2-Chlorophenyl)imino)-5-((<i>Z</i>)-5-fluoro-2-oxoindolin-3-ylidene)thiazolidin-4-one (<b>J30-8</b>)</h4><div class="NLM_p last">Reddish brown solid. Yield: 68%. mp > 380 °C (decomposed). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.02 (s, 1H), 11.19 (s, 1H), 8.62 (d, <i>J</i> = 12.3 Hz, 1H), 7.57 (d, <i>J</i> = 7.8 Hz, 1H), 7.39 (t, <i>J</i> = 7.6 Hz, 1H), 7.23 (td, <i>J</i> = 8.8, 2.6 Hz, 2H), 7.15 (d, <i>J</i> = 7.2 Hz, 1H), 6.92 (dd, <i>J</i> = 8.5, 4.6 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.8, 159.1, 156.7, 140.0, 134.6, 130.5, 128.6, 126.7, 126.1, 124.7 (d, <i>J</i> = 3.1 Hz, 1C), 123.1, 121.2 (d, <i>J</i> = 10.4 Hz, 1C), 118.5 (d, <i>J</i> = 24.3 Hz, 1C), 115.0 (d, <i>J</i> = 27.7 Hz, 1C), 111.4 (d, <i>J</i> = 8.5 Hz, 1C). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −121.30. HRMS (ESI) [M + H] <sup>+</sup> calcd for C<sub>17</sub>H<sub>10</sub>N<sub>3</sub>O<sub>2</sub>FSCl: 374.0166; found: 374.0163.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedures for Preparation of <b>J46</b><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></h3><div class="NLM_p">Sodium (17.4 mmol, 400 mg) was added to a solution of ethanol (100 mL) in portions and the mixture was stirred for 1 h. The newly prepared sodium ethanol/ethanol solution was obtained. A mixture solvent of α-naphthalene ethyl ketone (10 mmol, 1.70 g) and oxalic acid diethyl ester (15 mmol, 2.19 g) was dropwise added to the aforesaid sodium ethanol/ethanol solution at 0 °C and stirred for another 4 h at room temperature. Then, the mixture was poured into ice water and the pH value was adjusted to 2.0 with hydrochloric acid (2 M). The obtained solid was filtered and washed with water (10 mL), and the crude product ethyl 4-(naphthalen-1-yl)-2,4-dioxobutanoate was used for the next step without purification. A solution of the former crude product (2.0 mmol, 540 mg) and <i>o</i>-phenylenediamine (2 mmol, 216 mg) in ethanol (10 mL) was stirred for 4 h at room temperature. The yellow solid was filtered, and the filter cake was washed with ethanol (10 mL) and water (10 mL) in sequence and then recrystallized from a mixture solvent of DMF/ethanol (15:1).</div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>Z</i>)-3-(2-(Naphthalen-1-yl)-2-oxoethylidene)-3,4-dihydroquinoxalin-2(1<i>H</i>)-one (<b>J46</b>)</h4><div class="NLM_p last">Yellow solid. Yield: 26%. mp 251–252 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.57 (s, 1H), 12.07 (s, 1H), 8.60–8.46 (m, 1H), 8.07 (d, <i>J</i> = 8.2 Hz, 1H), 8.04–7.95 (m, 1H), 7.84 (d, <i>J</i> = 6.8 Hz, 1H), 7.67–7.52 (m, 4H), 7.25–7.09 (m, 3H), 6.58 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 193.6, 156.1, 145.6, 138.7, 133.9, 131.3, 130.0, 128.9, 127.4, 127.2, 126.8, 126.7, 126.0, 125.6, 124.5, 124.5, 124.2, 117.1, 115.9, 94.2. HRMS (ESI) [M + H] <sup>+</sup> calcd for C<sub>20</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>: 315.1134; found: 315.1134.</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Reagents and Cell Culture</h3><div class="NLM_p last">Reagents were purchased from Sigma-Aldrich unless otherwise noted. <b>SP600125</b> was purchased from Selleck Chemicals LLC. The human neuroblastoma cell line SH-SY5Y was donated by Peking University School of Basic Medical Sciences and cultured in Dulbecco’s modified Eagle’s medium containing 15% fetal bovine serum and 100 U/mL penicillin/streptomycin and maintained in a humidified atmosphere of 95% air and 5% CO<sub>2</sub>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Enzymatic Inhibition Assays</h3><div class="NLM_p last">The inhibition activities against JNK3 and 398 screened kinases were tested by Eurofins using KinaseProfiler Service Assay (details are available at <a href="https://www.eurofins.com/" class="extLink">https://www.eurofins.com/</a>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> JNK3 (h) (JNK1α1 (h) or JNK2α2 (h)) was incubated with 50 mM Tris pH 7.5, 0.1 mM ethylene glycol-bis(β-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid, 0.1% β-mercaptoethanol, 250 μM peptide (3 μM ATF2), 10 mM MgAcetate, and [γ-<sup>33</sup>P-ATP] (specific activity approximately 500 cpm/pmol, concentration as required). The reaction was initiated by the addition of the MgATP mix. After incubation for 40 min at room temperature, the reaction was terminated by the addition of 3% phosphoric acid solution. The reaction mixture (10 μL) was then spotted onto a P30 filter mat and washed three times for 5 min in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting. The activity was defined as the percentage of tested kinase activity in the absence of inhibitor, which was designated as 100%. The IC<sub>50</sub> values were determined as the concentration in which 50% inhibition is achieved from the Hill equation fitting.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Neuroprotection Assays</h3><div class="NLM_p last">The neuroprotection activity against amyloid β (Aβ)-induced toxicity of potential JNK3 inhibitors were determined in SH-SY5Y cells.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Aβ<sub>25–35</sub> (Aladdin, Shanghai, China) was previously dissolved in water to obtain a 1 mM stock solution and then incubated at 37 °C for 7 days for aging. The cells were seeded at a density of 1 × 10<sup>4</sup> per well in 96-well plates and cultured for 24 h. Then, the cells were treated with or without compounds (dissolved in DMSO) at the indicated concentrations; 1 h after addition of compounds, 20 μM Aβ<sub>25–35</sub> was introduced into each well. After 72 h of Aβ<sub>25–35</sub> treatment, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was performed to examine cell viability, and the absorbance was measured at 570 nm.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Animal and Treatments</h3><div class="NLM_p last">Animal procedures were according to the University Policies on the Use and Care of Animals. Homozygous APPswe/PS1dE9 double-transgenic mice were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China). Nine month old female mice were randomized into four groups (<i>n</i> = 8, each group), including three treatment groups, intraperitoneally injected <b>J30-8</b> or <b>SP600125</b> dissolved in phosphate-buffered saline (PBS) containing 2% DMSO at indicated doses once per day for 12 weeks, and one model group received an equal volume of 2% DMSO in PBS as control. During the study, all animals were exposed to pathogen-free, 12 h light/dark cycle environment, sufficient food and water were provided, and bedding was changed at least twice a week. The changes in body weight, activity, adverse drug reaction, and external stimulus were measured and observed weekly.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Behavioral Tests</h3><div class="NLM_p last">After 12 weeks of treatment, Morris water maze and passive avoidance test were used to evaluate the behavioral tests as reported previously.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Morris Water Maze</h3><div class="NLM_p last">Briefly, the pool was divided into four quadrants on average according to the four directions of southeast and northwest. For the acquisition training trials, the transparent platform was kept in the same target quadrant and 1.0 cm below the water surface. In each trial, the mice were monitored 90 s after entering the water. If the mice found the platform within 90 s and stayed on the platform for 20 s, it was judged as a successful platform search and the process was recorded as an escape latency period. If a mouse failed to find the platform within 90 s, the escape latency period was recorded as 90 s and the mouse was guided to the platform and allowed to stay on the platform for 20 s. Each mouse was trained once in each quadrant a day for 6 days. For testing the spatial memory, a space exploration experiment was performed after the completion of the last training trail with an interval of 24 h. The mice entered the water from different quadrants and swam freely for 60 s in the pool without an underwater platform for four times. The time ratio of the mice in the quadrant of the original platform was recorded to determine the spatial memory ability of the mice in each experimental group. For visual platform experiment, after the space exploration experiment was completed for 24 h, the platform was placed in the diagonal position of the original hidden platform, 1.0 cm above the water, and other experimental conditions remained unchanged. The mice were put into the pool from four quadrants, and the time and swimming speed required for the mice to reach the visual platform were recorded.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Passive Avoidance Test</h3><div class="NLM_p last">Briefly, the ENV-010MC shuttle box (Med Associates, Inc. Florida) consisted of one dark compartment and one light compartment, separated by a guillotine door. The stimulator device was connected with the stainless steel fence at the bottom of the dark box side. For the acquisition trial, each mouse was put into the lighted chamber, the guillotine door was opened after 60 s adaptation, and the time of each mouse entering the dark chamber from the light chamber was recorded as acquisition latency. After the mice entered the dark chamber, the gate was closed and a constant foot electric shock (0.3 mA) was given for 3 s. The mice were allowed to stay in the dark chamber for 5 s and then put back into the cage. For testing the retention memory, after 24 h of acquisition trial, the retention latency time was measured according to the aforementioned method without electric shocks. The time when each mouse entered the dark chamber was recorded as the retention latency. If the mice did not enter the dark box after 300 s, it was recorded as 300 s.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Brain Tissue Preparation</h3><div class="NLM_p last">After behavioral tests, all mice were deeply anesthetized with 10% chloral hydrate anesthesia (100 mg/kg, intraperitoneal injection) and cardiac perfusion was performed with precooled 0.9% normal saline (100 mL). After perfusion, the brain was divided into two hemispheres along the median sagittal suture. One hemisphere tissue was fixed by 4% paraformaldehyde for 12 h, paraffin embedding, and used for immunohistochemical analyses. The other hemisphere tissue was separated to hippocampus and cortex on the ice and then stored at −80 °C for biochemical analyses.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Immunohistochemical Analyses</h3><div class="NLM_p last">Paraffin section (4 μm thickness) was dewaxed with xylene and dehydrated with gradient alcohol. Antigen retrieval was performed by proteinase K (0.2 mg/mL) treatment, and endogenous peroxidase was inactivated by incubating with 3% H<sub>2</sub>O<sub>2</sub>. Nonspecific binding was blocked by incubating with normal goat serum at room temperature for 15 min. The sections were incubated with mouse monoclonal anti-Ab antibody (DE2) overnight at 4 °C for recognizing residues human Aβ<sub>1–16</sub> (1:200; Shanghai Haling Biological Technology Co. Ltd., Shanghai, China). Horseradish peroxidase (HRP)-conjugated secondary antibodies were added to detect the primary antibody, and it was visualized by a stable diaminobenzidine solution (Vector Laboratories, Burlingame, CA). The fibrillar Aβ plaques were stained by 1% Thioflavin S (Sigma-Aldrich) and then rinsed by ethanol and distilled water. Fluorescence microscopy was used to capture the green fluorescent fibrillar plaques. Images were observed using an Olympus (Tokyo, Japan) digital microscope. The plaques (total plaques, Aβ<sub>1–16</sub>-positive plaques, and fibrillar-positive plaques) were calculated by Image-Pro Plus imaging software (Media Cybernetics, Bethesda, MD) in square micrometers.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Western Blot Analyses</h3><div class="NLM_p last">The western blot assays of hippocampus and cortex were previously reported.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Briefly, tissues were homogenized and prepared using radioimmunoprecipitation assay buffer lysis buffer and total protein concentration was determined according to the protocol of the Pierce bicinchoninic acid assay. The polyacrylamide gel electrophoresis and poly(vinylidene difluoride) membranes were performed to separate and transfer the equal amounts of protein, respectively. The membranes were blocked by Tris-buffered saline with Tween (TBST) solution containing 5% skim milk and incubated at 4 °C overnight with the primary antibodies, including mouse anti-JNK antibody (1:500; Abcam, Cambridge, U.K.), rabbit anti-p-JNK antibody (1:1000, Abcam, Cambridge, U.K.), mouse anti-APP antibody (1:500, Covance, Princeton, New Jersey), rabbit anti-phosphorylated APP (p-APP; Thr668) antibody (1:500, Abcam, Cambridge, U.K.), mouse antihuman sAPPa (2B3) antibody (1:100, Immuno-Biological Laboratories, Germany), mouse antihuman sAPPb (6A1) antibody (1:100, Immuno-Biological Laboratories, Germany), rabbit anti-Tau antibody (1:500, Abcam, Cambridge, U.K.), rabbit anti-p-Tau (Ser235) antibody (1:500, Abcam, Cambridge, U.K.), rabbit anti-p-Tau (Thr205) antibody (1:500, Abcam, Cambridge, U.K.), and mouse anti-β-actin antibody (1:5000, Abcam, Cambridge, U.K.). The membranes were washed with TBST three times and incubated with goat anti-rabbit IgG (H + L) HRP-labeled secondary antibody (Earthox) for 1 h at room temperature. The blots were detected by ECL Detection Reagent (Thermo Fisher Scientific, Pittsburgh) and ChemiDoc XRS System (Bio-Rad, California).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Pharmacokinetics Study in Appswe/PS1dE9 Mice</h3><div class="NLM_p last">The HPLC conditions were as follows: column, YMC-Triart C18 (150 mm × 4.6 mm, 5 μm, 120 A); mobile phase, 0.1% FA in water/acetonitrile (Merck Company, Germany) (v/v, 0–3.0 min, 10:90; 3.0–8.0 min, 90:10); flow rate, 0.3 mL/min; column temperature, 40 °C. UV detection, 254 nm. Appswe/PS1dE9 mice (<i>n</i> = 6/group) were dosed with <b>J30-8</b> or <b>SP600125</b> via the tail vein for i.v. administration (3 mg/kg, 2% DMSO in saline) or i.p. administration (30 mg/kg, 2% DMSO in saline). After the last administration, 50 μL of orbital blood collection was extracted at 0.25, 0.5, 1, 2, 3, 4, 5, 6, 8, and 24 h. After separated by centrifugation, the sample was prepared for high-pressure liquid chromatography/tandem mass spectrometry (LC–MS/MS) analysis by protein precipitation with acetonitrile (500 ng/mL). The characteristic reaction monitoring transitions were <i>m</i>/<i>z</i> 372 → 220 (negative) for <b>J30-8</b> and <i>m</i>/<i>z</i> 221 → 165 (positive) for <b>SP600125</b>. The pharmacokinetic parameters were calculated through a noncompartmental approach in WinNonlin software v6.3 (Pharsight Corporation, Mountain View).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Pharmacokinetics Study in Plasma and Brain</h3><div class="NLM_p last">Appswe/PS1dE9 mice (<i>n</i> = 3/group) were dosed with <b>J30-8</b> or <b>SP600125</b> via i.p. administration (30 mg/kg, 2% DMSO in saline). At 0.5, 2, and 8 h after administration, the mice were executed and blood samples and brain tissues were collected. The plasma concentrations of the indicated compounds were analyzed through the aforementioned methods. Brain tissue (20 mg) was ground with ultrapure water (200 μL), then homogenate (50 μL) was mixed with 200 μL of 500 ng/mL ISTD, vortexed for 3 min, and centrifuged at 18 000 rpm for 5 min. The supernatant (200 μL) was collected and centrifuged at 18 000 rpm for 5 min. The supernatant was collected and analyzed by HPLC–MS/MS.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Statistical Analysis</h3><div class="NLM_p last">The data are presented as the mean ± standard deviation of the mean unless otherwise noted. The group differences in the behavioral test were analyzed by one-way analysis of variance, followed by post hoc least significant difference test for multiple comparisons. All other data were analyzed with the Student <i>t</i>-test. All statistical analyses were performed by GraphPad 7.0 software (GraphPad, San Diego, CA). Statistical significance was set at <i>p</i> < 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00537" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00537" class="ext-link">10.1021/acs.jmedchem.9b00537</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Selected active ligands of JNK3 (Figure S1); dose dependency curves (Figure S2); concentration–activity relationship (Figure S3); plasma concentration–time profiles (Figure S4); 2D binding modes (Figure S5); RMSD of protein and ligand (Figure S6); selected JNK3 crystal structures (Table S1); original RMSD values (Table S2); original Gscore values (Table S3); enrichment factor results (Table S4); Gscore and inhibition rate (Table S5); kinases panel selectivity (Table S6); and spectra of compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of tested compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Molecular formula strings of benchmarking data set (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf">jm9b00537_si_001.pdf (986.9 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_002.csv">jm9b00537_si_002.csv (6.84 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_003.csv">jm9b00537_si_003.csv (76.21 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00537" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liangren Zhang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#660a0f07080114030826040c0b1348030213480508"><span class="__cf_email__" data-cfemail="e68a8f878881948388a6848c8b93c8838293c88588">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenming Liu</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8993-4015" title="Orcid link">http://orcid.org/0000-0002-8993-4015</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#374d5a5b5e4277555d5a4219525342195459"><span class="__cf_email__" data-cfemail="0e746362677b4e6c64637b206b6a7b206d60">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaodong Dou</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4064-1051" title="Orcid link">http://orcid.org/0000-0002-4064-1051</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huixia Huang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yibo Li</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lan Jiang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanxing Wang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongwei Jin</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Jiao</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0290-9034" title="Orcid link">http://orcid.org/0000-0003-0290-9034</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lihe Zhang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3015-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the National Major Scientific and Technological Special Project for Significant New Drugs Development (2018ZX09735001-003), the National Natural Science Foundation of China (Grant Nos. 21572010, 81673279, and 21772005) and Beijing Municipal Natural Science Foundation (Grant No. 7172118). The authors thank Prof. Zhuang in Peking University School of Basic Medical Sciences for donating human neuroblastoma cell line SH-SY5Y and Prof. Tianyan Zhou for the kind help in pharmacokinetics data analysis.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">JNK3</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase 3</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β-protein</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">Aβ precursor protein</p></td></tr><tr><td class="NLM_term">NFT</td><td class="NLM_def"><p class="first last">neurofibrillary tangle</p></td></tr><tr><td class="NLM_term">VS</td><td class="NLM_def"><p class="first last">virtual screening</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">log <i>P</i></td><td class="NLM_def"><p class="first last">octanol/water partition coefficient</p></td></tr><tr><td class="NLM_term">RMSD</td><td class="NLM_def"><p class="first last">root-mean-square deviation</p></td></tr><tr><td class="NLM_term">ROC</td><td class="NLM_def"><p class="first last">receiver operating characteristic</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">EF</td><td class="NLM_def"><p class="first last">enrichment factor</p></td></tr><tr><td class="NLM_term">PKU-CNCL</td><td class="NLM_def"><p class="first last">Chinese National Compound Library of Peking University</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan assay interference compounds</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">Abl</td><td class="NLM_def"><p class="first last">tyrosine-protein kinase ABL</p></td></tr><tr><td class="NLM_term">Yes</td><td class="NLM_def"><p class="first last">tyrosine-protein kinase Yes</p></td></tr><tr><td class="NLM_term">DDR1</td><td class="NLM_def"><p class="first last">epithelial discoidin domain-containing receptor 1</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">Aβ<sub>25–35</sub></td><td class="NLM_def"><p class="first last">fragment of Aβ 25–35</p></td></tr><tr><td class="NLM_term">HR I</td><td class="NLM_def"><p class="first last">hydrophobic region I</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenous injection</p></td></tr><tr><td class="NLM_term">i.p.</td><td class="NLM_def"><p class="first last">intraperitoneal injection</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean retention time</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2(α)</sub></td><td class="NLM_def"><p class="first last">distribution half-life</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2(β)</sub></td><td class="NLM_def"><p class="first last">eliminate half-life</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentrations</p></td></tr><tr><td class="NLM_term">LC–MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography/tandem mass spectrometry</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheltens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breteler, M. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisoni, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salloway, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Flier, W. M.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(15)01124-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2FS0140-6736%2815%2901124-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=26921134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFOls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=505-517&author=P.+Scheltensauthor=K.+Blennowauthor=M.+M.+B.+Bretelerauthor=B.+de+Strooperauthor=G.+B.+Frisoniauthor=S.+Sallowayauthor=W.+M.+Van+der+Flier&title=Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2815%2901124-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Scheltens, Philip; Blennow, Kaj; Breteler, Monique M. B.; de Strooper, Bart; Frisoni, Giovanni B.; Salloway, Stephen; Van der Flier, Wiesje Maria</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10043</span>),
    <span class="NLM_cas:pages">505-517</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Although the prevalence of dementia continues to increase worldwide, incidence in the western world might have decreased as a result of better vascular care and improved brain health.  Alzheimer's disease, the most prevalent cause of dementia, is still defined by the combined presence of amyloid and tau, but researchers are gradually moving away from the simple assumption of linear causality as proposed in the original amyloid hypothesis.  Age-related, protective, and disease-promoting factors probably interact with the core mechanisms of the disease.  Amyloid β42, and tau proteins are established core cerebrospinal biomarkers; novel candidate biomarkers include amyloid β oligomers and synaptic markers.  MRI and fluorodeoxyglucose PET are established imaging techniques for diagnosis of Alzheimer's disease.  Amyloid PET is gaining traction in the clin. arena, but validity and cost-effectiveness remain to be established.  Tau PET might offer new insights and be of great help in differential diagnosis and selection of patients for trials.  In the search for understanding the disease mechanism and keys to treatment, research is moving increasingly into the earliest phase of disease.  Preclin. Alzheimer's disease is defined as biomarker evidence of Alzheimer's pathol. changes in cognitively healthy individuals.  Patients with subjective cognitive decline have been identified as a useful population in whom to look for preclin. Alzheimer's disease.  Moderately pos. results for interventions targeting several lifestyle factors in non-demented elderly patients and moderately pos. interim results for lowering amyloid in pre-dementia Alzheimer's disease suggest that, ultimately, there will be a future in which specific anti-Alzheimer's therapy will be combined with lifestyle interventions targeting general brain health to jointly combat the disease.  In this Seminar, we discuss the main developments in Alzheimer's research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWZLFEpEZFe7Vg90H21EOLACvtfcHk0lhU9JU3b8VDSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFOls7c%253D&md5=4aca6ac6d79fb10ef1bab5348b31e24a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2815%2901124-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252815%252901124-1%26sid%3Dliteratum%253Aachs%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DBreteler%26aufirst%3DM.%2BM.%2BB.%26aulast%3Dde%2BStrooper%26aufirst%3DB.%26aulast%3DFrisoni%26aufirst%3DG.%2BB.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DVan%2Bder%2BFlier%26aufirst%3DW.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26spage%3D505%26epage%3D517%26doi%3D10.1016%2FS0140-6736%2815%2901124-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stopschinski, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M. I.</span></span> <span> </span><span class="NLM_article-title">The prion model for progression and diversity of neurodegenerative diseases</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">332</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(17)30037-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2FS1474-4422%2817%2930037-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=28238712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=323-332&author=B.+E.+Stopschinskiauthor=M.+I.+Diamond&title=The+prion+model+for+progression+and+diversity+of+neurodegenerative+diseases&doi=10.1016%2FS1474-4422%2817%2930037-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The prion model for progression and diversity of neurodegenerative diseases</span></div><div class="casAuthors">Stopschinski, Barbara E.; Diamond, Marc I.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-332</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The neuropathol. of different neurodegenerative diseases begins in different brain regions, and involves distinct brain networks.  Evidence indicates that transcellular propagation of protein aggregation, which is the basis of prion disease, might underlie the progression of pathol. in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.  The prion model predicts specific patterns of neuronal vulnerability and network involvement on the basis of the conformation of pathol. proteins.  Indeed, evidence indicates that self-propagating aggregate conformers, or so-called strains, are assocd. with distinct neuropathol. syndromes.  The extension of this hypothesis to our understanding of common neurodegenerative disorders can suggest new therapeutic approaches, such as immunotherapy and small mols., to block transcellular propagation, and new diagnostic tools to detect early evidence of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnR2DhaWpjBbVg90H21EOLACvtfcHk0lgGKAZmRRo97w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGkt7w%253D&md5=e42b6241cba73884d43777c0bfc85b50</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2817%2930037-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252817%252930037-6%26sid%3Dliteratum%253Aachs%26aulast%3DStopschinski%26aufirst%3DB.%2BE.%26aulast%3DDiamond%26aufirst%3DM.%2BI.%26atitle%3DThe%2520prion%2520model%2520for%2520progression%2520and%2520diversity%2520of%2520neurodegenerative%2520diseases%26jtitle%3DLancet%2520Neurol.%26date%3D2017%26volume%3D16%26spage%3D323%26epage%3D332%26doi%3D10.1016%2FS1474-4422%2817%2930037-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Alzheimer’s Disease
International</span>.  <i>World Alzheimer Report
2018</i>. <a href="http://ps://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf" class="extLink">ps://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf</a> (accessed
Mar 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=Alzheimer%E2%80%99s+Disease%0AInternational&title=World+Alzheimer+Report%0A2018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Alzheimer%2520Report%250A2018%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkin-Groner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaikin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalom, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weill, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsburg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, M.</span></span> <span> </span><span class="NLM_article-title">Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10700</span>– <span class="NLM_lpage">10715</span>, <span class="refDoi"> DOI: 10.1021/jm301411g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301411g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10700-10715&author=I.+Yanovskyauthor=E.+Finkin-Gronerauthor=A.+Zaikinauthor=L.+Lermanauthor=H.+Shalomauthor=S.+Zeeliauthor=T.+Weillauthor=I.+Ginsburgauthor=A.+Nudelmanauthor=M.+Weinstock&title=Carbamate+derivatives+of+indolines+as+cholinesterase+inhibitors+and+antioxidants+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301411g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamate Derivatives of Indolines as Cholinesterase Inhibitors and Antioxidants for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yanovsky, Inessa; Finkin-Groner, Efrat; Zaikin, Andrey; Lerman, Lena; Shalom, Hila; Zeeli, Shani; Weill, Tehilla; Ginsburg, Isaac; Nudelman, Abraham; Weinstock, Marta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10700-10715</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cascade of events that occurs in Alzheimer's disease involving oxidative stress and the redn. in cholinergic transmission can be better addressed by multifunctional drugs than cholinesterase inhibitors alone.  For this purpose, we prepd. a large no. of derivs. of indoline-3-propionic acids and esters.  They showed scavenging activity against different radicals in soln. and significant protection against cytotoxicity in cardiomyocytes and primary cultures of neuronal cells exposed to H2O2 species and serum deprivation at concns. ranging from 1 nM to 10 μM depending on the compd.  For most of the indoline-3-propionic acid derivs., introduction of N-methyl-N-Et or N-methyl-N-(4-methoxyphenyl) carbamate moieties at positions 4, 6, or 7 conferred both acetyl (AChE) and butyryl (BuChE) cholinesterase inhibitory activities at similar concns. to those that showed antioxidant activity.  The most potent AChE inhibitors were I.2HCl [3-(2-aminoethyl)indolin-4-yl ethyl(methyl)carbamate dihydrochloride] and II.HCl [3-(3-methoxy-3-oxopropyl)-4-[((4-methoxyphenyl)(methyl)carbamoyl)oxy]indolin-1-ium chloride] with IC50s of 0.4 and 1.2 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEMfB-21FGL7Vg90H21EOLACvtfcHk0lgGKAZmRRo97w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs73J&md5=139fc0296d7da235f3f3ae885165a8e2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm301411g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301411g%26sid%3Dliteratum%253Aachs%26aulast%3DYanovsky%26aufirst%3DI.%26aulast%3DFinkin-Groner%26aufirst%3DE.%26aulast%3DZaikin%26aufirst%3DA.%26aulast%3DLerman%26aufirst%3DL.%26aulast%3DShalom%26aufirst%3DH.%26aulast%3DZeeli%26aufirst%3DS.%26aulast%3DWeill%26aufirst%3DT.%26aulast%3DGinsburg%26aufirst%3DI.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DCarbamate%2520derivatives%2520of%2520indolines%2520as%2520cholinesterase%2520inhibitors%2520and%2520antioxidants%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10700%26epage%3D10715%26doi%3D10.1021%2Fjm301411g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trincavelli, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span> <span> </span><span class="NLM_article-title">Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9708</span>– <span class="NLM_lpage">9721</span>, <span class="refDoi"> DOI: 10.1021/jm3009458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9708-9721&author=E.+Simoniauthor=S.+Danieleauthor=G.+Bottegoniauthor=D.+Pizziraniauthor=M.+L.+Trincavelliauthor=L.+Goldoniauthor=G.+Tarozzoauthor=A.+Reggianiauthor=C.+Martiniauthor=D.+Piomelliauthor=C.+Melchiorreauthor=M.+Rosiniauthor=A.+Cavalli&title=Combining+galantamine+and+memantine+in+multitargeted%2C+new+chemical+entities+potentially+useful+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm3009458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer's Disease</span></div><div class="casAuthors">Simoni, Elena; Daniele, Simona; Bottegoni, Giovanni; Pizzirani, Daniela; Trincavelli, Maria L.; Goldoni, Luca; Tarozzo, Glauco; Reggiani, Angelo; Martini, Claudia; Piomelli, Daniele; Melchiorre, Carlo; Rosini, Michela; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9708-9721</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we report on a novel series of multitargeted compds. obtained by linking together galantamine and memantine.  The compds. were designed by taking advantage of the crystal structures of acetylcholinesterase (AChE) in complex with galantamine derivs.  Sixteen novel derivs. were synthesized, using spacers of different lengths and chem. compn.  The mols. were then tested as inhibitors of AChE and as binders of the N-methyl-d-aspartate (NMDA) receptor (NMDAR).  Some of the new compds. were nanomolar inhibitors of AChE and showed micromolar affinities for NMDAR.  All compds. were also tested for selectivity toward NMDAR contg. the 2B subunit (NR2B).  Some of the new derivs. showed a micromolar affinity for NR2B.  Finally, selected compds. were tested using a cell-based assay to measure their neuroprotective activity.  Three of them showed a remarkable neuroprotective profile, inhibiting the NMDA-induced neurotoxicity at subnanomolar concns. (e.g., 5, named memagal, IC50 = 0.28 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSQQfPMtkC0bVg90H21EOLACvtfcHk0lgQvN3TLLdECA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLjL&md5=2db81502732f6337c02f9a1a3afa84f3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm3009458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009458%26sid%3Dliteratum%253Aachs%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DDaniele%26aufirst%3DS.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DGoldoni%26aufirst%3DL.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DCombining%2520galantamine%2520and%2520memantine%2520in%2520multitargeted%252C%2520new%2520chemical%2520entities%2520potentially%2520useful%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9708%26epage%3D9721%26doi%3D10.1021%2Fjm3009458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span> <span> </span><span class="NLM_article-title">Lessons learned from alzheimer disease: clinical trials with negative outcomes</span>. <i>Clin. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1111/cts.12491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1111%2Fcts.12491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=28767185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A280%3ADC%252BC1cfjsVyqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=147-152&author=J.+Cummings&title=Lessons+learned+from+alzheimer+disease%3A+clinical+trials+with+negative+outcomes&doi=10.1111%2Fcts.12491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes</span></div><div class="casAuthors">Cummings Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and translational science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-152</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4EcVa2l0ofS86Js-BCLiifW6udTcc2eatJ2ObN2quXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfjsVyqtA%253D%253D&md5=6318eac19ef6e09ab99933284f55bf96</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fcts.12491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcts.12491%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%26atitle%3DLessons%2520learned%2520from%2520alzheimer%2520disease%253A%2520clinical%2520trials%2520with%2520negative%2520outcomes%26jtitle%3DClin.%2520Transl.%2520Sci.%26date%3D2018%26volume%3D11%26spage%3D147%26epage%3D152%26doi%3D10.1111%2Fcts.12491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geldmacher, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provenzano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McRae, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ieni, J. R.</span></span> <span> </span><span class="NLM_article-title">Donepezil is associated with delayed nursing home placement in patients with Alzheimer’s disease</span>. <i>J. Am. Geriatr. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">937</span>– <span class="NLM_lpage">944</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2389.2003.51306.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1046%2Fj.1365-2389.2003.51306.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=12834513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A280%3ADC%252BD3sznsFyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=937-944&author=D.+S.+Geldmacherauthor=G.+Provenzanoauthor=T.+McRaeauthor=V.+Masteyauthor=J.+R.+Ieni&title=Donepezil+is+associated+with+delayed+nursing+home+placement+in+patients+with+Alzheimer%E2%80%99s+disease&doi=10.1046%2Fj.1365-2389.2003.51306.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease</span></div><div class="casAuthors">Geldmacher David S; Provenzano George; McRae Thomas; Mastey Vera; Ieni John R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Geriatrics Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">937-44</span>
        ISSN:<span class="NLM_cas:issn">0002-8614</span>.
    </div><div class="casAbstract">OBJECTIVES:  To assess the relationship between donepezil treatment and time to nursing home placement (NHP) for patients with Alzheimer's disease (AD).  DESIGN:  Observational follow-up of patient NHP and vital status.  SETTING:  Community.  PARTICIPANTS:  Patients previously enrolled in one of three randomized, double-blind, placebo-controlled clinical trials of donepezil and two subsequent open-label studies (total N = 1,115); 671 patients provided complete data for analysis.  MEASUREMENTS:  Data were obtained through follow-up interviews with caregivers and chart reviews of patients with AD.  Comparison groups were defined by whether patients received an effective dose of donepezil (>/=5 mg/d; >/=80% compliance) for specific numbers of weeks during the double-blind or open-label trial phase, in both phases, or in neither.  Cox proportional hazards models were used to estimate risk ratios for NHP and survival curves from which median times to NHP were estimated for first dementia-related placement of longer than 2 weeks and permanent placement.  The models were adjusted for age, sex, baseline Mini-Mental State Examination score, whether the caregiver was a spouse, caregiver continuity, and use of other cholinesterase inhibitors after the clinical trials.  RESULTS:  Use of donepezil of 5 mg/d or more was associated with significant delays in NHP.  A cumulative dose-response relationship was observed between longer-term sustained donepezil use and delay of NHP.  When donepezil was taken at an effective dose for at least 9 to 12 months, conservative estimates of the time gained before NHP were 21.4 months for first dementia-related NHP and 17.5 months for permanent NHP.  CONCLUSION:  Use of donepezil by AD patients resulted in significant delays in NHP.  Long-term use of donepezil may help AD patients live longer in community settings, with consequent personal, social, and economic benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXmoyhFZauwfcsfMJQC1ZdfW6udTcc2eatJ2ObN2quXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sznsFyrsw%253D%253D&md5=ba06fb717bec801eb57215ea4d53185e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2389.2003.51306.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2389.2003.51306.x%26sid%3Dliteratum%253Aachs%26aulast%3DGeldmacher%26aufirst%3DD.%2BS.%26aulast%3DProvenzano%26aufirst%3DG.%26aulast%3DMcRae%26aufirst%3DT.%26aulast%3DMastey%26aufirst%3DV.%26aulast%3DIeni%26aufirst%3DJ.%2BR.%26atitle%3DDonepezil%2520is%2520associated%2520with%2520delayed%2520nursing%2520home%2520placement%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Am.%2520Geriatr.%2520Soc.%26date%3D2003%26volume%3D51%26spage%3D937%26epage%3D944%26doi%3D10.1046%2Fj.1365-2389.2003.51306.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilienfeld, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span> <span> </span><span class="NLM_article-title">A 5-month, randomized, placebo-controlled trial of galantamine in AD. The galantamine USA-10 study group</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2269</span>– <span class="NLM_lpage">2276</span>, <span class="refDoi"> DOI: 10.1212/WNL.54.12.2269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1212%2FWNL.54.12.2269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10881251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFSmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=2269-2276&author=P.+N.+Tariotauthor=P.+R.+Solomonauthor=J.+C.+Morrisauthor=P.+Kershawauthor=S.+Lilienfeldauthor=C.+Ding&title=A+5-month%2C+randomized%2C+placebo-controlled+trial+of+galantamine+in+AD.+The+galantamine+USA-10+study+group&doi=10.1212%2FWNL.54.12.2269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A 5-month, randomized, placebo-controlled trial of galantamine in AD</span></div><div class="casAuthors">Tariot, P. N.; Solomon, P. R.; Morris, J. C.; Kershaw, P.; Lilienfeld, S.; Ding, C.; Ahern, G.; Aronson, S.; Brenner, R.; Burke, W.; Cochran, J.; Cohen, S.; Cummins, H.; Drachman, D.; Duboff, E.; Farlow, M.; Ferris, S.; Forchetti, C.; Frey, J.; Grossberg, G.; Harrell, L.; Hoffstetter, M.; Holub, R.; Kaye, J.; Landbloom, R.; Levin, K.; Lindahl, L.; Londborg, P.; Lyketsos, C.; Maguire, G.; Mallya, G.; Merideth, C.; Mintzer, J.; Morris, J.; Newhouse, P.; Ng, K.; Plopper, M.; Porteinsson, A.; Probst, T.; Raskind, M.; Reichman, W.; Richardson, B.; Richter, R.; Ross, J.; Sadowsky, C.; Saur, D.; Sauter, M.; Scharre, D.; Schindler, R.; Schneider, L.; Scinto, L.; Siegal, A.; Smith, W.; Solomon, P.; Steinberg, A.; Stone, W.; Tariot, P. N.; Thein, S.; Van Dyck, C.; Visser, J.; Walshe, T., III; Weiner, M.; West, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2269-2276</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The efficacy and tolerability of galantamine, using a slow dose escalation schedule of up to 8 wk, were evaluated in 978 patients with mild to moderate AD.  The study consisted of a 5-mo multicenter, placebo-controlled, double-blind trial.  Following a 4-wk placebo run-in, patients were randomized to one of four treatment arms: placebo or galantamine escalated to final maintenance doses of 8, 16, or 24 mg/day.  Outcome measures included the cognitive subscale of the AD Assessment Scale (ADAS-cog), the Clinician's Interview-Based Impression of Change plus Caregiver Input (CIBIC-plus), the AD Cooperative Study Activities of Daily Living inventory, and the Neuropsychiatric Inventory.  Std. safety evaluations and adverse event monitoring were carried out.  After 5 mo, the galantamine-placebo differences on ADAS-cog were 3.3 points for the 16 mg/day group and 3.6 points for the 24 mg/day group (p < 0.001 vs. placebo, both doses).  Compared with placebo, the galantamine 16- and 24-mg/day groups also had a significantly better outcome on CIBIC-plus, activities of daily living, and behavioral symptoms.  Treatment discontinuations due to adverse events were low in all galantamine groups (6 to 10%) and comparable with the discontinuation rate in the placebo group (7%).  The incidence of adverse events in the galantamine groups, notably gastrointestinal symptoms, was low and most adverse events were mild.  Galantamine 16 and 24 mg/day significantly benefits the cognitive, functional, and behavioral symptoms of AD as compared with placebo.  Slow dose escalation appears to enhance the tolerability of galantamine, minimizing the incidence and severity of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn9bdC2XgNr7Vg90H21EOLACvtfcHk0lhOXEAWH_s9GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFSmsL8%253D&md5=1833030f74b7331699a45fbe3f750dcb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1212%2FWNL.54.12.2269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.54.12.2269%26sid%3Dliteratum%253Aachs%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DSolomon%26aufirst%3DP.%2BR.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DKershaw%26aufirst%3DP.%26aulast%3DLilienfeld%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DC.%26atitle%3DA%25205-month%252C%2520randomized%252C%2520placebo-controlled%2520trial%2520of%2520galantamine%2520in%2520AD.%2520The%2520galantamine%2520USA-10%2520study%2520group%26jtitle%3DNeurology%26date%3D2000%26volume%3D54%26spage%3D2269%26epage%3D2276%26doi%3D10.1212%2FWNL.54.12.2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span> <i>Clinical Trials in Alzheimer’s Disease.</i> <a href="https://www.ctad-alzheimer.com/" class="extLink">https://www.ctad-alzheimer.com/</a> (accessed Mar 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=M.+Geng&title=Clinical+Trials+in+Alzheimer%E2%80%99s+Disease."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DM.%26jtitle%3DClinical%2520Trials%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease.%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of c-Jun N-terminal kinases: an update</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1021/jm501212r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501212r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=72-95&author=P.+Kochauthor=M.+Gehringerauthor=S.+A.+Laufer&title=Inhibitors+of+c-Jun+N-terminal+kinases%3A+an+update&doi=10.1021%2Fjm501212r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of c-Jun N-Terminal Kinases: An Update</span></div><div class="casAuthors">Koch, Pierre; Gehringer, Matthias; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-95</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The c-Jun N-terminal kinases (JNKs) are serine/threonine kinases implicated in the pathogenesis of various diseases.  Recent advances in the development of novel inhibitors of JNKs will be reviewed.  Significant progress in the design of JNK inhibitors displaying selectivity vs. other kinases has been achieved within the past 4 years.  However, the development of isoform selective JNK inhibitors is still an open task.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_LzW9t04ImLVg90H21EOLACvtfcHk0lhOXEAWH_s9GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FN&md5=0d1c32e1463de951c8b47f35882f90ab</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm501212r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501212r%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DInhibitors%2520of%2520c-Jun%2520N-terminal%2520kinases%253A%2520an%2520update%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D72%26epage%3D95%26doi%3D10.1021%2Fjm501212r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tournier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimnual, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. J.</span></span> <span> </span><span class="NLM_article-title">Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">870</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1126/science.288.5467.870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1126%2Fscience.288.5467.870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10797012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFGisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2000&pages=870-874&author=C.+Tournierauthor=P.+Hessauthor=D.+D.+Yangauthor=J.+Xuauthor=T.+K.+Turnerauthor=A.+Nimnualauthor=D.+Bar-Sagiauthor=S.+N.+Jonesauthor=R.+A.+Flavellauthor=R.+J.+Davis&title=Requirement+of+JNK+for+stress-induced+activation+of+the+cytochrome+c-mediated+death+pathway&doi=10.1126%2Fscience.288.5467.870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway</span></div><div class="casAuthors">Tournier, Cathhy; Hess, Patricia; Yang, Derek D.; Xu, Jie; Turner, Tod K.; Nimnual, Anjaruwee; Bar-Sagi, Dafna; Jones, Stephen N.; Flavell, Richard A.; Davis, Roger J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">5467</span>),
    <span class="NLM_cas:pages">870-874</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The c-Jun NH2-terminal kinase (JNK) is activated when cells are exposed to UV radiation.  However, the functional consequence of JNK activation in UV-irradiated cells has not been established.  It is shown here that JNK is required for UV-induced apoptosis in primary murine embryonic fibroblasts.  Fibroblasts with simultaneous targeted disruptions of all the functional Jnk genes were protected against UV-stimulated apoptosis.  The absence of JNK caused a defect in the mitochondrial death signaling pathway, including the failure to release cytochrome c.  These data indicate that mitochondria are influenced by proapoptotic signal transduction through the JNK pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvUKbVwr9pErVg90H21EOLACvtfcHk0lhOXEAWH_s9GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFGisLg%253D&md5=919ddffe16984321cbc14d9bddc3dbe4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.288.5467.870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.288.5467.870%26sid%3Dliteratum%253Aachs%26aulast%3DTournier%26aufirst%3DC.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DD.%2BD.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTurner%26aufirst%3DT.%2BK.%26aulast%3DNimnual%26aufirst%3DA.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DS.%2BN.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26atitle%3DRequirement%2520of%2520JNK%2520for%2520stress-induced%2520activation%2520of%2520the%2520cytochrome%2520c-mediated%2520death%2520pathway%26jtitle%3DScience%26date%3D2000%26volume%3D288%26spage%3D870%26epage%3D874%26doi%3D10.1126%2Fscience.288.5467.870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cargnello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, P. P.</span></span> <span> </span><span class="NLM_article-title">Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">496</span>, <span class="refDoi"> DOI: 10.1128/MMBR.00013-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1128%2FMMBR.00013-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2012&pages=496&author=M.+Cargnelloauthor=P.+P.+Roux&title=Activation+and+function+of+the+MAPKs+and+their+substrates%2C+the+MAPK-activated+protein+kinases&doi=10.1128%2FMMBR.00013-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00013-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00013-12%26sid%3Dliteratum%253Aachs%26aulast%3DCargnello%26aufirst%3DM.%26aulast%3DRoux%26aufirst%3DP.%2BP.%26atitle%3DActivation%2520and%2520function%2520of%2520the%2520MAPKs%2520and%2520their%2520substrates%252C%2520the%2520MAPK-activated%2520protein%2520kinases%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2012%26volume%3D76%26spage%3D496%26doi%3D10.1128%2FMMBR.00013-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, E. T.</span></span> <span> </span><span class="NLM_article-title">Nuclear and cytosolic JNK signalling in neurons</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1038/nrn3729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1038%2Fnrn3729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=24739785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlagsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=285-299&author=E.+T.+Coffey&title=Nuclear+and+cytosolic+JNK+signalling+in+neurons&doi=10.1038%2Fnrn3729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear and cytosolic JNK signalling in neurons</span></div><div class="casAuthors">Coffey, Eleanor T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">285-299</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It has been over 20 years since JUN amino-terminal kinases (JNKs) were identified as protein kinases that are strongly activated by cellular stress and that have a key role in apoptosis.  Examn. of Jnk-knockout mice and characterization of JNK behavior in neuronal cells has further revealed the importance of the JNK family in the nervous system.  As well as regulating neuronal death, JNKs govern brain morphogenesis and axodendritic architecture during development, and regulate important neuron-specific functions such as synaptic plasticity and memory formation.  This Review examines the evidence that the spatial segregation of JNKs in neurons underlies their distinct functions and that compartment-specific targeting of JNKs may offer promising new therapeutic avenues for the treatment of diseases of the nervous system, such as stroke and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmWx_u9jXjdrVg90H21EOLACvtfcHk0lhCCXnh8YlweA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlagsLY%253D&md5=3663cf6a809ff8ff5e836bf37f82c69e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrn3729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3729%26sid%3Dliteratum%253Aachs%26aulast%3DCoffey%26aufirst%3DE.%2BT.%26atitle%3DNuclear%2520and%2520cytosolic%2520JNK%2520signalling%2520in%2520neurons%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2014%26volume%3D15%26spage%3D285%26epage%3D299%26doi%3D10.1038%2Fnrn3729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. J.</span></span> <span> </span><span class="NLM_article-title">Signal transduction by the JNK group of MAP kinases</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)00116-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2FS0092-8674%2800%2900116-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=11057897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns1Cltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2000&pages=239-252&author=R.+J.+Davis&title=Signal+transduction+by+the+JNK+group+of+MAP+kinases&doi=10.1016%2FS0092-8674%2800%2900116-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transduction by the JNK group of MAP kinases</span></div><div class="casAuthors">Davis, Roger J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-252</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 132 refs.  The purpose of this review is to summarize recent advances that have been made toward understanding the JNK signaling pathway.  It is now known that JNK is required for embryonic morphogenesis and that this signaling pathway contributes to the regulation of cell proliferation and apoptosis.  JNK also contributes to the function of some differentiated cells.  Thus, the JNK signal transduction pathway is implicated in multiple physiol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMPzQW8epuZ7Vg90H21EOLACvtfcHk0lhCCXnh8YlweA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns1Cltrk%253D&md5=eeb3712790a731b15d2676a94197057a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900116-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900116-1%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26atitle%3DSignal%2520transduction%2520by%2520the%2520JNK%2520group%2520of%2520MAP%2520kinases%26jtitle%3DCell%26date%3D2000%26volume%3D103%26spage%3D239%26epage%3D252%26doi%3D10.1016%2FS0092-8674%2800%2900116-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitmarsh, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavanagh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluss, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derijard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. J.</span></span> <span> </span><span class="NLM_article-title">Selective interaction of JNK protein kinase isoforms with transcription factors</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2760</span>– <span class="NLM_lpage">2770</span>, <span class="refDoi"> DOI: 10.1002/j.1460-2075.1996.tb00636.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1002%2Fj.1460-2075.1996.tb00636.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=8654373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADyaK28XjvVWitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=2760-2770&author=S.+Guptaauthor=T.+Barrettauthor=A.+J.+Whitmarshauthor=J.+Cavanaghauthor=H.+K.+Slussauthor=B.+Derijardauthor=R.+J.+Davis&title=Selective+interaction+of+JNK+protein+kinase+isoforms+with+transcription+factors&doi=10.1002%2Fj.1460-2075.1996.tb00636.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Selective interaction of JNK protein kinase isoforms with transcription factors</span></div><div class="casAuthors">Gupta, Shashi; Barret, Tamera; Whitmarsh, Alan J.; Cavanagh, Julie; Sluss, Hayla K.; Derijard, Benoit; Davis, Roger J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2760-2770</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The JNK protein kinase is a member of the MAP kinase group that is activated in response to dual phosphorylation on threonine and tyrosine.  Ten JNK isoforms were identified in human brain by mol. cloning.  These protein kinases correspond to alternatively spliced isoforms derived from the JNK1, JNK2 and JNK3 genes.  The protein kinase activity of these JNK isoforms was measured using the transcription factors ATF2, Elk-1 and members of the Jun family as substrates.  Treatment of cells with interleukin-1 (IL-1) caused activation of the JNK isoforms.  This activation was blocked by expression of the MAP kinase phosphatase MKP-1.  Comparison of the binding activity of the JNK isoforms demonstrated that the JNK proteins differ in their interaction with ATF2, Elk-1 and Jun transcription factors.  Individual members of the JNK group may therefore selectively target specific transcription factors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX1aO5n8MPFbVg90H21EOLACvtfcHk0li2E9oYXI118g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVWitbo%253D&md5=2947079a9a607c139115a34cf389d933</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1996.tb00636.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1996.tb00636.x%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DBarrett%26aufirst%3DT.%26aulast%3DWhitmarsh%26aufirst%3DA.%2BJ.%26aulast%3DCavanagh%26aufirst%3DJ.%26aulast%3DSluss%26aufirst%3DH.%2BK.%26aulast%3DDerijard%26aufirst%3DB.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26atitle%3DSelective%2520interaction%2520of%2520JNK%2520protein%2520kinase%2520isoforms%2520with%2520transcription%2520factors%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D2760%26epage%3D2770%26doi%3D10.1002%2Fj.1460-2075.1996.tb00636.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waetzig, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdegen, T.</span></span> <span> </span><span class="NLM_article-title">Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2005.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.tips.2005.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=16054242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslCgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=455-461&author=V.+Waetzigauthor=T.+Herdegen&title=Context-specific+inhibition+of+JNKs%3A+overcoming+the+dilemma+of+protection+and+damage&doi=10.1016%2Fj.tips.2005.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage</span></div><div class="casAuthors">Waetzig, Vicki; Herdegen, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The c-Jun N-terminal kinases (JNKs), which are essential regulators of physiol. and pathol. processes, are involved in several diseases including diabetes, atherosclerosis, stroke, and Parkinson's and Alzheimer's diseases.  Inhibition of JNKs suppresses pathol. features of these diseases but the many physiol. functions of these enzymes argue against the use of sustained, systemic, nonspecific inhibition in the treatment of these diseases.  For example, deletion of the gene that encodes JNK1 prevents insulin resistance but disrupts neuronal cytoarchitecture and initiates the pathol. of Alzheimer's disease.  Thus, it is not sufficient to inhibit selectively either JNKs or individual isoforms of JNK.  Instead, the aim is to inhibit the damaging actions of JNK.  This can be achieved using peptides that selectively target mol. domains of individual JNK signaling complexes (exclusively) that form under pathol. conditions.  To date, peptide inhibitors of JNK have been successful in protecting against ischemia-induced brain damage and insulin resistance following obesity.  In this review, we discuss novel pharmacol. strategies to inhibit JNK and the limitations of these strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUU8sMkwub97Vg90H21EOLACvtfcHk0li2E9oYXI118g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslCgsL0%253D&md5=e9b12c2b4258c0a7f71b871f5528a751</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DWaetzig%26aufirst%3DV.%26aulast%3DHerdegen%26aufirst%3DT.%26atitle%3DContext-specific%2520inhibition%2520of%2520JNKs%253A%2520overcoming%2520the%2520dilemma%2520of%2520protection%2520and%2520damage%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D455%26epage%3D461%26doi%3D10.1016%2Fj.tips.2005.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sclip, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forloni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borsello, T.</span></span> <span> </span><span class="NLM_article-title">JNK regulates APP cleavage and degradation in a model of Alzheimer’s disease</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">525</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2008.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.nbd.2008.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=19166938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVSjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=518-525&author=A.+Colomboauthor=A.+Bastoneauthor=C.+Ploiaauthor=A.+Sclipauthor=M.+Salmonaauthor=G.+Forloniauthor=T.+Borsello&title=JNK+regulates+APP+cleavage+and+degradation+in+a+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.nbd.2008.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">JNK regulates APP cleavage and degradation in a model of Alzheimer's disease</span></div><div class="casAuthors">Colombo, Alessio; Bastone, Antonio; Ploia, Cristina; Sclip, Alessandra; Salmona, Mario; Forloni, Gianluigi; Borsello, Tiziana</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">518-525</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Secretion of Amyloid-beta peptide (Aβ) circulating oligomers and their aggregate forms derived by processing of beta-amyloid precursor protein (APP) are a key event in Alzheimer's disease (AD).  We show that phosphorylation of APP on threonine 668 may play a role in APP metab. in H4-APPsw cell line, a degenerative AD model.  We proved that JNK plays a fundamental role in this phosphorylation since its specific inhibition, with the JNK inhibitor peptide (D-JNKI1), induced APP degrdn. and prevented APP phosphorylation at T668.  This results in a significant drop of βAPPs, Aβ fragments and Aβ circulating oligomers.  Moreover the D-JNKI1 treatment produced a switch in the APP metab., since the peptide reduced the rate of the amyloidogenic processing in favor of the non-amyloidogenic one.  All together our results suggest an important link between APP metab. and the JNK pathway and contribute to shed light on the mol. signalling pathway of this disease indicating JNK as an innovative target for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-j8BPYvgDB7Vg90H21EOLACvtfcHk0li2H7Ti8YgyTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVSjt74%253D&md5=7e7ba36777e13a3bf5430b8be9c1cc14</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2008.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2008.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DA.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DPloia%26aufirst%3DC.%26aulast%3DSclip%26aufirst%3DA.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DForloni%26aufirst%3DG.%26aulast%3DBorsello%26aufirst%3DT.%26atitle%3DJNK%2520regulates%2520APP%2520cleavage%2520and%2520degradation%2520in%2520a%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D33%26spage%3D518%26epage%3D525%26doi%3D10.1016%2Fj.nbd.2008.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Triaca, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sposato, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciotti, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelicci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruni, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupidi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maletta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feligioni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nistico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calissano, P.</span></span> <span> </span><span class="NLM_article-title">NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer’s disease</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1111/acel.12473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1111%2Facel.12473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=27076121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVSnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=661-672&author=V.+Triacaauthor=V.+Sposatoauthor=G.+Bolascoauthor=M.+T.+Ciottiauthor=P.+Pelicciauthor=A.+C.+Bruniauthor=C.+Cupidiauthor=R.+Malettaauthor=M.+Feligioniauthor=R.+Nisticoauthor=N.+Canuauthor=P.+Calissano&title=NGF+controls+APP+cleavage+by+downregulating+APP+phosphorylation+at+Thr668%3A+relevance+for+Alzheimer%E2%80%99s+disease&doi=10.1111%2Facel.12473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease</span></div><div class="casAuthors">Triaca, Viviana; Sposato, Valentina; Bolasco, Giulia; Ciotti, Maria Teresa; Pelicci, Piergiuseppe; Bruni, Amalia C.; Cupidi, Chiara; Maletta, Raffaele; Feligioni, Marco; Nistico, Robert; Canu, Nadia; Calissano, Pietro</div><div class="citationInfo"><span class="NLM_cas:title">Aging Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">661-672</span>CODEN:
                <span class="NLM_cas:coden">ACGECQ</span>;
        ISSN:<span class="NLM_cas:issn">1474-9718</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : NGF has been implicated in forebrain neuroprotection from amyloidogenesis and Alzheimer's disease (AD).  However, the underlying mol. mechanisms are still poorly understood.  Here, we investigated the role of NGF signalling in the metab. of amyloid precursor protein (APP) in forebrain neurons using primary cultures of septal neurons and acute septo-hippocampal brain slices.  In this study, we show that NGF controls the basal level of APP phosphorylation at Thr668 (T668) by downregulating the activity of the Ser/Thr kinase JNK(p54) through the Tyr kinase signalling adaptor SH2-contg. sequence C (ShcC).  We also found that the specific NGF receptor, Tyr kinase A (TrkA), which is known to bind to APP, fails to interact with the fraction of APP mols. phosphorylated at T668 (APPpT668).  Accordingly, the amt. of TrkA bound to APP is significantly reduced in the hippocampus of ShcC KO mice and of patients with AD in which elevated APPpT668 levels are detected.  NGF promotes TrkA binding to APP and APP trafficking to the Golgi, where APP-BACE interaction is hindered, finally resulting in reduced generation of sAPPβ, CTFβ and amyloid-beta (1-42).  These results demonstrate that NGF signalling directly controls basal APP phosphorylation, subcellular localization and BACE cleavage, and pave the way for novel approaches specifically targeting ShcC signalling and/or the APP-TrkA interaction in AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrETcaIiFrU_rVg90H21EOLACvtfcHk0li2H7Ti8YgyTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVSnsbs%253D&md5=9ea05402edaba1535ac435cc8d392b6a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Facel.12473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Facel.12473%26sid%3Dliteratum%253Aachs%26aulast%3DTriaca%26aufirst%3DV.%26aulast%3DSposato%26aufirst%3DV.%26aulast%3DBolasco%26aufirst%3DG.%26aulast%3DCiotti%26aufirst%3DM.%2BT.%26aulast%3DPelicci%26aufirst%3DP.%26aulast%3DBruni%26aufirst%3DA.%2BC.%26aulast%3DCupidi%26aufirst%3DC.%26aulast%3DMaletta%26aufirst%3DR.%26aulast%3DFeligioni%26aufirst%3DM.%26aulast%3DNistico%26aufirst%3DR.%26aulast%3DCanu%26aufirst%3DN.%26aulast%3DCalissano%26aufirst%3DP.%26atitle%3DNGF%2520controls%2520APP%2520cleavage%2520by%2520downregulating%2520APP%2520phosphorylation%2520at%2520Thr668%253A%2520relevance%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAging%2520Cell%26date%3D2016%26volume%3D15%26spage%3D661%26epage%3D672%26doi%3D10.1111%2Facel.12473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozer, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tep, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastorino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunwar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahara, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuszynski, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.</span></span> <span> </span><span class="NLM_article-title">JNK3 perpetuates metabolic stress induced by Abeta peptides</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2012.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.neuron.2012.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=22958823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSktrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=824-837&author=S.+O.+Yoonauthor=D.+J.+Parkauthor=J.+C.+Ryuauthor=H.+G.+Ozerauthor=C.+Tepauthor=Y.+J.+Shinauthor=T.+H.+Limauthor=L.+Pastorinoauthor=A.+J.+Kunwarauthor=J.+C.+Waltonauthor=A.+H.+Nagaharaauthor=K.+P.+Luauthor=R.+J.+Nelsonauthor=M.+H.+Tuszynskiauthor=K.+Huang&title=JNK3+perpetuates+metabolic+stress+induced+by+Abeta+peptides&doi=10.1016%2Fj.neuron.2012.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides</span></div><div class="casAuthors">Yoon, Sung Ok; Park, Dong Ju; Ryu, Jae Cheon; Ozer, Hatice Gulcin; Tep, Chhavy; Shin, Yong Jae; Lim, Tae Hee; Pastorino, Lucia; Kunwar, Ajaya J.; Walton, James C.; Nagahara, Alan H.; Lu, Kun Ping; Nelson, Randy J.; Tuszynski, Mark H.; Huang, Kun</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">824-837</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although Aβ peptides are causative agents in Alzheimer's disease (AD), the underlying mechanisms are still elusive.  We report that Aβ42 induces a translational block by activating AMPK, thereby inhibiting the mTOR pathway.  This translational block leads to widespread ER stress, which activates JNK3.  JNK3 in turn phosphorylates APP at T668, thereby facilitating its endocytosis and subsequent processing.  In support, pharmacol. blocking translation results in a significant increase in Aβ42 in a JNK3-dependent manner.  Thus, JNK3 activation, which is increased in human AD cases and a familial AD (FAD) mouse model, is integral to perpetuating Aβ42 prodn.  Concomitantly, deletion of JNK3 from FAD mice results in a dramatic redn. in Aβ42 levels and overall plaque loads and increased neuronal no. and improved cognition.  This reveals AD as a metabolic disease that is under tight control by JNK3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOAk5iFWtmHLVg90H21EOLACvtfcHk0lg2zd--eWsLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSktrrI&md5=d54d63193d35184d8f8ef14e0631c03e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2012.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2012.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DS.%2BO.%26aulast%3DPark%26aufirst%3DD.%2BJ.%26aulast%3DRyu%26aufirst%3DJ.%2BC.%26aulast%3DOzer%26aufirst%3DH.%2BG.%26aulast%3DTep%26aufirst%3DC.%26aulast%3DShin%26aufirst%3DY.%2BJ.%26aulast%3DLim%26aufirst%3DT.%2BH.%26aulast%3DPastorino%26aufirst%3DL.%26aulast%3DKunwar%26aufirst%3DA.%2BJ.%26aulast%3DWalton%26aufirst%3DJ.%2BC.%26aulast%3DNagahara%26aufirst%3DA.%2BH.%26aulast%3DLu%26aufirst%3DK.%2BP.%26aulast%3DNelson%26aufirst%3DR.%2BJ.%26aulast%3DTuszynski%26aufirst%3DM.%2BH.%26aulast%3DHuang%26aufirst%3DK.%26atitle%3DJNK3%2520perpetuates%2520metabolic%2520stress%2520induced%2520by%2520Abeta%2520peptides%26jtitle%3DNeuron%26date%3D2012%26volume%3D75%26spage%3D824%26epage%3D837%26doi%3D10.1016%2Fj.neuron.2012.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillozet-Bongaarts, A.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cryns, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binder, L. I.</span></span> <span> </span><span class="NLM_article-title">Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1005</span>– <span class="NLM_lpage">1014</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.03784.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1111%2Fj.1471-4159.2006.03784.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=16606369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVOntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2006&pages=1005-1014&author=A.%0AL.+Guillozet-Bongaartsauthor=M.+E.+Cahillauthor=V.+L.+Crynsauthor=M.+R.+Reynoldsauthor=R.+W.+Berryauthor=L.+I.+Binder&title=Pseudophosphorylation+of+tau+at+serine+422+inhibits+caspase+cleavage%3A+in+vitro+evidence+and+implications+for+tangle+formation+in+vivo&doi=10.1111%2Fj.1471-4159.2006.03784.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo</span></div><div class="casAuthors">Guillozet-Bongaarts, Angela L.; Cahill, Michael E.; Cryns, Vincent L.; Reynolds, Matthew R.; Berry, Robert W.; Binder, Lester I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1005-1014</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The tangles of Alzheimer's disease (AD) are comprised of the tau protein displaying numerous alterations, including phosphorylation at serine 422 (S422) and truncation at aspartic acid 421 (D421).  Truncation at the latter site appears to result from activation of caspases, a class of proteases that cleave specifically at aspartic acid residues.  It has been proposed that phosphorylation at or near caspase cleavage sites could regulate the ability of the protease to cleave at those sites.  Here, we use tau pseudophosphorylated at S422 (S422E) to examine the effects of tau phosphorylation on its cleavage by caspase 3.  We find that S422E tau is more resistant to proteolysis by caspase 3 than non-pseudophosphorylated tau.  Addnl., we use antibodies directed against the phosphorylation site and against the truncation epitope to assess the presence of these epitopes in neurofibrillary tangles in the aged human brain.  We show that phosphorylation precedes truncation during tangle maturation.  Moreover, the distribution of the two epitopes suggests that a significant length of time (perhaps as much as two decades) elapses between S422 phosphorylation and cleavage at D421.  We further conclude that tau phosphorylation at S422 may be a protective mechanism that inhibits cleavage in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8FRMpyiZv4bVg90H21EOLACvtfcHk0lg2zd--eWsLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVOntro%253D&md5=6124e371597607c8482e7e046e782b3e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03784.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03784.x%26sid%3Dliteratum%253Aachs%26aulast%3DGuillozet-Bongaarts%26aufirst%3DA.%2BL.%26aulast%3DCahill%26aufirst%3DM.%2BE.%26aulast%3DCryns%26aufirst%3DV.%2BL.%26aulast%3DReynolds%26aufirst%3DM.%2BR.%26aulast%3DBerry%26aufirst%3DR.%2BW.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26atitle%3DPseudophosphorylation%2520of%2520tau%2520at%2520serine%2520422%2520inhibits%2520caspase%2520cleavage%253A%2520in%2520vitro%2520evidence%2520and%2520implications%2520for%2520tangle%2520formation%2520in%2520vivo%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D97%26spage%3D1005%26epage%3D1014%26doi%3D10.1111%2Fj.1471-4159.2006.03784.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagalwar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillozet-Bongaarts, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binder, L. I.</span></span> <span> </span><span class="NLM_article-title">Formation of phospho-SAPK/JNK is an early event in granules in the hippocampus Alzheimer disease</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1097/01.jnen.0000229236.98124.d8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1097%2F01.jnen.0000229236.98124.d8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=16772869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A280%3ADC%252BD28zlvVClsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2006&pages=455-464&author=S.+Lagalwarauthor=A.+L.+Guillozet-Bongaartsauthor=R.+W.+Berryauthor=L.+I.+Binder&title=Formation+of+phospho-SAPK%2FJNK+is+an+early+event+in+granules+in+the+hippocampus+Alzheimer+disease&doi=10.1097%2F01.jnen.0000229236.98124.d8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease</span></div><div class="casAuthors">Lagalwar Sarita; Guillozet-Bongaarts Angela L; Berry Robert W; Binder Lester I</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuropathology and experimental neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">455-64</span>
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    </div><div class="casAbstract">The mitogen-activated protein (MAP) kinase SAPK/JNK phosphorylates tau protein at many of its proline-directed serine/threonine residues in vitro and is a likely candidate kinase to phosphorylate the pathologically relevant S422 site on tau.  Since phosphorylation of tau, particularly at S422, is a relatively early marker of AD and seems to precede tangle formation, it appears likely that an early form of activated SAPK/JNK might be detected by immunohistochemical means around the time that tau begins to aggregate into tangles.  We report here that an antibody to phospho-SAPK/JNK (p-SAPK/JNK) reacts with several types of lesions including granular bodies in limbic areas; NFTs in limbic cortex and temporal neocortex; occasional neuritic plaques in temporal neocortex; and select axons in the hippocampus, entorhinal cortex, and inferior temporal cortex.  In order to characterize the appearance of granular p-SAPK/JNK and determine if it appears early in disease, we employed an immunohistochemical study of postmortem limbic tissue from 20 cases ranging from Braak stages I-VI.  By co-staining with anti-tau antibodies specific to different molecular events that occur during tangle evolution, we were able to identify the appearance of p-SAPK/JNK in early Braak stages with an increased elevation during the limbic stages of AD and during the early stages of the formation of individual hippocampal tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSV9hlaR5K7dsScOqQTSkOffW6udTcc2eZoheBQlsWkTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zlvVClsw%253D%253D&md5=7b8c3821d7c871d1ca28560d94554b5c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1097%2F01.jnen.0000229236.98124.d8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.jnen.0000229236.98124.d8%26sid%3Dliteratum%253Aachs%26aulast%3DLagalwar%26aufirst%3DS.%26aulast%3DGuillozet-Bongaarts%26aufirst%3DA.%2BL.%26aulast%3DBerry%26aufirst%3DR.%2BW.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26atitle%3DFormation%2520of%2520phospho-SAPK%252FJNK%2520is%2520an%2520early%2520event%2520in%2520granules%2520in%2520the%2520hippocampus%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2006%26volume%3D65%26spage%3D455%26epage%3D464%26doi%3D10.1097%2F01.jnen.0000229236.98124.d8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1002/ana.24361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1002%2Fana.24361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=25611954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlt1WqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2015&pages=637-654&author=Q.+Zhouauthor=M.+Wangauthor=Y.+Duauthor=W.+Zhangauthor=M.+Baiauthor=Z.+Zhangauthor=Z.+Liauthor=J.+Miao&title=Inhibition+of+c-Jun+N-terminal+kinase+activation+reverses+Alzheimer+disease+phenotypes+in+APPswe%2FPS1dE9+mice&doi=10.1002%2Fana.24361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice</span></div><div class="casAuthors">Zhou, Qiong; Wang, Man; Du, Ying; Zhang, Wei; Bai, Miao; Zhang, Zhuo; Li, Zhuyi; Miao, Jianting</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">637-654</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : Growing evidence indicates that the activation of c-Jun N-terminal kinase (JNK) is implicated in the multiple major pathol. features of Alzheimer disease (AD).  However, whether specific inhibition of JNK activation could prevent disease progression in adult transgenic AD models at moderate stage remains unknown.  Here we first investigated the potential disease-modifying therapeutic effect of systemic administration of SP600125, a small-mol. JNK-specific inhibitor, in middle-aged APPswe/PS1dE9 mice.  Methods : Using behavioral, histol., and biochem. methods, outcomes of SP600125 treatment on neuropathol. and cognitive deficits were studied in APPswe/PS1dE9 mice.  Results : Compared with vehicle-treated APPswe/PS1dE9 mice, chronic treatment of SP600125 for 12 wk potently inhibited JNK activation, which resulted in a marked improvement of behavioral measures of cognitive deficits and a dramatic redn. in amyloid plaque burden, β-amyloid prodn., tau hyperphosphorylation, inflammatory responses, and synaptic loss in these transgenic animals.  In particular, we found that SP600125 treatment strongly promoted nonamyloidogenic amyloid precursor protein (APP) processing and inhibited amyloidogenic APP processing via regulating APP-cleavage secretase expression (ie, ADAM10, BACE1, and PS1) in APPswe/PS1dE9 mice.  Interpretation : Our findings demonstrate that chronic SP600125 treatment is powerfully effective in slowing down disease progression by markedly reducing multiple pathol. features and ameliorating cognitive deficits assocd. with AD.  This study highlights the concept that active JNK actually contributes to the development of the disease, and provides crit. preclin. evidence that specific inhibition of JNK activation by SP600125 treatment may be a novel promising disease-modifying therapeutic strategy for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOwnT-t3qHXbVg90H21EOLACvtfcHk0lg2zd--eWsLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlt1WqtLc%253D&md5=0f6ce5cdf905ffc7aea5cb38d90de401</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fana.24361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24361%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBai%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMiao%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520c-Jun%2520N-terminal%2520kinase%2520activation%2520reverses%2520Alzheimer%2520disease%2520phenotypes%2520in%2520APPswe%252FPS1dE9%2520mice%26jtitle%3DAnn.%2520Neurol.%26date%3D2015%26volume%3D77%26spage%3D637%26epage%3D654%26doi%3D10.1002%2Fana.24361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crocker, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lograsso, P.</span></span> <span> </span><span class="NLM_article-title">JNK inhibition protects dopamine neurons and provides behavioral improvement in a rat 6-hydroxydopamine model of Parkinson’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1021/cn1001107</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn1001107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFalsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=207-212&author=C.+E.+Crockerauthor=S.+Khanauthor=M.+D.+Cameronauthor=H.+A.+Robertsonauthor=G.+S.+Robertsonauthor=P.+Lograsso&title=JNK+inhibition+protects+dopamine+neurons+and+provides+behavioral+improvement+in+a+rat+6-hydroxydopamine+model+of+Parkinson%E2%80%99s+disease&doi=10.1021%2Fcn1001107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-Hydroxydopamine Model of Parkinson's Disease</span></div><div class="casAuthors">Crocker, Candice E.; Khan, Susan; Cameron, Michael D.; Robertson, Harold A.; Robertson, George S.; LoGrasso, Philip</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">207-212</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) results from the loss of dopamine neurons located in the substantia nigra pars compacta (SNpc) that project to the striatum.  A therapeutic has yet to be identified that halts this neurodegenerative process, and as such, development of a brain penetrant small mol. neuroprotective agent would represent a significant advancement in the treatment of the disease.  To fill this void, we developed an aminopyrimidine JNK inhibitor (SR-3306) that reduced the loss of dopaminergic cell bodies in the SNpc and their terminals in the striatum produced by unilateral injection of 6-hydroxydopamine (6-OHDA) into the nigrostriatal pathway.  Administration of SR-3306 [10 mg/kg/day (s.c.) for 14 days] increased the no. of tyrosine hydroxylase immunoreactive (TH+) neurons in the SNpc by 6-fold and reduced the loss of the TH+ terminals in the striatum relative to the corresponding side of 6-OHDA-lesioned rats that received only vehicle (p < 0.05).  In addn., SR-3306 [10 mg/kg/day (s.c.) for 14 days] decreased d-amphetamine-induced circling by 87% compared to 6-OHDA-lesioned animals given vehicle.  Steady-state brain levels of SR-3306 at day 14 were 347 nM, which was approx. 2-fold higher than the cell-based IC50 for this compd.  Finally, immunohistochem. staining for phospho-c-jun (p-c-jun) revealed that SR-3306 [10 mg/kg/day (s.c.) for 14 days] produced a 2.3-fold redn. of the no. of immunoreactive neurons in the SNpc relative to vehicle treated rats.  Collectively, these data suggest that orally bioavailable JNK inhibitors may be useful neuroprotective agents for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ZXdX36RxpLVg90H21EOLACvtfcHk0libNH7-ECMCpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFalsbo%253D&md5=3254d7fb8fe2ffbc8be28d22a5b0d650</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcn1001107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1001107%26sid%3Dliteratum%253Aachs%26aulast%3DCrocker%26aufirst%3DC.%2BE.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DRobertson%26aufirst%3DH.%2BA.%26aulast%3DRobertson%26aufirst%3DG.%2BS.%26aulast%3DLograsso%26aufirst%3DP.%26atitle%3DJNK%2520inhibition%2520protects%2520dopamine%2520neurons%2520and%2520provides%2520behavioral%2520improvement%2520in%2520a%2520rat%25206-hydroxydopamine%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D207%26epage%3D212%26doi%3D10.1021%2Fcn1001107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. G.</span></span> <span> </span><span class="NLM_article-title">Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1373</span>– <span class="NLM_lpage">1383</span>, <span class="refDoi"> DOI: 10.1517/13543784.14.11.1373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1517%2F13543784.14.11.1373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=16255677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGqsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1373-1383&author=G.+Y.+Zhangauthor=Q.+G.+Zhang&title=Agents+targeting+c-Jun+N-terminal+kinase+pathway+as+potential+neuroprotectants&doi=10.1517%2F13543784.14.11.1373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants</span></div><div class="casAuthors">Zhang, Guang-Yi; Zhang, Quan-Guang</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1373-1383</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  C-Jun N-terminal kinase (JNK) plays an integral role in neuronal death in multiple cell lines following a wide variety of stimuli and in a no. of physiol. functions that may be involved in human disease, including CNS diseases.  In the past decades, many researchers in this field have found and reinforced the concept that prolonged activation of JNK signaling can induce neuronal cell death by both a transcriptional induction of death-promoting genes and modulation of the mitochondrial apoptosis pathways.  Data are emerging to extend the understanding of the JNK signaling and confirm the possibility that targeting JNK signaling may offer an effective therapy for pathol. conditions in the near future.  This review will focus on the pro-apoptotic role of JNK signaling and updated pharmacol. inhibitors of this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquWjsT9BECMrVg90H21EOLACvtfcHk0libNH7-ECMCpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGqsrnN&md5=4b8775a51ae9a318693e2e36d9fb38ff</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.11.1373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.11.1373%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%2BY.%26aulast%3DZhang%26aufirst%3DQ.%2BG.%26atitle%3DAgents%2520targeting%2520c-Jun%2520N-terminal%2520kinase%2520pathway%2520as%2520potential%2520neuroprotectants%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D1373%26epage%3D1383%26doi%3D10.1517%2F13543784.14.11.1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span> <span> </span><span class="NLM_article-title">JNK inhibitor SP600125 attenuates paraquat-induced acute lung injury: an in vivo and in vitro study</span>. <i>Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1319</span>– <span class="NLM_lpage">1330</span>, <span class="refDoi"> DOI: 10.1007/s10753-017-0575-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1007%2Fs10753-017-0575-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=28474156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFait7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2017&pages=1319-1330&author=H.+Shenauthor=N.+Wuauthor=Y.+Wangauthor=X.+Hanauthor=Q.+Zhengauthor=X.+Caiauthor=H.+Zhangauthor=M.+Zhao&title=JNK+inhibitor+SP600125+attenuates+paraquat-induced+acute+lung+injury%3A+an+in+vivo+and+in+vitro+study&doi=10.1007%2Fs10753-017-0575-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">JNK Inhibitor SP600125 Attenuates Paraquat-Induced Acute Lung Injury: an In Vivo and In Vitro Study</span></div><div class="casAuthors">Shen, Haitao; Wu, Na; Wang, Yu; Han, Xinfei; Zheng, Qiang; Cai, Xue; Zhang, Honglei; Zhao, Min</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1319-1330</span>CODEN:
                <span class="NLM_cas:coden">INFLD4</span>;
        ISSN:<span class="NLM_cas:issn">0360-3997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Acute lung injury (ALI) is a major complication soon after paraquat poisoning and rapidly progresses with high mortality.  However, the specific mechanism underlying paraquat-induced ALI is still unclear.  In this study, the mechanism underlying the protective effects of SP600125 on paraquat-induced ALI was investigated according to oxidative stress, inflammation, and apoptosis.  The rats were randomly assigned into the control group (CON), the paraquat poisoning group (PQ), and the PQ + SP600125 group (SP).  A549 cells were divided into the Con group, Pq group, and Sp group.  H&E staining and detection of lung wet/dry ratio were employed to evaluate lung injury.  Annexin V-PI staining was done to evaluate A549 cell apoptosis.  Dihydroethidium fluorescence was used to measure reactive oxygen species (ROS) in the lungs and A549 cells.  ELISA was performed to detect TNF-α and IL-6 in the supernatant of bronchoalveolar lavage fluid (BALF) and A549 cells.  RT-qPCR was done to measure the mRNA (mRNA) expression of TNF-α and IL-6 in the lungs and A549 cells.  Western blotting assay was performed to detect the protein expression of phospho-JNK, total JNK, and cleaved caspase-3.  Electrophoretic mobility shift assay was employed to detect the DNA binding activities of AP-1 and P-p65.  JNK inhibitor SP600125 reduced JNK phosphorylation, downregulated cleaved caspase-3 protein level, decreased AP-1 transcriptional activity and ROS level, and reduced the transcription and expression of TNF-α and IL-6, which improved ALI and cell apoptosis after paraquat poisoning.  Our results indicate that JNK/AP-1 mediates ALI as well as oxidative stress and inflammation deterioration secondary to paraquat poisoning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp61hG43Jlvx7Vg90H21EOLACvtfcHk0lhEPhne0Wbzsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFait7Y%253D&md5=9f83f1279e08c875c2ede1b3f1f4cc45</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10753-017-0575-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10753-017-0575-8%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DM.%26atitle%3DJNK%2520inhibitor%2520SP600125%2520attenuates%2520paraquat-induced%2520acute%2520lung%2520injury%253A%2520an%2520in%2520vivo%2520and%2520in%2520vitro%2520study%26jtitle%3DInflammation%26date%3D2017%26volume%3D40%26spage%3D1319%26epage%3D1330%26doi%3D10.1007%2Fs10753-017-0575-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, D.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lograsso, P.</span></span> <span> </span><span class="NLM_article-title">Small molecule c-Jun-N-terminal kinase (JNK) inhibitors protect dopaminergic neurons in a model of Parkinson’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.1021/cn100109k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100109k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFalsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=198-206&author=J.+W.+Chambersauthor=A.+Pachoriauthor=S.+Howardauthor=M.+Gannoauthor=D.+Hansenauthor=T.+Kameneckaauthor=X.+Songauthor=D.+Duckettauthor=W.+Chenauthor=Y.+Y.+Lingauthor=L.+Cherryauthor=M.+D.+Cameronauthor=L.+Linauthor=C.+H.+Ruizauthor=P.+Lograsso&title=Small+molecule+c-Jun-N-terminal+kinase+%28JNK%29+inhibitors+protect+dopaminergic+neurons+in+a+model+of+Parkinson%E2%80%99s+disease&doi=10.1021%2Fcn100109k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson's Disease</span></div><div class="casAuthors">Chambers, Jeremy W.; Pachori, Alok; Howard, Shannon; Ganno, Michelle; Hansen, Donald; Kamenecka, Ted; Song, Xinyi; Duckett, Derek; Chen, Weimin; Ling, Yuan Yuan; Cherry, Lisa; Cameron, Michael D.; Lin, Li; Ruiz, Claudia H.; LoGrasso, Philip</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">198-206</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are currently no drugs to treat neurodegeneration in Parkinson's disease (PD), and all existing medications only treat symptoms, lose efficacy over time, and produce untoward side effects.  In the current work, we report the first highly selective, orally bioavailable c-jun-N-terminal kinase (JNK) inhibitor for protection of dopaminergic neurons in vitro and in vivo.  At 300 nM, this compd. showed statistically significant protection of primary dopaminergic neurons exposed to 1-methyl-4-phenylpyridinium (MPP+), had pharmacokinetic properties in rodents consistent with twice daily (b.i.d.) dosing, and was orally efficacious at 30 mg/kg in a mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson's disease.  Moreover, a dose-dependent target modulation of c-jun phosphorylation served as a biomarker for demonstrating on-target inhibition of JNK as the mechanism of action for this compd.  Collectively, these results suggest that this JNK inhibitor could be a promising therapeutic neuroprotective agent in the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr64E9S-UR66bVg90H21EOLACvtfcHk0lhEPhne0Wbzsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFalsb0%253D&md5=b68177290319f0922a59743440d557e7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcn100109k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100109k%26sid%3Dliteratum%253Aachs%26aulast%3DChambers%26aufirst%3DJ.%2BW.%26aulast%3DPachori%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DGanno%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DD.%26aulast%3DKamenecka%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DDuckett%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLing%26aufirst%3DY.%2BY.%26aulast%3DCherry%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DRuiz%26aufirst%3DC.%2BH.%26aulast%3DLograsso%26aufirst%3DP.%26atitle%3DSmall%2520molecule%2520c-Jun-N-terminal%2520kinase%2520%2528JNK%2529%2520inhibitors%2520protect%2520dopaminergic%2520neurons%2520in%2520a%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D198%26epage%3D206%26doi%3D10.1021%2Fcn100109k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graczyk, P. P.</span></span> <span> </span><span class="NLM_article-title">JNK inhibitors as anti-inflammatory and neuroprotective agents</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.4155/fmc.13.34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.4155%2Ffmc.13.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=23573972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsF2nsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=539-551&author=P.+P.+Graczyk&title=JNK+inhibitors+as+anti-inflammatory+and+neuroprotective+agents&doi=10.4155%2Ffmc.13.34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">JNK inhibitors as anti-inflammatory and neuroprotective agents</span></div><div class="casAuthors">Graczyk, Piotr P.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">539-551</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  JNK is involved in a broad range of physiol. processes.  Several inflammatory and neurodegenerative diseases, such as multiple sclerosis, Alzheimer's and Parkinson's disease have been linked with the dysregulated JNK pathway.  Research on disease models using the relevant knockout mice has highlighted the importance of specific JNK isoforms in particular disorders and has stimulated further efforts in the drug-discovery area.  However, most of the exptl. evidence for the efficacy of JNK inhibition in animal models is from studies using JNK inhibitors, which are not isoform selective.  Some of the more recent compds. exhibit good oral bioavailability, CNS penetration and selectivity against the rest of the kinome.  Efforts to design isoform-selective inhibitors have produced a no. of examples with various selectivity profiles.  This article presents recent progress in this area and comment on the role of isoform selectivity for efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqFxJRbS2D57Vg90H21EOLACvtfcHk0lhEPhne0Wbzsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsF2nsL0%253D&md5=5b60481d1f6347aab1c3f0ead1c8eede</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.34%26sid%3Dliteratum%253Aachs%26aulast%3DGraczyk%26aufirst%3DP.%2BP.%26atitle%3DJNK%2520inhibitors%2520as%2520anti-inflammatory%2520and%2520neuroprotective%2520agents%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D539%26epage%3D551%26doi%3D10.4155%2Ffmc.13.34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leisten, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motiwala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagwat, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. W.</span></span> <span> </span><span class="NLM_article-title">SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">13681</span>– <span class="NLM_lpage">13686</span>, <span class="refDoi"> DOI: 10.1073/pnas.251194298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1073%2Fpnas.251194298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=11717429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVynsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=13681-13686&author=B.+L.+Bennettauthor=D.+T.+Sasakiauthor=B.+W.+Murrayauthor=E.+C.+O%E2%80%99Learyauthor=S.+T.+Sakataauthor=W.+Xuauthor=J.+C.+Leistenauthor=A.+Motiwalaauthor=S.+Pierceauthor=Y.+Satohauthor=S.+S.+Bhagwatauthor=A.+M.+Manningauthor=D.+W.+Anderson&title=SP600125%2C+an+anthrapyrazolone+inhibitor+of+Jun+N-terminal+kinase&doi=10.1073%2Fpnas.251194298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase</span></div><div class="casAuthors">Bennett, Brydon L.; Sasaki, Dennis T.; Murray, Brion W.; O'Leary, Eoin C.; Sakata, Steve T.; Xu, Weiming; Leisten, Jim C.; Motiwala, Aparna; Pierce, Steve; Satoh, Yoshitaka; Bhagwat, Shripad S.; Manning, Anthony M.; Anderson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13681-13686</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Jun N-terminal kinase (JNK) is a stress-activated protein kinase that can be induced by inflammatory cytokines, bacterial endotoxin, osmotic shock, UV radiation, and hypoxia.  We report the identification of an anthrapyrazolone series with significant inhibition of JNK1, -2, and -3 (Ki = 0.19 μM).  SP600125 is a reversible ATP-competitive inhibitor with >20-fold selectivity vs. a range of kinases and enzymes tested.  In cells, SP600125 dose-dependently inhibited the phosphorylation of c-Jun, the expression of inflammatory genes COX-2, IL-2, IFN-γ, TNF-α, and prevented the activation and differentiation of primary human CD4 cell cultures.  In animal studies, SP600125 blocked (bacterial) lipopolysaccharide-induced expression of tumor necrosis factor-α and inhibited anti-CD3-induced apoptosis of CD4+ CD8+ thymocytes.  Our study supports targeting JNK as an important strategy in inflammatory disease, apoptotic cell death, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3oaSuth8djbVg90H21EOLACvtfcHk0ljspkAw5u04Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVynsbg%253D&md5=011499f96b13981c568d06120ba0a740</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.251194298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.251194298%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DB.%2BL.%26aulast%3DSasaki%26aufirst%3DD.%2BT.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DE.%2BC.%26aulast%3DSakata%26aufirst%3DS.%2BT.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLeisten%26aufirst%3DJ.%2BC.%26aulast%3DMotiwala%26aufirst%3DA.%26aulast%3DPierce%26aufirst%3DS.%26aulast%3DSatoh%26aufirst%3DY.%26aulast%3DBhagwat%26aufirst%3DS.%2BS.%26aulast%3DManning%26aufirst%3DA.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BW.%26atitle%3DSP600125%252C%2520an%2520anthrapyrazolone%2520inhibitor%2520of%2520Jun%2520N-terminal%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D13681%26epage%3D13686%26doi%3D10.1073%2Fpnas.251194298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedi, K. L.</span></span> <span> </span><span class="NLM_article-title">SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats</span>. <i>Pharmacol. Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2010.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.pbb.2010.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=20600246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2010&pages=386-394&author=N.+Sharmaauthor=R.+Deshmukhauthor=K.+L.+Bedi&title=SP600125%2C+a+competitive+inhibitor+of+JNK+attenuates+streptozotocin+induced+neurocognitive+deficit+and+oxidative+stress+in+rats&doi=10.1016%2Fj.pbb.2010.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats</span></div><div class="casAuthors">Sharma, Nidhi; Deshmukh, Rahul; Bedi, K. L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">386-394</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activated JNK has been reported to be located in nucleus in mild cases of Alzheimer's disease (AD), but is exclusively in cytoplasm in more advanced stages of AD and implicated in its pathogenesis, suggesting that activation and re-distribution of JNK correlate with the progress of AD.  The present study was designed to investigate the role of JNK in intracerebroventricular streptozotocin (i.c.v. STZ) induced cognitive impairment and oxidative stress.  Streptozotocin has been obsd. to impair learning and memory, increase oxidative-nitritive stress, induce cholinergic hypofunction and neuronal damage in rat brain.  Chronic treatment with SP600125 from day 10 to 28 following i.c.v. STZ injections significantly improved spatial memory, attenuate oxidative-nitritive stress.  In addn., significant increase in acetylcholinesterase activity and lactate dehydrogenase (LDH) levels was obsd. in the present model indicating cholinergic hypofunction and increase in neuronal cell damage.  Whereas, SP600125 treatment significantly restored acetylcholinesterase activity and reduced LDH levels indicating restorative capacity of SP600125 with respect to cholinergic functions and preventing the neuronal damage.  In line with previous report, the current study also supports the potential of JNK inhibition as a possible therapeutic strategy to ameliorate neurodegenerative disorders assocd. with oxidative stress and cognitive impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSQpQLt3UsHrVg90H21EOLACvtfcHk0ljspkAw5u04Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtLjE&md5=573872186130882faeccef35ec52039e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2010.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2010.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DDeshmukh%26aufirst%3DR.%26aulast%3DBedi%26aufirst%3DK.%2BL.%26atitle%3DSP600125%252C%2520a%2520competitive%2520inhibitor%2520of%2520JNK%2520attenuates%2520streptozotocin%2520induced%2520neurocognitive%2520deficit%2520and%2520oxidative%2520stress%2520in%2520rats%26jtitle%3DPharmacol.%2520Biochem.%2520Behav.%26date%3D2010%26volume%3D96%26spage%3D386%26epage%3D394%26doi%3D10.1016%2Fj.pbb.2010.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W. X.</span></span> <span> </span><span class="NLM_article-title">SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrest</span>. <i>Pharmazie</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">942</span>– <span class="NLM_lpage">946</span>, <span class="refDoi"> DOI: 10.1691/ph.2012.1849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1691%2Fph.2012.1849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=23210245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVOi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=942-946&author=J.+Y.+Liauthor=J.+Y.+Huangauthor=B.+Xingauthor=K.+W.+Renauthor=M.+Liauthor=D.+Weiauthor=P.+Y.+Guauthor=G.+Chenauthor=B.+Guauthor=G.+F.+Zhangauthor=W.+X.+Hu&title=SP600125%2C+a+JNK+inhibitor%2C+suppresses+growth+of+JNK-inactive+glioblastoma+cells+through+cell-cycle+G2%2FM+phase+arrest&doi=10.1691%2Fph.2012.1849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrest</span></div><div class="casAuthors">Li, J. Y.; Huang, J. Y.; Xing, B.; Ren, K. W.; Li, M.; Wei, D.; Gu, P. Y.; Chen, G.; Gu, B.; Zhang, G. F.; Hu, W. X.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmazie</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">942-946</span>CODEN:
                <span class="NLM_cas:coden">PHARAT</span>;
        ISSN:<span class="NLM_cas:issn">0031-7144</span>.
    
            (<span class="NLM_cas:orgname">Govi-Verlag Pharmazeutischer Verlag GmbH</span>)
        </div><div class="casAbstract">SP600125 is a well studied inhibitor of c-Jun N-terminal kinase (JNK).  Its direct biochem. effects on JNK-inactive tumor cells are usually ignored.  In this study, we investigated the effects of SP600125 on JNK-inactive U251 human glioblastoma cells.  Our results demonstrate that, 20 μM or more SP600125 can induce significant cell growth inhibition and cell-cycle G2/M phase arrest in U251 cells.  Interestingly, we also found that SP600125 can stop the duplicated chromosomes from sepg. into two cells and the karyokinesis progression.  Our study opened up a new perspective for further studies involved in JNK inhibitors or anti-glioma therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmEKvzwbPPjLVg90H21EOLACvtfcHk0ljspkAw5u04Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVOi&md5=450e7f37a1a75cef6ecbacc3a72f9a8c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1691%2Fph.2012.1849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1691%252Fph.2012.1849%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BY.%26aulast%3DHuang%26aufirst%3DJ.%2BY.%26aulast%3DXing%26aufirst%3DB.%26aulast%3DRen%26aufirst%3DK.%2BW.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DP.%2BY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DG.%2BF.%26aulast%3DHu%26aufirst%3DW.%2BX.%26atitle%3DSP600125%252C%2520a%2520JNK%2520inhibitor%252C%2520suppresses%2520growth%2520of%2520JNK-inactive%2520glioblastoma%2520cells%2520through%2520cell-cycle%2520G2%252FM%2520phase%2520arrest%26jtitle%3DPharmazie%26date%3D2012%26volume%3D67%26spage%3D942%26epage%3D946%26doi%3D10.1691%2Fph.2012.1849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anand, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruthi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, P. P.</span></span> <span> </span><span class="NLM_article-title">The specific, reversible JNK inhibitor SP600125 improves survivability and attenuates neuronal cell death in experimental cerebral malaria (ECM)</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1959</span>– <span class="NLM_lpage">1966</span>, <span class="refDoi"> DOI: 10.1007/s00436-013-3352-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1007%2Fs00436-013-3352-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=23455938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A280%3ADC%252BC3svislWgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2013&pages=1959-1966&author=S.+S.+Anandauthor=M.+Maruthiauthor=P.+P.+Babu&title=The+specific%2C+reversible+JNK+inhibitor+SP600125+improves+survivability+and+attenuates+neuronal+cell+death+in+experimental+cerebral+malaria+%28ECM%29&doi=10.1007%2Fs00436-013-3352-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The specific, reversible JNK inhibitor SP600125 improves survivability and attenuates neuronal cell death in experimental cerebral malaria (ECM)</span></div><div class="casAuthors">Anand Sripada Santosh; Maruthi Mulaka; Babu Phanithi Prakash</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1959-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cerebral malaria (CM) is the most severe complication of Plasmodium falciparum in humans and major cause of death.  SP600125 is a specific, small molecule inhibitor of JNK that prevents the phosphorylation of c-Jun and blocks the expression of proinflammatory cytokines and attenuates neuronal apoptosis in several neurodegenerative disorders.  We evaluated the effect of SP600125 treatment on the survival of Plasmodium berghei ANKA (PbA)-infected C57BL/6J mice.  Administration of SP600125 improved survival in PbA-infected C57BL6J mice but has no effect on parasitemia.  Further, SP600125 administration resulted in attenuation of neuronal cell death along with inhibition of proinflammatory mediators TNF-α and COX-2 and proapoptotic mediators p-c-Jun and active caspase 3 in PbA-infected mice.  The promising findings of this study make SP600125 a potential agent for supportive therapy to alleviate inflammation and neuronal cell death associated with CM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7MlQKb0V41cScOqQTSkOffW6udTcc2eYfUz7Oeb0gqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svislWgsQ%253D%253D&md5=09f4bee1fd760200645930b57943c100</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00436-013-3352-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-013-3352-0%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DS.%2BS.%26aulast%3DMaruthi%26aufirst%3DM.%26aulast%3DBabu%26aufirst%3DP.%2BP.%26atitle%3DThe%2520specific%252C%2520reversible%2520JNK%2520inhibitor%2520SP600125%2520improves%2520survivability%2520and%2520attenuates%2520neuronal%2520cell%2520death%2520in%2520experimental%2520cerebral%2520malaria%2520%2528ECM%2529%26jtitle%3DParasitol.%2520Res.%26date%3D2013%26volume%3D112%26spage%3D1959%26epage%3D1966%26doi%3D10.1007%2Fs00436-013-3352-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halazy, S.</span></span> <span> </span><span class="NLM_article-title">Designing heterocyclic selective kinase inhibitors: from concept to new drug candidates</span>. <i>ARKIVOC</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_fpage">496</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.3998/ark.5550190.0007.734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.3998%2Fark.5550190.0007.734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1eqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=496-508&author=S.+Halazy&title=Designing+heterocyclic+selective+kinase+inhibitors%3A+from+concept+to+new+drug+candidates&doi=10.3998%2Fark.5550190.0007.734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Designing heterocyclic selective kinase inhibitors: from concept to new drug candidates</span></div><div class="casAuthors">Halazy, Serge</div><div class="citationInfo"><span class="NLM_cas:title">ARKIVOC (Gainesville, FL, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">496-508</span>CODEN:
                <span class="NLM_cas:coden">AGFUAR</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Arkat USA Inc.</span>)
        </div><div class="casAbstract">Kinases represent one of the most popular and promising target class in drug discovery.  Success in finding new therapeutics will depend on the validation of the kinase chosen with respect to the disease of interest, and on the ability of chemists to design and synthesize inhibitors which are selective for this particular kinase.  One of the most powerful validation tool for kinases is the Analog-Sensitive Kinase Allele (ASKA) technol., where chemists and biologists have engineered modified kinases and inhibitors by generating functionally active kinase mutants which are specifically inhibited by a chem. modified inhibitor, thus allowing to study specific responses in knock-in animals.  The design of selective, ATP competitive kinase inhibitors has been successfully achieved by combining different technologies like computational chem., structure-based design and combinatorial chem. as illustrated by the discovery of AS602801, a potent and selective JNK inhibitor with therapeutic potential in MS and fibrosis.  The exploration of non ATP-competitive inhibitors is also very promising, as illustrated by the case of MEK inhibitors which show strong interest as anti-cancer agents.  In the future, the rationale design of selective kinase inhibitors will move to the design of compds. that will induce a selective perturbation of cell regulation, where kinases play a crit. role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaVzLpUfqHObVg90H21EOLACvtfcHk0ljxaBW3nU2uaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1eqtbY%253D&md5=c3d6d5846564619e75877588d0131bda</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3998%2Fark.5550190.0007.734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3998%252Fark.5550190.0007.734%26sid%3Dliteratum%253Aachs%26aulast%3DHalazy%26aufirst%3DS.%26atitle%3DDesigning%2520heterocyclic%2520selective%2520kinase%2520inhibitors%253A%2520from%2520concept%2520to%2520new%2520drug%2520candidates%26jtitle%3DARKIVOC%26date%3D2006%26spage%3D496%26epage%3D508%26doi%3D10.3998%2Fark.5550190.0007.734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tos, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotteland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osteen, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruner-Tran, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nataraja, S. G.</span></span> <span> </span><span class="NLM_article-title">Bentamapimod (JNK inhibitor AS602801) induces regression of endometriotic lesions in animal models</span>. <i>Reprod. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1177/1933719115600553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1177%2F1933719115600553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=26335175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVensrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=11-23&author=S.+S.+Palmerauthor=M.+Altanauthor=D.+Denisauthor=E.+G.+Tosauthor=J.+P.+Gottelandauthor=K.+G.+Osteenauthor=K.+L.+Bruner-Tranauthor=S.+G.+Nataraja&title=Bentamapimod+%28JNK+inhibitor+AS602801%29+induces+regression+of+endometriotic+lesions+in+animal+models&doi=10.1177%2F1933719115600553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Bentamapimod (JNK inhibitor AS602801) induces regression of endometriotic lesions in animal models</span></div><div class="casAuthors">Palmer, Stephen S.; Altan, Melis; Denis, Deborah; Tos, Enrico Gillio; Gotteland, Jean-Pierre; Osteen, Kevin G.; Bruner-Tran, Kaylon L.; Nataraja, Selvaraj G.</div><div class="citationInfo"><span class="NLM_cas:title">Reproductive Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-23</span>CODEN:
                <span class="NLM_cas:coden">RSECC3</span>;
        ISSN:<span class="NLM_cas:issn">1933-7191</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Endometriosis is an estrogen (ER)-dependent gynecol. disease caused by the growth of endometrial tissue at extrauterine sites.  Current endocrine therapies address the estrogenic aspect of disease and offer some relief from pain but are assocd. with significant side effects.  Immune dysfunction is also widely believed to be an underlying contributor to the pathogenesis of this disease.  This study evaluated an inhibitor of c-Jun N-terminal kinase, bentamapimod (AS602801), which interrupts immune pathways, in 2 rodent endometriosis models.  Treatment of nude mice bearing xenografts biopsied from women with endometriosis (BWE) with 30 mg/kg AS602801 caused 29% regression of lesion.  Medroxyprogesterone acetate (MPA) or progesterone (PR) alone did not cause regression of BWE lesions, but combining 10 mg/kg AS602801 with MPA caused 38% lesion regression.  In human endometrial organ cultures (from healthy women), treatment with AS602801 or MPA reduced matrix metalloproteinase-3 (MMP-3) release into culture medium.  In organ cultures established with BWE, PR or MPA failed to inhibit MMP-3 secretion, whereas AS602801 alone or MPA + AS602801 suppressed MMP-3 prodn.  In an autologous rat endometriosis model, AS602801 caused 48% regression of lesions compared to GnRH antagonist Antide (84%).  AS602801 reduced inflammatory cytokines in endometriotic lesions, while levels of cytokines in ipsilateral horns were unaffected.  Furthermore, AS602801 enhanced natural killer cell activity, without apparent neg. effects on uterus.  These results indicate that bentamapimod induced regression of endometriotic lesions in endometriosis rodent animal models without suppressing ER action. c-Jun N-terminal kinase inhibition mediated a comprehensive redn. in cytokine secretion and moreover was able to overcome PR resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5FGFNcm6HpLVg90H21EOLACvtfcHk0ljxaBW3nU2uaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVensrY%253D&md5=f8604d4855f38f0a3888a59cf27f463e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1177%2F1933719115600553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1933719115600553%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DS.%2BS.%26aulast%3DAltan%26aufirst%3DM.%26aulast%3DDenis%26aufirst%3DD.%26aulast%3DTos%26aufirst%3DE.%2BG.%26aulast%3DGotteland%26aufirst%3DJ.%2BP.%26aulast%3DOsteen%26aufirst%3DK.%2BG.%26aulast%3DBruner-Tran%26aufirst%3DK.%2BL.%26aulast%3DNataraja%26aufirst%3DS.%2BG.%26atitle%3DBentamapimod%2520%2528JNK%2520inhibitor%2520AS602801%2529%2520induces%2520regression%2520of%2520endometriotic%2520lesions%2520in%2520animal%2520models%26jtitle%3DReprod.%2520Sci.%26date%3D2016%26volume%3D23%26spage%3D11%26epage%3D23%26doi%3D10.1177%2F1933719115600553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span>NCT01630252.
JNK ClinicalTrials.gov. <a href="https://clinicaltrials.gov/" class="extLink">https://clinicaltrials.gov/</a> (accessed Mar 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=NCT01630252.%0AJNK+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2F+%28accessed+Mar+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krenitsky, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadolny, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clareen, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgraf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Sidocky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapienza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahmanyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muir, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celeridad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachowitzer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moghaddam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatsenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benish, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodine, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blease, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cathers, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1438</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.bmcl.2011.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=22244937" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1433-1438&author=V.+P.+Krenitskyauthor=L.+Nadolnyauthor=M.+Delgadoauthor=L.+Ayalaauthor=S.+S.+Clareenauthor=R.+Hilgrafauthor=R.+Albersauthor=S.+Hegdeauthor=N.+D%E2%80%99Sidockyauthor=J.+Sapienzaauthor=J.+Wrightauthor=M.+McCarrickauthor=S.+Bahmanyarauthor=P.+Chamberlainauthor=S.+L.+Delkerauthor=J.+Muirauthor=D.+Giegelauthor=L.+Xuauthor=M.+Celeridadauthor=J.+Lachowitzerauthor=B.+Bennettauthor=M.+Moghaddamauthor=O.+Khatsenkoauthor=J.+Katzauthor=R.+Fanauthor=A.+Baiauthor=Y.+Tangauthor=M.+A.+Shirleyauthor=B.+Benishauthor=T.+Bodineauthor=K.+Bleaseauthor=H.+Raymonauthor=B.+E.+Cathersauthor=Y.+Satoh&title=Discovery+of+CC-930%2C+an+orally+active+anti-fibrotic+JNK+inhibitor&doi=10.1016%2Fj.bmcl.2011.12.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DKrenitsky%26aufirst%3DV.%2BP.%26aulast%3DNadolny%26aufirst%3DL.%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DAyala%26aufirst%3DL.%26aulast%3DClareen%26aufirst%3DS.%2BS.%26aulast%3DHilgraf%26aufirst%3DR.%26aulast%3DAlbers%26aufirst%3DR.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Sidocky%26aufirst%3DN.%26aulast%3DSapienza%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DMcCarrick%26aufirst%3DM.%26aulast%3DBahmanyar%26aufirst%3DS.%26aulast%3DChamberlain%26aufirst%3DP.%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DMuir%26aufirst%3DJ.%26aulast%3DGiegel%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DCeleridad%26aufirst%3DM.%26aulast%3DLachowitzer%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DB.%26aulast%3DMoghaddam%26aufirst%3DM.%26aulast%3DKhatsenko%26aufirst%3DO.%26aulast%3DKatz%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DR.%26aulast%3DBai%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DShirley%26aufirst%3DM.%2BA.%26aulast%3DBenish%26aufirst%3DB.%26aulast%3DBodine%26aufirst%3DT.%26aulast%3DBlease%26aufirst%3DK.%26aulast%3DRaymon%26aufirst%3DH.%26aulast%3DCathers%26aufirst%3DB.%2BE.%26aulast%3DSatoh%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520CC-930%252C%2520an%2520orally%2520active%2520anti-fibrotic%2520JNK%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1433%26epage%3D1438%26doi%3D10.1016%2Fj.bmcl.2011.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span>NCT01466725,
NCT01203943. JNK ClinicalTrials.gov. <a href="https://clinicaltrials.gov/" class="extLink">https://clinicaltrials.gov/</a> (accessed Mar 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=NCT01466725%2C%0ANCT01203943.+JNK+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2F+%28accessed+Mar+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoGrasso, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of highly potent and isoform selective JNK3 inhibitors: SAR studies on aminopyrazole derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10013</span>– <span class="NLM_lpage">10030</span>, <span class="refDoi"> DOI: 10.1021/jm501256y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501256y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWns7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10013-10030&author=K.+Zhengauthor=S.+Iqbalauthor=P.+Hernandezauthor=H.+Parkauthor=P.+V.+LoGrassoauthor=Y.+Feng&title=Design+and+synthesis+of+highly+potent+and+isoform+selective+JNK3+inhibitors%3A+SAR+studies+on+aminopyrazole+derivatives&doi=10.1021%2Fjm501256y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole Derivatives</span></div><div class="casAuthors">Zheng, Ke; Iqbal, Sarah; Hernandez, Pamela; Park, HaJeung; LoGrasso, Philip V.; Feng, Yangbo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10013-10030</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The c-jun N-terminal kinase 3 (JNK3) is expressed primarily in the brain.  Numerous reports have shown that inhibition of JNK3 is a promising strategy for treatment of neurodegeneration.  The optimization of aminopyrazole-based JNK3 inhibitors with improved potency, isoform selectivity, and pharmacol. properties by structure-activity relationship (SAR) studies utilizing biochem. and cell-based assays, and structure-based drug design is reported.  These inhibitors had high selectivity over JNK1 and p38α, minimal cytotoxicity, potent inhibition of 6-OHDA-induced mitochondrial membrane potential dissipation and ROS generation, and good drug metab. and pharmacokinetic (DMPK) properties for iv dosing. 26n was profiled against 464 kinases and was found to be highly selective hitting only seven kinases with >80% inhibition at 10 μM.  Moreover, 26n showed good soly., good brain penetration, and good DMPK properties.  Finally, the crystal structure of 26k in complex with JNK3 was solved at 1.8 Å to explore the binding mode of aminopyrazole based JNK3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLNAzFBTMXr7Vg90H21EOLACvtfcHk0lhtK5P0wZ1QQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWns7fJ&md5=fd826c83f112d7270ef669b74e6ef6f0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm501256y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501256y%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DIqbal%26aufirst%3DS.%26aulast%3DHernandez%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DFeng%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520highly%2520potent%2520and%2520isoform%2520selective%2520JNK3%2520inhibitors%253A%2520SAR%2520studies%2520on%2520aminopyrazole%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10013%26epage%3D10030%26doi%3D10.1021%2Fjm501256y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Messoussi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feneyrolles, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deroide, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayde-Cazals, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheve, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hijfte, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauvel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougrin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasri, A.</span></span> <span> </span><span class="NLM_article-title">Recent progress in the design, study, and development of c-jun N-terminal kinase inhibitors as anticancer agents</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1443</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2014.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.chembiol.2014.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=25442375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOrtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1433-1443&author=A.+Messoussiauthor=C.+Feneyrollesauthor=A.+Brosauthor=A.+Deroideauthor=B.+Dayde-Cazalsauthor=G.+Cheveauthor=N.+Van+Hijfteauthor=B.+Fauvelauthor=K.+Bougrinauthor=A.+Yasri&title=Recent+progress+in+the+design%2C+study%2C+and+development+of+c-jun+N-terminal+kinase+inhibitors+as+anticancer+agents&doi=10.1016%2Fj.chembiol.2014.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Design, Study, and Development of c-Jun N-Terminal Kinase Inhibitors as Anticancer Agents</span></div><div class="casAuthors">Messoussi, Abdellah; Feneyrolles, Clemence; Bros, Aurelie; Deroide, Arthur; Dayde-Cazals, Benedicte; Cheve, Gwenael; Van Hijfte, Nathalie; Fauvel, Benedicte; Bougrin, Khalid; Yasri, Aziz</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1433-1443</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The c-Jun N-terminal kinase (JNK) family, with its three members JNK1, JNK2, and JNK3, is a subfamily of mitogen-activated protein kinases.  Involved in many aspects of cellular processes, JNK has been also assocd. with pathol. states such as neurodegenerative diseases, inflammation, and cancers.  In oncol., each isoform plays a distinct role depending on the context of the targeted tissue/organ, the tumor stage, and, most likely, the signaling pathway activated upstream.  Consequently, the current challenge in finding new successful anti-JNK therapies is to design isoform-selective inhibitors of the JNKs.  In this review, a particular focus is given to the JNK inhibitors that have been developed thus far when examg. 3D structures of various JNK-inhibitor complexes.  Using current data regarding structure-activity relationships and medicinal chem. approaches, our objective is to provide a better understanding of the design and development of selective JNK inhibitors in the present and future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3mHBbGq0JBrVg90H21EOLACvtfcHk0lhtK5P0wZ1QQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOrtLzI&md5=3efe4c042059334f46ae5725e811c32d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DMessoussi%26aufirst%3DA.%26aulast%3DFeneyrolles%26aufirst%3DC.%26aulast%3DBros%26aufirst%3DA.%26aulast%3DDeroide%26aufirst%3DA.%26aulast%3DDayde-Cazals%26aufirst%3DB.%26aulast%3DCheve%26aufirst%3DG.%26aulast%3DVan%2BHijfte%26aufirst%3DN.%26aulast%3DFauvel%26aufirst%3DB.%26aulast%3DBougrin%26aufirst%3DK.%26aulast%3DYasri%26aufirst%3DA.%26atitle%3DRecent%2520progress%2520in%2520the%2520design%252C%2520study%252C%2520and%2520development%2520of%2520c-jun%2520N-terminal%2520kinase%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D1433%26epage%3D1443%26doi%3D10.1016%2Fj.chembiol.2014.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muth, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doring, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druckes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothbauer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Tetra-substituted pyridinylimidazoles as dual inhibitors of p38alpha mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.1021/jm501557a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501557a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=443-456&author=F.+Muthauthor=M.+Guntherauthor=S.+M.+Bauerauthor=E.+Doringauthor=S.+Fischerauthor=J.+Maierauthor=P.+Druckesauthor=J.+Kopplerauthor=J.+Trappeauthor=U.+Rothbauerauthor=P.+Kochauthor=S.+A.+Laufer&title=Tetra-substituted+pyridinylimidazoles+as+dual+inhibitors+of+p38alpha+mitogen-activated+protein+kinase+and+c-Jun+N-terminal+kinase+3+for+potential+treatment+of+neurodegenerative+diseases&doi=10.1021%2Fjm501557a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases</span></div><div class="casAuthors">Muth, Felix; Guenther, Marcel; Bauer, Silke M.; Doering, Eva; Fischer, Sabine; Maier, Julia; Drueckes, Peter; Koeppler, Juergen; Trappe, Joerg; Rothbauer, Ulrich; Koch, Pierre; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">443-456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tetra-substituted imidazoles were designed as dual inhibitors of c-Jun N-terminal kinase (JNK) 3 and p38α mitogen-activated protein (MAP) kinase.  A library of 45 derivs. was prepd. and evaluated in a kinase activity assay for their ability to inhibit both kinases, JNK3 and p38α MAP kinase.  Dual inhibitors with IC50 values down to the low double-digit nanomolar range at both enzymes were identified.  The best balanced dual JNK3/p38α MAP kinase inhibitors are I (IC50: JNK3, 18 nM; p38α, 30 nM) and II (IC50: JNK3, 26 nM; p38α, 34 nM) featuring both excellent soly. and metabolic stability.  They may serve as useful tool compds. for preclin. proof-of-principle studies in order to validate the synergistic role of both kinases in the progression of Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNwp_1AD67j7Vg90H21EOLACvtfcHk0li0VB8PuawFdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FJ&md5=3b17ce2ed0396efcee28302d6f6910e7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm501557a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501557a%26sid%3Dliteratum%253Aachs%26aulast%3DMuth%26aufirst%3DF.%26aulast%3DGunther%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DDoring%26aufirst%3DE.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DMaier%26aufirst%3DJ.%26aulast%3DDruckes%26aufirst%3DP.%26aulast%3DKoppler%26aufirst%3DJ.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DRothbauer%26aufirst%3DU.%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DTetra-substituted%2520pyridinylimidazoles%2520as%2520dual%2520inhibitors%2520of%2520p38alpha%2520mitogen-activated%2520protein%2520kinase%2520and%2520c-Jun%2520N-terminal%2520kinase%25203%2520for%2520potential%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D443%26epage%3D456%26doi%3D10.1021%2Fjm501557a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarza, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, M. J.</span></span> <span> </span><span class="NLM_article-title">c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer’s disease</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">321</span>, <span class="refDoi"> DOI: 10.3389/fphar.2015.00321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.3389%2Ffphar.2015.00321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=26793112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=321&author=R.+Yarzaauthor=S.+Velaauthor=M.+Solasauthor=M.+J.+Ramirez&title=c-Jun+N-terminal+kinase+%28JNK%29+signaling+as+a+therapeutic+target+for+Alzheimer%E2%80%99s+disease&doi=10.3389%2Ffphar.2015.00321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer's disease</span></div><div class="casAuthors">Yarza, Ramon; Vela, Silvia; Solas, Maite; Ramirez, Maria J.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">321/1-321/12</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">C-Jun N-terminal kinases (JNKs) are a family of protein kinases that play a central role in stress signaling pathways implicated in gene expression, neuronal plasticity, regeneration, cell death, and regulation of cellular senescence.  It has been shown that there is a JNK pathway activation after exposure to different stressing factors, including cytokines, growth factors, oxidative stress, unfolded protein response signals or Aβ peptides.  Altogether, JNKs have become a focus of screening strategies searching for new therapeutic approaches to diabetes, cancer or liver diseases.  In addn., activation of JNK has been identified as a key element responsible for the regulation of apoptosis signals and therefore, it is crit. for pathol. cell death assocd. with neurodegenerative diseases and, among them, with Alzheimer's disease (AD).  In addn., in vitro and in vivo studies have reported alterations of JNK pathways potentially assocd. with pathogenesis and neuronal death in AD.  JNK's, particularly JNK3, not only enhance Aβ prodn., moreover it plays a key role in the maturation and development of neurofibrillary tangles.  This review aims to explain the rationale behind testing therapies based on inhibition of JNK signaling for AD in terms of current knowledge about the pathophysiol. of the disease.  Keeping in mind that JNK3 is specifically expressed in the brain and activated by stress-stimuli, it is possible to hypothesize that inhibition of JNK3 might be considered as a potential target for treating neurodegenerative mechanisms assocd. with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL1r26YWz0XrVg90H21EOLACvtfcHk0li0VB8PuawFdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSiug%253D%253D&md5=bb9c3d594b4414dca03e66af69f231ee</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2015.00321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2015.00321%26sid%3Dliteratum%253Aachs%26aulast%3DYarza%26aufirst%3DR.%26aulast%3DVela%26aufirst%3DS.%26aulast%3DSolas%26aufirst%3DM.%26aulast%3DRamirez%26aufirst%3DM.%2BJ.%26atitle%3Dc-Jun%2520N-terminal%2520kinase%2520%2528JNK%2529%2520signaling%2520as%2520a%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Pharmacol.%26date%3D2015%26volume%3D6%26spage%3D321%26doi%3D10.3389%2Ffphar.2015.00321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antoniou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falconi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borsello, T.</span></span> <span> </span><span class="NLM_article-title">JNK3 as a therapeutic target for neurodegenerative diseases</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.3233/JAD-2011-091567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.3233%2FJAD-2011-091567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=21321401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFyrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=633-642&author=X.+Antoniouauthor=M.+Falconiauthor=D.+Di+Marinoauthor=T.+Borsello&title=JNK3+as+a+therapeutic+target+for+neurodegenerative+diseases&doi=10.3233%2FJAD-2011-091567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">JNK3 as a Therapeutic Target for Neurodegenerative Diseases</span></div><div class="casAuthors">Antoniou, Xanthi; Falconi, Mattia; Di Marino, Daniele; Borsello, Tiziana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">633-642</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  C-Jun N-terminal kinases (JNKs) and in particular JNK3 the neuronal specific isoform, have been recognized as important enzymes in the pathol. of diverse neurol. disorders.  Indeed, several efforts have been made to design drugs that inhibit JNK signaling.  The success that characterized the new generation of cell permeable peptides raise the hope in the field of neurodegeneration for new therapeutic routes.  However, in order to design new and more efficient therapeutical approaches careful re-examn. of current knowledge is required.  Scaffold proteins are key endogenous regulators of JNK signaling: they can modulate spatial and temporal activation of the JNK signaling and can thus provide the basis for the design of more specific inhibitors.  This review focuses on delineating the role of scaffold proteins on the regulation of JNK signaling in neurons.  Furthermore the possibility to design a new JNK3 cell permeable peptide inhibitor by targeting the β-arrestin-JNK3 interaction is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWEl6zvv3NKLVg90H21EOLACvtfcHk0li0VB8PuawFdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFyrsr8%253D&md5=cb087071a51bf1f91c70bfacec7dddae</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-091567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-091567%26sid%3Dliteratum%253Aachs%26aulast%3DAntoniou%26aufirst%3DX.%26aulast%3DFalconi%26aufirst%3DM.%26aulast%3DDi%2BMarino%26aufirst%3DD.%26aulast%3DBorsello%26aufirst%3DT.%26atitle%3DJNK3%2520as%2520a%2520therapeutic%2520target%2520for%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D24%26spage%3D633%26epage%3D642%26doi%3D10.3233%2FJAD-2011-091567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiwaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaniwa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekiguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirasawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, K.</span></span> <span> </span><span class="NLM_article-title">Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">396</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.ejmech.2015.04.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=25912672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslarurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2015&pages=396-404&author=I.+Nakanishiauthor=K.+Murataauthor=N.+Nagataauthor=M.+Kuronoauthor=T.+Kinoshitaauthor=M.+Yasueauthor=T.+Miyazakiauthor=Y.+Takeiauthor=S.+Nakamuraauthor=A.+Sakuraiauthor=N.+Iwamotoauthor=K.+Nishiwakiauthor=T.+Nakaniwaauthor=Y.+Sekiguchiauthor=A.+Hirasawaauthor=G.+Tsujimotoauthor=K.+Kitaura&title=Identification+of+protein+kinase+CK2+inhibitors+using+solvent+dipole+ordering+virtual+screening&doi=10.1016%2Fj.ejmech.2015.04.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening</span></div><div class="casAuthors">Nakanishi, Isao; Murata, Katsumi; Nagata, Naoya; Kurono, Masakuni; Kinoshita, Takayoshi; Yasue, Misato; Miyazaki, Takako; Takei, Yoshinori; Nakamura, Shinya; Sakurai, Atsushi; Iwamoto, Nobuko; Nishiwaki, Keiji; Nakaniwa, Tetsuko; Sekiguchi, Yusuke; Hirasawa, Akira; Tsujimoto, Gozoh; Kitaura, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">396-404</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Novel protein kinase CK2 inhibitors were identified using the solvent dipole ordering virtual screening method.  A total of 26 compds. categorized in 15 distinct scaffold classes inhibited greater than 50% of enzyme activity at 50 μM, and eight exhibited IC50 values less than 10 μM.  Most of the identified compds. are lead-like and dissimilar to known inhibitors.  The crystal structures of two of the CK2 complexes revealed the high accuracy of the predicted binding modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr09zbCwMAnoLVg90H21EOLACvtfcHk0litrsxK-Wcw9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslarurs%253D&md5=c6ac78194f5ab517aa271567753c7508</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DI.%26aulast%3DMurata%26aufirst%3DK.%26aulast%3DNagata%26aufirst%3DN.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DYasue%26aufirst%3DM.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DTakei%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DIwamoto%26aufirst%3DN.%26aulast%3DNishiwaki%26aufirst%3DK.%26aulast%3DNakaniwa%26aufirst%3DT.%26aulast%3DSekiguchi%26aufirst%3DY.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DKitaura%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520protein%2520kinase%2520CK2%2520inhibitors%2520using%2520solvent%2520dipole%2520ordering%2520virtual%2520screening%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D96%26spage%3D396%26epage%3D404%26doi%3D10.1016%2Fj.ejmech.2015.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilchmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcaida, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boss, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonczy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymond, J. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a selective Aurora A kinase inhibitor by virtual screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7188</span>– <span class="NLM_lpage">7211</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFersrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7188-7211&author=F.+Kilchmannauthor=M.+J.+Marcaidaauthor=S.+Kotakauthor=T.+Schickauthor=S.+D.+Bossauthor=M.+Awaleauthor=P.+Gonczyauthor=J.+L.+Reymond&title=Discovery+of+a+selective+Aurora+A+kinase+inhibitor+by+virtual+screening&doi=10.1021%2Facs.jmedchem.6b00709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening</span></div><div class="casAuthors">Kilchmann, Falco; Marcaida, Maria J.; Kotak, Sachin; Schick, Thomas; Boss, Silvan D.; Awale, Mahendra; Gonczy, Pierre; Reymond, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7188-7211</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here we report the discovery of a selective inhibitor of Aurora A, a key regulator of cell division and potential anticancer target.  We used the atom category extended ligand overlap score (xLOS), a 3D ligand-based virtual screening method recently developed in our group, to select 437 shape and pharmacophore analogs of ref. kinase inhibitors.  Biochem. screening uncovered two inhibitor series with scaffolds unprecedented among kinase inhibitors.  One of them was successfully optimized by structure-based design to a potent Aurora A inhibitor (IC50 = 2 nM) with very high kinome selectivity for Aurora kinases.  This inhibitor locks Aurora A in an inactive conformation and disrupts binding to its activator protein TPX2, which impairs Aurora A localization at the mitotic spindle and induces cell division defects.  This phenotype can be rescued by inhibitor-resistant Aurora A mutants.  The inhibitor furthermore does not induce Aurora B specific effects in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQCO8boEwSO7Vg90H21EOLACvtfcHk0litrsxK-Wcw9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFersrjP&md5=0928f42cef599fb5d7a26bdafeb79d3e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00709%26sid%3Dliteratum%253Aachs%26aulast%3DKilchmann%26aufirst%3DF.%26aulast%3DMarcaida%26aufirst%3DM.%2BJ.%26aulast%3DKotak%26aufirst%3DS.%26aulast%3DSchick%26aufirst%3DT.%26aulast%3DBoss%26aufirst%3DS.%2BD.%26aulast%3DAwale%26aufirst%3DM.%26aulast%3DGonczy%26aufirst%3DP.%26aulast%3DReymond%26aufirst%3DJ.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520Aurora%2520A%2520kinase%2520inhibitor%2520by%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7188%26epage%3D7211%26doi%3D10.1021%2Facs.jmedchem.6b00709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.ejmech.2017.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=28231524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=275-286&author=T.+Wangauthor=Z.+Yangauthor=Y.+Zhangauthor=W.+Yanauthor=F.+Wangauthor=L.+Heauthor=Y.+Zhouauthor=L.+Chen&title=Discovery+of+novel+CDK8+inhibitors+using+multiple+crystal+structures+in+docking-based+virtual+screening&doi=10.1016%2Fj.ejmech.2017.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening</span></div><div class="casAuthors">Wang, Taijin; Yang, Zhuang; Zhang, Yongguang; Yan, Wei; Wang, Fang; He, Linhong; Zhou, Yuanyuan; Chen, Lijuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">275-286</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The cyclin dependent kinase CDK8, along with Med12 and Med13, form the kinase module of the Mediator complex.  CDK8 expression assocs. with the activation of β-catenin in colon and gastric cancers.  Herein, we applied docking-based virtual screening (VS) using the multiple crystal structures to identify several potent CDK8 inhibitors.  The appropriate use of multiple crystal structures obtained a better enrichment of CDK8 conformations to cope with the protein flexibility.  Later on, the 2D similarity search was used to find the derivs. of the high inhibitory CDK8 inhibitors we discovered by VS.  Finally, we measured the dose response behaviors, the IC50 values of compd. W-34, W-37, W-8, WS-2 are 6.5 nM, 36 nM, 93 nM, 9 nM, resp.  These novel leads provided good starting points to design and synthesis a series of highly selective and potent CDK8 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3tNFP1H7AnbVg90H21EOLACvtfcHk0litrsxK-Wcw9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGjsrs%253D&md5=bb1500bb9d7f805f5f81f2c51b4198a9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520novel%2520CDK8%2520inhibitors%2520using%2520multiple%2520crystal%2520structures%2520in%2520docking-based%2520virtual%2520screening%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D129%26spage%3D275%26epage%3D286%26doi%3D10.1016%2Fj.ejmech.2017.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. S.</span></span> <span> </span><span class="NLM_article-title">An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1450</span>, <span class="refDoi"> DOI: 10.1021/ci500062f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500062f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVektLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=1433-1450&author=J.+Xiaauthor=H.+Jinauthor=Z.+Liuauthor=L.+Zhangauthor=X.+S.+Wang&title=An+unbiased+method+to+build+benchmarking+sets+for+ligand-based+virtual+screening+and+its+application+to+GPCRs&doi=10.1021%2Fci500062f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">An Unbiased Method To Build Benchmarking Sets for Ligand-Based Virtual Screening and its Application To GPCRs</span></div><div class="casAuthors">Xia, Jie; Jin, Hongwei; Liu, Zhenming; Zhang, Liangren; Wang, Xiang Simon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1433-1450</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benchmarking data sets have become common in recent years for the purpose of virtual screening, though the main focus had been placed on the structure-based virtual screening (SBVS) approaches.  Due to the lack of crystal structures, there is great need for unbiased benchmarking sets to evaluate various ligand-based virtual screening (LBVS) methods for important drug targets such as G protein-coupled receptors (GPCRs).  To date these ready-to-apply data sets for LBVS are fairly limited, and the direct usage of benchmarking sets designed for SBVS could bring the biases to the evaluation of LBVS.  Herein, we propose an unbiased method to build benchmarking sets for LBVS and validate it on a multitude of GPCRs targets.  To be more specific, our methods can (1) ensure chem. diversity of ligands, (2) maintain the physicochem. similarity between ligands and decoys, (3) make the decoys dissimilar in chem. topol. to all ligands to avoid false negatives, and (4) maximize spatial random distribution of ligands and decoys.  We evaluated the quality of our Unbiased Ligand Set (ULS) and Unbiased Decoy Set (UDS) using three common LBVS approaches, with Leave-One-Out (LOO) Cross-Validation (CV) and a metric of av. AUC of the ROC curves.  Our method has greatly reduced the "artificial enrichment" and "analog bias" of a published GPCRs benchmarking set, i.e., GPCR Ligand Library (GLL)/GPCR Decoy Database (GDD).  In addn., we addressed an important issue about the ratio of decoys per ligand and found that for a range of 30 to 100 it does not affect the quality of the benchmarking set, so we kept the original ratio of 39 from the GLL/GDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreeqZHc9Xi0LVg90H21EOLACvtfcHk0li9d-rdczdLSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVektLY%253D&md5=aa1b9d3f990859e9335e163f6e8f9052</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fci500062f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500062f%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%2BS.%26atitle%3DAn%2520unbiased%2520method%2520to%2520build%2520benchmarking%2520sets%2520for%2520ligand-based%2520virtual%2520screening%2520and%2520its%2520application%2520to%2520GPCRs%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D1433%26epage%3D1450%26doi%3D10.1021%2Fci500062f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balius, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroz, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algaa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span> <span> </span><span class="NLM_article-title">Ultra-large library docking for discovering new chemotypes</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>566</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-0917-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1038%2Fs41586-019-0917-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=30728502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmt1yns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=566&publication_year=2019&pages=224-229&author=J.+Lyuauthor=S.+Wangauthor=T.+E.+Baliusauthor=I.+Singhauthor=A.+Levitauthor=Y.+S.+Morozauthor=M.+J.+O%E2%80%99Mearaauthor=T.+Cheauthor=E.+Algaaauthor=K.+Tolmachovaauthor=A.+A.+Tolmachevauthor=B.+K.+Shoichetauthor=B.+L.+Rothauthor=J.+J.+Irwin&title=Ultra-large+library+docking+for+discovering+new+chemotypes&doi=10.1038%2Fs41586-019-0917-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ultra-large library docking for discovering new chemotypes</span></div><div class="casAuthors">Lyu, Jiankun; Wang, Sheng; Balius, Trent E.; Singh, Isha; Levit, Anat; Moroz, Yurii S.; O'Meara, Matthew J.; Che, Tao; Algaa, Enkhjargal; Tolmachova, Kateryna; Tolmachev, Andrey A.; Shoichet, Brian K.; Roth, Bryan L.; Irwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">566</span>
        (<span class="NLM_cas:issue">7743</span>),
    <span class="NLM_cas:pages">224-229</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite intense interest in expanding chem. space, libraries contg. hundreds-of-millions to billions of diverse mols. have remained inaccessible.  Here we investigate structure-based docking of 170 million make-on-demand compds. from 130 well-characterized reactions.  The resulting library is diverse, representing over 10.7 million scaffolds that are otherwise unavailable.  For each compd. in the library, docking against AmpC β-lactamase (AmpC) and the D4 dopamine receptor were simulated.  From the top-ranking mols., 44 and 549 compds. were synthesized and tested for interactions with AmpC and the D4 dopamine receptor, resp.  We found a phenolate inhibitor of AmpC, which revealed a group of inhibitors without known precedent.  This mol. was optimized to 77 nM, which places it among the most potent non-covalent AmpC inhibitors known.  Crystal structures of this and other AmpC inhibitors confirmed the docking predictions.  Against the D4 dopamine receptor, hit rates fell almost monotonically with docking score, and a hit-rate vs. score curve predicted that the library contained 453,000 ligands for the D4 dopamine receptor.  Of 81 new chemotypes discovered, 30 showed submicromolar activity, including a 180-pM subtype-selective agonist of the D4 dopamine receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc_Nuo9pc-Z7Vg90H21EOLACvtfcHk0li9d-rdczdLSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmt1yns70%253D&md5=589fb81ef11f9cbec645b9a3818648d1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-0917-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-0917-9%26sid%3Dliteratum%253Aachs%26aulast%3DLyu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBalius%26aufirst%3DT.%2BE.%26aulast%3DSingh%26aufirst%3DI.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DMoroz%26aufirst%3DY.%2BS.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%2BJ.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DAlgaa%26aufirst%3DE.%26aulast%3DTolmachova%26aufirst%3DK.%26aulast%3DTolmachev%26aufirst%3DA.%2BA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26atitle%3DUltra-large%2520library%2520docking%2520for%2520discovering%2520new%2520chemotypes%26jtitle%3DNature%26date%3D2019%26volume%3D566%26spage%3D224%26epage%3D229%26doi%3D10.1038%2Fs41586-019-0917-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0li9d-rdczdLSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egan, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, J. J.</span></span> <span> </span><span class="NLM_article-title">Prediction of drug absorption using multivariate statistics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3867</span>– <span class="NLM_lpage">3877</span>, <span class="refDoi"> DOI: 10.1021/jm000292e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000292e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3867-3877&author=W.+J.+Eganauthor=K.+M.+Merzauthor=J.+J.+Baldwin&title=Prediction+of+drug+absorption+using+multivariate+statistics&doi=10.1021%2Fjm000292e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Drug Absorption Using Multivariate Statistics</span></div><div class="casAuthors">Egan, William J.; Merz, Kenneth M. Jr.; Baldwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3867-3877</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Literature data on compds. both well- and poorly-absorbed in humans were used to build a statistical pattern recognition model of passive intestinal absorption.  Robust outlier detection was utilized to analyze the well-absorbed compds., some of which were intermingled with the poorly-absorbed compds. in the model space.  Outliers were identified as being actively transported.  The descriptors chosen for inclusion in the model were PSA and AlogP98, based on consideration of the phys. processes involved in membrane permeability and the interrelationships and redundancies between available descriptors.  These descriptors are quite straightforward for a medicinal chemist to interpret, enhancing the utility of the model.  Mol. wt., while often used in passive absorption models, was shown to be superfluous, as it is already a component of both PSA and AlogP98.  Extensive validation of the model on hundreds of known orally delivered drugs, "drug-like" mols., and Pharmacopeia, Inc. compds., which had been assayed for Caco-2 cell permeability, demonstrated a good rate of successful predictions (74-92%, depending on the dataset and exact criterion used).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbZF9e_GNz8LVg90H21EOLACvtfcHk0li9d-rdczdLSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitLk%253D&md5=44f909ad1fd6187840921e7f07497b4e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm000292e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000292e%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DW.%2BJ.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520drug%2520absorption%2520using%2520multivariate%2520statistics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3867%26epage%3D3877%26doi%3D10.1021%2Fjm000292e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andreichikov, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitirimova, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraeva, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gein, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plakhina, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voronova, L. A.</span></span> <span> </span><span class="NLM_article-title">3-Phenacyl-2-quinoxalones and 3-phenacylidene-3,4-dihydro-2-quinoxalones</span>. <i>Khim. Geterotsikl. Soedin.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1007/BF00470572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1007%2FBF00470572" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1978&pages=407-410&author=Y.+S.+Andreichikovauthor=S.+G.+Pitirimovaauthor=R.+F.+Saraevaauthor=V.+L.+Geinauthor=G.+D.+Plakhinaauthor=L.+A.+Voronova&title=3-Phenacyl-2-quinoxalones+and+3-phenacylidene-3%2C4-dihydro-2-quinoxalones&doi=10.1007%2FBF00470572"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2FBF00470572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00470572%26sid%3Dliteratum%253Aachs%26aulast%3DAndreichikov%26aufirst%3DY.%2BS.%26aulast%3DPitirimova%26aufirst%3DS.%2BG.%26aulast%3DSaraeva%26aufirst%3DR.%2BF.%26aulast%3DGein%26aufirst%3DV.%2BL.%26aulast%3DPlakhina%26aufirst%3DG.%2BD.%26aulast%3DVoronova%26aufirst%3DL.%2BA.%26atitle%3D3-Phenacyl-2-quinoxalones%2520and%25203-phenacylidene-3%252C4-dihydro-2-quinoxalones%26jtitle%3DKhim.%2520Geterotsikl.%2520Soedin.%26date%3D1978%26volume%3D3%26spage%3D407%26epage%3D410%26doi%3D10.1007%2FBF00470572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaminskyy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Hartog, G. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtyra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelyukh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gzella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bast, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesyk, R.</span></span> <span> </span><span class="NLM_article-title">Antifibrotic and anticancer action of 5-ene amino/iminothiazolidinones</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.ejmech.2016.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=26896707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28Xislyqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2016&pages=180-195&author=D.+Kaminskyyauthor=G.+J.+M.+den+Hartogauthor=M.+Wojtyraauthor=M.+Lelyukhauthor=A.+Gzellaauthor=A.+Bastauthor=R.+Lesyk&title=Antifibrotic+and+anticancer+action+of+5-ene+amino%2Fiminothiazolidinones&doi=10.1016%2Fj.ejmech.2016.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Antifibrotic and anticancer action of 5-ene amino/iminothiazolidinones</span></div><div class="casAuthors">Kaminskyy, Danylo; den Hartog, Gertjan J. M.; Wojtyra, Magdalena; Lelyukh, Maryan; Gzella, Andrzej; Bast, Aalt; Lesyk, Roman</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">180-195</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Here we describe the synthesis and the antifibrotic and anticancer activity detn. of amino(imino)thiazolidinone derivs.  An efficient one-pot three-component reaction which involved [2 + 3]-cyclocondensation and Knoevenagel condensation was used for the synthesis of 5-ene-2-amino(imino)-4-thiazolidinones.  Following amino-imino tautomerism, the compd. structures were confirmed by X-ray anal.  Comparison of SRB assays on fibroblasts and cancer cells revealed that compds. which significantly reduced the viability of fibroblasts did not possess an anticancer effect.  A series of thiazolidinone derivs. as interesting candidates for further testing has been identified.  Among the tested compds. 2-{3-furan-2-ylmethyl-2-[(2-methyl-3-phenylallylidene)hydrazono]-thiazolidin-4-one-5-yl}-N-(3-trifluoromethylphenyl)-acetamide, N-(2-methoxyphenyl)-2-[5-(4-oxothiazolidin-2-ylideneamino)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetamide, 3-[3-allyl-4-oxo-2-(thiazol-2-ylimino)thiazolidin-5-ylidene]-1,3-dihydroindol-2-one, and 5(Z)-(thiophen-2-ylmethylene)-4-(4-chlorophenylamino)thiazol-2(5H)-one possessed high antifibrotic activity levels, had a similar effect as Pirfenidone, and did not scavenge superoxide radicals.  Their antifibrotic potential was confirmed using the xCelligence system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn9EH9so_baLVg90H21EOLACvtfcHk0ljps4gzIpR87w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xislyqsbo%253D&md5=ec9388a3e08c29a5ae23375b7aca275c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DKaminskyy%26aufirst%3DD.%26aulast%3Dden%2BHartog%26aufirst%3DG.%2BJ.%2BM.%26aulast%3DWojtyra%26aufirst%3DM.%26aulast%3DLelyukh%26aufirst%3DM.%26aulast%3DGzella%26aufirst%3DA.%26aulast%3DBast%26aufirst%3DA.%26aulast%3DLesyk%26aufirst%3DR.%26atitle%3DAntifibrotic%2520and%2520anticancer%2520action%2520of%25205-ene%2520amino%252Fiminothiazolidinones%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D112%26spage%3D180%26epage%3D195%26doi%3D10.1016%2Fj.ejmech.2016.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. X.</span></span> <span> </span><span class="NLM_article-title">C-glycosylflavones alleviate tau phosphorylation and amyloid neurotoxicity through GSK3beta inhibition</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">912</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00059</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00059" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28XotlCnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=912-923&author=Z.+Liangauthor=B.+Zhangauthor=W.+W.+Suauthor=P.+G.+Williamsauthor=Q.+X.+Li&title=C-glycosylflavones+alleviate+tau+phosphorylation+and+amyloid+neurotoxicity+through+GSK3beta+inhibition&doi=10.1021%2Facschemneuro.6b00059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">C-Glycosylflavones Alleviate Tau Phosphorylation and Amyloid Neurotoxicity through GSK3β Inhibition</span></div><div class="casAuthors">Liang, Zhibin; Zhang, Bei; Su, Wei Wen; Williams, Philip G.; Li, Qing X.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">912-923</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common brain disorder worldwide.  Aberrant tau hyperphosphorylation and accumulation play crit. roles in the formation of neurofibrillary tangles highly assocd. with neuronal dysfunction and cognitive impairment in AD pathogenesis.  Glycogen synthase kinase-3β (GSK3β) is a key kinase responsible for tau hyperphosphorylation.  Selective inhibition of GSK3β is a promising strategy in AD therapy.  Corn silks (CS, Zea mays L.) have been traditionally used as a medicinal herb and recently noted for their potentially cognitive benefits.  However, the neuroprotective components of CS and their mol. mechanism have received little attention to date.  As part of our effort screening phytochems. against a broad panel of kinases targeting AD tauopathy, we found inhibition of GSK3β by CS exts.  Subsequent bioassay-guided fractionation led to the isolation and identification of two 6-C-glycosylflavones, isoorientin (1) and 3'-methoxymaysin (2), with selective inhibition against GSK3β in vitro.  Enzyme kinetics and mol. docking studies demonstrated that 1 specifically inhibited GSK3β via an ATP noncompetitive mechanism, acting as a substrate competitive inhibitor of GSK3β.  Further in vitro cellular studies demonstrated that 1 effectively attenuated tau phosphorylation mediated by GSK3β and was neuroprotective against β-amyloid-induced tau hyperphosphorylation and neurotoxicity in SH-SY5Y cells.  The C-glycosylflavones represent new lead candidates with a novel mechanism of action for the development of AD phytopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoULrY7iLLHRLVg90H21EOLACvtfcHk0ljps4gzIpR87w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotlCnsbk%253D&md5=de0a55c2cad16ac52d8335757a8628fd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00059%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DW.%2BW.%26aulast%3DWilliams%26aufirst%3DP.%2BG.%26aulast%3DLi%26aufirst%3DQ.%2BX.%26atitle%3DC-glycosylflavones%2520alleviate%2520tau%2520phosphorylation%2520and%2520amyloid%2520neurotoxicity%2520through%2520GSK3beta%2520inhibition%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D912%26epage%3D923%26doi%3D10.1021%2Facschemneuro.6b00059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mora, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoGrasso, P.</span></span> <span> </span><span class="NLM_article-title">Structural basis and biological consequences for JNK2/3 isoform selective aminopyrazoles</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">8047</span> <span class="refDoi"> DOI: 10.1038/srep08047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1038%2Fsrep08047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=25623238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKjurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&author=H.+Parkauthor=S.+Iqbalauthor=P.+Hernandezauthor=R.+Moraauthor=K.+Zhengauthor=Y.+Fengauthor=P.+LoGrasso&title=Structural+basis+and+biological+consequences+for+JNK2%2F3+isoform+selective+aminopyrazoles&doi=10.1038%2Fsrep08047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and Biological Consequences for JNK2/3 Isoform Selective Aminopyrazoles</span></div><div class="casAuthors">Park, Ha Jeung; Iqbal, Sarah; Hernandez, Pamela; Mora, Rudy; Zheng, Ke; Feng, Yangbo; LoGrasso, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8047</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Three JNK isoforms, JNK1, JNK2, and JNK3 have been reported and unique biol. function has been ascribed to each.  It is unknown if selective inhibition of these isoforms would confer therapeutic or safety benefit.  To probe JNK isoform function we designed JNK2/3 inhibitors that have >30-fold selectivity over JNK1.  Utilizing site-directed mutagenesis and x-ray crystallog. we identified L144 in JNK3 as a key residue for selectivity.  To test whether JNK2/3 selective inhibitors protect human dopaminergic neurons against neurotoxin-induced mitochondrial dysfunction, we monitored reactive oxygen species (ROS) generation and mitochondrial membrane potential (MMP).  The results showed that JNK2/3 selective inhibitors protected against 6-hydroxydopamine-induced ROS generation and MMP depolarization.  These results suggest that it was possible to develop JNK2/3 selective inhibitors and that residues in hydrophobic pocket I were responsible for selectivity.  Moreover, the findings also suggest that inhibition of JNK2/3 likely contributed to protecting mitochondrial function and prevented ultimate cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppecXktwxC9LVg90H21EOLACvtfcHk0ljps4gzIpR87w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKjurrE&md5=f895abe1774b76fd5e24be52c7860d4c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fsrep08047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep08047%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%26aulast%3DIqbal%26aufirst%3DS.%26aulast%3DHernandez%26aufirst%3DP.%26aulast%3DMora%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DLoGrasso%26aufirst%3DP.%26atitle%3DStructural%2520basis%2520and%2520biological%2520consequences%2520for%2520JNK2%252F3%2520isoform%2520selective%2520aminopyrazoles%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26doi%3D10.1038%2Fsrep08047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashwell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gero, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcombe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ready, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowsell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toader, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasbinder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabludoff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureas</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5130</span>– <span class="NLM_lpage">5142</span>, <span class="refDoi"> DOI: 10.1021/jm300025r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300025r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVWgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5130-5142&author=V.+Ozaauthor=S.+Ashwellauthor=L.+Almeidaauthor=P.+Brassilauthor=J.+Breedauthor=C.+Dengauthor=T.+Geroauthor=M.+Grondineauthor=C.+Hornauthor=S.+Ioannidisauthor=D.+Liuauthor=P.+Lyneauthor=N.+Newcombeauthor=M.+Passauthor=J.+Readauthor=S.+Readyauthor=S.+Rowsellauthor=M.+Suauthor=D.+Toaderauthor=M.+Vasbinderauthor=D.+Yuauthor=Y.+Yuauthor=Y.+Xueauthor=S.+Zabludoffauthor=J.+Janetka&title=Discovery+of+checkpoint+kinase+inhibitor+%28S%29-5-%283-fluorophenyl%29-N-%28piperidin-3-yl%29-3-ureidothiophene-2-carboxamide+%28AZD7762%29+by+structure-based+design+and+optimization+of+thiophenecarboxamide+ureas&doi=10.1021%2Fjm300025r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Checkpoint Kinase Inhibitor (S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by Structure-Based Design and Optimization of Thiophenecarboxamide Ureas</span></div><div class="casAuthors">Oza, Vibha; Ashwell, Susan; Almeida, Lynsie; Brassil, Patrick; Breed, Jason; Deng, Chun; Gero, Thomas; Grondine, Michael; Horn, Candice; Ioannidis, Stephanos; Liu, Dongfang; Lyne, Paul; Newcombe, Nicholas; Pass, Martin; Read, Jon; Ready, Shannon; Rowsell, Sian; Su, Mei; Toader, Dorin; Vasbinder, Melissa; Yu, Dingwei; Yu, Yan; Xue, Yafeng; Zabludoff, Sonya; Janetka, James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5130-5142</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Checkpoint kinases CHK1 and CHK2 are activated in response to DNA damage that results in cell cycle arrest, allowing sufficient time for DNA repair.  Agents that lead to abrogation of such checkpoints have potential to increase the efficacy of such compds. as chemo- and radiotherapies.  Thiophenecarboxamide ureas (TCUs) were identified as inhibitors of CHK1 by high throughput screening.  A structure-based approach is described using crystal structures of JNK1 and CHK1 in complex with 1 and 2 and of the CHK1-3b complex.  The ribose binding pocket of CHK1 was targeted to generate inhibitors with excellent cellular potency and selectivity over CDK1and IKKβ, key features lacking from the initial compds.  Optimization of 3b resulted in the identification of a regioisomeric 3-TCU lead 12a.  Optimization of 12a led to the discovery of the clin. candidate 4 (AZD7762, I), which strongly potentiates the efficacy of a variety of DNA-damaging agents in preclin. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra8G75JTejhbVg90H21EOLACvtfcHk0liEoS070b7wyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVWgtbc%253D&md5=f2880b57af6d1def8f91d3ee694e0182</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm300025r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300025r%26sid%3Dliteratum%253Aachs%26aulast%3DOza%26aufirst%3DV.%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DBrassil%26aufirst%3DP.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DGero%26aufirst%3DT.%26aulast%3DGrondine%26aufirst%3DM.%26aulast%3DHorn%26aufirst%3DC.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLyne%26aufirst%3DP.%26aulast%3DNewcombe%26aufirst%3DN.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DReady%26aufirst%3DS.%26aulast%3DRowsell%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DToader%26aufirst%3DD.%26aulast%3DVasbinder%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DJanetka%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520checkpoint%2520kinase%2520inhibitor%2520%2528S%2529-5-%25283-fluorophenyl%2529-N-%2528piperidin-3-yl%2529-3-ureidothiophene-2-carboxamide%2520%2528AZD7762%2529%2520by%2520structure-based%2520design%2520and%2520optimization%2520of%2520thiophenecarboxamide%2520ureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5130%26epage%3D5142%26doi%3D10.1021%2Fjm300025r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villasenor, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsing, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>383</i></span>,  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.08.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.jmb.2008.08.086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=18801372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1egtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2008&pages=885-893&author=D.+Shawauthor=S.+M.+Wangauthor=A.+G.+Villasenorauthor=S.+Tsingauthor=D.+Walterauthor=M.+F.+Brownerauthor=J.+Barnettauthor=A.+Kuglstatter&title=The+crystal+structure+of+JNK2+reveals+conformational+flexibility+in+the+MAP+kinase+insert+and+indicates+its+involvement+in+the+regulation+of+catalytic+activity&doi=10.1016%2Fj.jmb.2008.08.086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The Crystal Structure of JNK2 Reveals Conformational Flexibility in the MAP Kinase Insert and Indicates Its Involvement in the Regulation of Catalytic Activity</span></div><div class="casAuthors">Shaw, David; Wang, Sandra M.; Villasenor, Armando G.; Tsing, Stan; Walter, David; Browner, Michelle F.; Barnett, Jim; Kuglstatter, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">885-893</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">C-Jun N-terminal kinase (JNK) 2 is a member of the mitogen-activated protein (MAP) kinase group of signaling proteins.  MAP kinases share a common sequence insertion called "MAP kinase insert", which, for ERK2, has been shown to interact with regulatory proteins and, for p38α, has been proposed to be involved in the regulation of catalytic activity.  We have detd. the crystal structure of human JNK2 complexed with an indazole inhibitor by applying a high-throughput protein engineering and surface-site mutagenesis approach.  A novel conformation of the activation loop is obsd., which is not compatible with its phosphorylation by upstream kinases.  This activation inhibitory conformation of JNK2 is stabilized by the MAP kinase insert that interacts with the activation loop in an induced-fit manner.  We therefore suggest that the MAP kinase insert of JNK2 plays a role in the regulation of JNK2 activation, possibly by interacting with intracellular binding partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquRAOL6mYaC7Vg90H21EOLACvtfcHk0liEoS070b7wyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1egtLnM&md5=a2dbcbe2d4bc8146cd8ef48f9162c268</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.08.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.08.086%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%2BM.%26aulast%3DVillasenor%26aufirst%3DA.%2BG.%26aulast%3DTsing%26aufirst%3DS.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DBrowner%26aufirst%3DM.%2BF.%26aulast%3DBarnett%26aufirst%3DJ.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DThe%2520crystal%2520structure%2520of%2520JNK2%2520reveals%2520conformational%2520flexibility%2520in%2520the%2520MAP%2520kinase%2520insert%2520and%2520indicates%2520its%2520involvement%2520in%2520the%2520regulation%2520of%2520catalytic%2520activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D383%26spage%3D885%26epage%3D893%26doi%3D10.1016%2Fj.jmb.2008.08.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span> <span> </span><span class="NLM_article-title">Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">18281</span>– <span class="NLM_lpage">18289</span>, <span class="refDoi"> DOI: 10.1073/pnas.1207759109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1073%2Fpnas.1207759109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=22988103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslymtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=18281-18289&author=M.+McTigueauthor=B.+W.+Murrayauthor=J.+H.+Chenauthor=Y.+L.+Dengauthor=J.+Solowiejauthor=R.+S.+Kania&title=Molecular+conformations%2C+interactions%2C+and+properties+associated+with+drug+efficiency+and+clinical+performance+among+VEGFR+TK+inhibitors&doi=10.1073%2Fpnas.1207759109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors</span></div><div class="casAuthors">McTigue, Michele; Murray, Brion William; Chen, Jeffrey H.; Deng, Ya-Li; Solowiej, James; Kania, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18281-18289, S18281/1-S18281/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Analyses of compds. in clin. development have shown that ligand efficient-mols. with privileged phys. properties and low dose are less likely to fail in the various stages of clin. testing, have fewer postapproval withdrawals, and are less likely to receive black box safety warnings.  However, detailed side-by-side examn. of mol. interactions and properties within single drug classes are lacking.  As a class, VEGF receptor tyrosine kinase inhibitors (VEGFR TKIs) have changed the landscape of how cancer is treated, particularly in clear cell renal cell carcinoma, which is molecularly linked to the VEGF signaling axis.  Despite the clear role of the mol. target, member mols. of this validated drug class exhibit distinct clin. efficacy and safety profiles in comparable renal cell carcinoma clin. studies.  The first head-to-head randomized phase III comparative study between active VEGFR TKIs has confirmed significant differences in clin. performance.  To elucidate how fundamental drug potency-efficiency is achieved and impacts differentiation within the VEGFR TKI class, we detd. potencies, time dependence, selectivities, and X-ray structures of the drug-kinase complexes using a VEGFR2 TK construct inclusive of the important juxtamembrane domain.  Collectively, the studies elucidate unique drug-kinase interactions that are dependent on distinct juxtamembrane domain conformations, resulting in significant potency and ligand efficiency differences.  The identified structural trends are consistent with in vitro measurements, which translate well to clin. performance, underscoring a principle that may be broadly applicable to prospective drug design for optimal in vivo performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsIUWiD4sXtbVg90H21EOLACvtfcHk0lhKqYBE0eICQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslymtb3I&md5=4a5ec677298a8c924c0f9557ca688a79</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1207759109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1207759109%26sid%3Dliteratum%253Aachs%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26atitle%3DMolecular%2520conformations%252C%2520interactions%252C%2520and%2520properties%2520associated%2520with%2520drug%2520efficiency%2520and%2520clinical%2520performance%2520among%2520VEGFR%2520TK%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D18281%26epage%3D18289%26doi%3D10.1073%2Fpnas.1207759109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of new GSK-3beta inhibitors through structure-based virtual screening</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.11.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.bmcl.2017.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=29208522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgs7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=160-166&author=X.+Douauthor=L.+Jiangauthor=Y.+Wangauthor=H.+Jinauthor=Z.+Liuauthor=L.+Zhang&title=Discovery+of+new+GSK-3beta+inhibitors+through+structure-based+virtual+screening&doi=10.1016%2Fj.bmcl.2017.11.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new GSK-3β inhibitors through structure-based virtual screening</span></div><div class="casAuthors">Dou, Xiaodong; Jiang, Lan; Wang, Yanxing; Jin, Hongwei; Liu, Zhenming; Zhang, Liangren</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">160-166</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3β (GSK-3β) is an attractive therapeutic target for human diseases, such as diabetes, cancer, neurodegenerative diseases, and inflammation.  Thus, structure-based virtual screening was performed to identify novel scaffolds of GSK-3β inhibitors, and we obsd. that conserved water mols. of GSK-3β were suitable for virtual screening.  We found 14 hits and D1 (IC50 of 0.71 μM) were identified.  Furthermore, the neuroprotection activity of D1-D3 was validated on a cellular level. 2D similarity searches were used to find derivs. of high inhibitory compds. and an enriched structure-activity relationship suggested that these skeletons were worthy of study as potent GSK-3β inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Poir6nudnbVg90H21EOLACvtfcHk0lhKqYBE0eICQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgs7bN&md5=9c972f8578594d2965a038304c72f251</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DDou%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520new%2520GSK-3beta%2520inhibitors%2520through%2520structure-based%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D160%26epage%3D166%26doi%3D10.1016%2Fj.bmcl.2017.11.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowotka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutowo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cibrian-Uhalte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magarinos, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadatos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span> <span> </span><span class="NLM_article-title">The ChEMBL database in 2017</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">D945</span>– <span class="NLM_lpage">D954</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw1074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1093%2Fnar%2Fgkw1074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=27899562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D945-D954&author=A.+Gaultonauthor=A.+Herseyauthor=M.+Nowotkaauthor=A.+P.+Bentoauthor=J.+Chambersauthor=D.+Mendezauthor=P.+Mutowoauthor=F.+Atkinsonauthor=L.+J.+Bellisauthor=E.+Cibrian-Uhalteauthor=M.+Daviesauthor=N.+Dedmanauthor=A.+Karlssonauthor=M.+P.+Magarinosauthor=J.+P.+Overingtonauthor=G.+Papadatosauthor=I.+Smitauthor=A.+R.+Leach&title=The+ChEMBL+database+in+2017&doi=10.1093%2Fnar%2Fgkw1074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The ChEMBL database in 2017</span></div><div class="casAuthors">Gaulton, Anna; Hersey, Anne; Nowotka, Micha-l; Bento, A. Patricia; Chambers, Jon; Mendez, David; Mutowo, Prudence; Atkinson, Francis; Bellis, Louisa J.; Cibrian-Uhalte, Elena; Davies, Mark; Dedman, Nathan; Karlsson, Anneli; Magarinos, Maria Paula; Overington, John P.; Papadatos, George; Smit, Ines; Leach, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D945-D954</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an open large-scale bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012 and 2014 Nucleic Acids Research Database Issues.  Since then, alongside the continued extn. of data from the medicinal chem. literature, new sources of bioactivity data have also been added to the database.  These include: deposited data sets from neglected disease screening; crop protection data; drug metab. and disposition data and bioactivity data from patents.  A no. of improvements and new features have also been incorporated.  These include the annotation of assays and targets using ontologies, the inclusion of targets and indications for clin. candidates, addn. of metabolic pathways for drugs and calcn. of structural alerts.  The ChEMBL data can be accessed via a web-interface, RDF distribution, data downloads and RESTful web-services.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB0IuNShSHIrVg90H21EOLACvtfcHk0lhKqYBE0eICQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D&md5=1dcbb641f8c2d11410663f97505a4911</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1074%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DNowotka%26aufirst%3DM.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DMendez%26aufirst%3DD.%26aulast%3DMutowo%26aufirst%3DP.%26aulast%3DAtkinson%26aufirst%3DF.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DCibrian-Uhalte%26aufirst%3DE.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DDedman%26aufirst%3DN.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DMagarinos%26aufirst%3DM.%2BP.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DPapadatos%26aufirst%3DG.%26aulast%3DSmit%26aufirst%3DI.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26atitle%3DThe%2520ChEMBL%2520database%2520in%25202017%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26spage%3DD945%26epage%3DD954%26doi%3D10.1093%2Fnar%2Fgkw1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mysinger, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolstad, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R. G.</span></span> <span> </span><span class="NLM_article-title">ZINC: a free tool to discover chemistry for biology</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1757</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1021/ci3001277</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci3001277" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFGnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1757-1768&author=J.+J.+Irwinauthor=T.+Sterlingauthor=M.+M.+Mysingerauthor=E.+S.+Bolstadauthor=R.+G.+Coleman&title=ZINC%3A+a+free+tool+to+discover+chemistry+for+biology&doi=10.1021%2Fci3001277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">ZINC: A Free Tool to Discover Chemistry for Biology</span></div><div class="casAuthors">Irwin, John J.; Sterling, Teague; Mysinger, Michael M.; Bolstad, Erin S.; Coleman, Ryan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1757-1768</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ZINC is a free public resource for ligand discovery.  The database contains over twenty million com. available mols. in biol. relevant representations that may be downloaded in popular ready-to-dock formats and subsets.  The Web site also enables searches by structure, biol. activity, phys. property, vendor, catalog no., name, and CAS no.  Small custom subsets may be created, edited, shared, docked, downloaded, and conveyed to a vendor for purchase.  The database is maintained and curated for a high purchasing success rate and is freely available at zinc.docking.org.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotyhntxgvRpbVg90H21EOLACvtfcHk0lgeRNbW9nKZqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFGnsrg%253D&md5=97f2ede64afc6b5e3ea2f279e38e32a0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fci3001277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3001277%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DSterling%26aufirst%3DT.%26aulast%3DMysinger%26aufirst%3DM.%2BM.%26aulast%3DBolstad%26aufirst%3DE.%2BS.%26aulast%3DColeman%26aufirst%3DR.%2BG.%26atitle%3DZINC%253A%2520a%2520free%2520tool%2520to%2520discover%2520chemistry%2520for%2520biology%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1757%26epage%3D1768%26doi%3D10.1021%2Fci3001277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span> <i>LigPrep</i>, version 2.3; <span class="NLM_publisher-name">Schrodinger,
LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+LigPrep%2C+version+2.3%3B+Schrodinger%2C%0ALLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchrodinger%252C%250ALLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span> <i>Epic</i>,
version 3.2; <span class="NLM_publisher-name">Schrodinger,
LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Epic%2C%0Aversion+3.2%3B+Schrodinger%2C%0ALLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DEpic%26pub%3DSchrodinger%252C%250ALLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lgeRNbW9nKZqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairley, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flemington, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopcroft, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsay, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Gallay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, B.</span></span> <span> </span><span class="NLM_article-title">Structure-guided discovery of potent and selective inhibitors of ERK1/2 from a modestly active and promiscuous chemical start point</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3438</span>– <span class="NLM_lpage">3450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00267</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00267" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1Gls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3438-3450&author=R.+A.+Wardauthor=P.+Bethelauthor=C.+Cookauthor=E.+Daviesauthor=J.+E.+Debreczeniauthor=G.+Fairleyauthor=L.+Feronauthor=V.+Flemingtonauthor=M.+A.+Grahamauthor=R.+Greenwoodauthor=N.+Griffinauthor=L.+Hansonauthor=P.+Hopcroftauthor=T.+D.+Howardauthor=J.+Hudsonauthor=M.+Jamesauthor=C.+D.+Jonesauthor=C.+R.+Jonesauthor=S.+Lamontauthor=R.+Lewisauthor=N.+Lindsayauthor=K.+Robertsauthor=I.+Simpsonauthor=S.+St-Gallayauthor=S.+Swallowauthor=J.+Tangauthor=M.+Tongeauthor=Z.+Wangauthor=B.+Zhai&title=Structure-guided+discovery+of+potent+and+selective+inhibitors+of+ERK1%2F2+from+a+modestly+active+and+promiscuous+chemical+start+point&doi=10.1021%2Facs.jmedchem.7b00267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point</span></div><div class="casAuthors">Ward, Richard A.; Bethel, Paul; Cook, Calum; Davies, Emma; Debreczeni, Judit E.; Fairley, Gary; Feron, Lyman; Flemington, Vikki; Graham, Mark A.; Greenwood, Ryan; Griffin, Nicola; Hanson, Lyndsey; Hopcroft, Philip; Howard, Tina D.; Hudson, Julian; James, Michael; Jones, Clifford D.; Jones, Christopher R.; Lamont, Scott; Lewis, Richard; Lindsay, Nicola; Roberts, Karen; Simpson, Iain; St-Gallay, Steve; Swallow, Steve; Tang, Jia; Tonge, Michael; Wang, Zhenhua; Zhai, Baochang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3438-3450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are a no. of small-mol. inhibitors targeting the RAS/RAF/MEK/ERK signaling pathway that have either been approved or are in clin. development for oncol. across a range of disease indications.  The inhibition of ERK1/2 is of significant current interest, as cell lines with acquired resistance to BRAF and MEK inhibitors have been shown to maintain sensitivity to ERK1/2 inhibition in preclin. models.  This article reports on authors' recent work to identify novel, potent, and selective reversible ERK1/2 inhibitors from a low-mol.-wt., modestly active, and highly promiscuous chem. start point, compd. I.  To guide and inform the evolution of this series, inhibitor binding mode information from X-ray crystal structures was crit. in the rapid exploration of this template to compd. II, which was active when tested in in vivo antitumor efficacy expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokuJLRaK0sLLVg90H21EOLACvtfcHk0lgeRNbW9nKZqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1Gls7c%253D&md5=2ab5cd30f6a9c887a9a21010b492cb34</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00267%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DBethel%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DE.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DFairley%26aufirst%3DG.%26aulast%3DFeron%26aufirst%3DL.%26aulast%3DFlemington%26aufirst%3DV.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DGriffin%26aufirst%3DN.%26aulast%3DHanson%26aufirst%3DL.%26aulast%3DHopcroft%26aufirst%3DP.%26aulast%3DHoward%26aufirst%3DT.%2BD.%26aulast%3DHudson%26aufirst%3DJ.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DJones%26aufirst%3DC.%2BR.%26aulast%3DLamont%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DLindsay%26aufirst%3DN.%26aulast%3DRoberts%26aufirst%3DK.%26aulast%3DSimpson%26aufirst%3DI.%26aulast%3DSt-Gallay%26aufirst%3DS.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DTonge%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhai%26aufirst%3DB.%26atitle%3DStructure-guided%2520discovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520ERK1%252F2%2520from%2520a%2520modestly%2520active%2520and%2520promiscuous%2520chemical%2520start%2520point%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3438%26epage%3D3450%26doi%3D10.1021%2Facs.jmedchem.7b00267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L. H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of LX2343 derivatives as neuroprotective agents for the treatment of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">633</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.ejmech.2017.12.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=29339255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVensrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2018&pages=622-633&author=G.+L.+Sunauthor=J.+W.+Wangauthor=X.+D.+Guoauthor=M.+Leiauthor=Y.+N.+Zhangauthor=X.+C.+Wangauthor=X.+Shenauthor=L.+H.+Hu&title=Design%2C+synthesis+and+biological+evaluation+of+LX2343+derivatives+as+neuroprotective+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2017.12.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of LX2343 derivatives as neuroprotective agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Sun, Guanglong; Wang, Junwei; Guo, Xiaodan; Lei, Min; Zhang, Yinan; Wang, Xiachang; Shen, Xu; Hu, Lihong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">622-633</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of LX2343 derivs. were designed, synthesized and evaluated as neuroprotective agents for Alzheimer's disease (AD) in vitro.  Most of the compds. displayed potent neuroprotective activities.  Esp. for compd. 2-(N-(5-chloro-2-methoxyphenyl)phenylsulfonamido)-N-((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)acetamide, exhibited a remarkable EC50 value of 0.22 μM and further investigation demonstrated that this compd. can significantly reduce Aβ prodn. and increase Aβ clearance, and alleviate Tau hyperphosphorylation.  Most importantly, this compd. could ameliorate learning and memory impairments in APP/PS1 transgenic mice.  The present study evidently showed that compd. 2-(N-(5-chloro-2-methoxyphenyl)phenylsulfonamido)-N-((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)acetamide is a potent neuroprotective agent and might serve as a promising lead candidate for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0WARoMg_Av7Vg90H21EOLACvtfcHk0lilKElPaYyC8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVensrk%253D&md5=faac9af0289d5514c60f690437f3abfe</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.080%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DG.%2BL.%26aulast%3DWang%26aufirst%3DJ.%2BW.%26aulast%3DGuo%26aufirst%3DX.%2BD.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%2BN.%26aulast%3DWang%26aufirst%3DX.%2BC.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%2BH.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520LX2343%2520derivatives%2520as%2520neuroprotective%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D145%26spage%3D622%26epage%3D633%26doi%3D10.1016%2Fj.ejmech.2017.12.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praticò, D.</span></span> <span> </span><span class="NLM_article-title">Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">863</span>, <span class="refDoi"> DOI: 10.1002/ana.24145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1002%2Fana.24145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=24644038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2murjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=851-863&author=J.-G.+Liauthor=J.+Chuauthor=C.+Barreroauthor=S.+Meraliauthor=D.+Pratic%C3%B2&title=Homocysteine+exacerbates+%CE%B2-amyloid+pathology%2C+tau+pathology%2C+and+cognitive+deficit+in+a+mouse+model+of+Alzheimer+disease+with+plaques+and+tangles&doi=10.1002%2Fana.24145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles</span></div><div class="casAuthors">Li, Jian-Guo; Chu, Jin; Barrero, Carlos; Merali, Salim; Pratico, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">851-863</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective : High level of homocysteine (Hcy) is a recognized risk factor for developing Alzheimer disease (AD).  However, the mechanisms involved are unknown.  Previously, it was shown that high Hcy increases brain β-amyloid (Aβ) levels in amyloid precursor protein transgenic mice, but no data are available on the effect that it may have on the other main pathol. features of AD such as tau.  Methods : 3xTg mice with diet-induced high Hcy were compared with mice having normal Hcy.  Neuronal cells were incubated with and without Hcy.  Results : Diet-induced high Hcy resulted in an exacerbation of the entire AD-like phenotype of the 3xTg mice.  In particular, we found that compared with controls, mice with high Hcy developed significant memory and learning deficits, and had elevated Aβ levels and deposition, which was mediated by an activation of the γ-secretase pathway.  In addn., the same mice had a significant increase in the insol. fraction of tau and its phosphorylation at specific epitopes, which was mediated by the cdk5 pathway.  In vitro studies confirmed these observations and provided evidence that the effects of Hcy on Aβ and tau are independent from each other.  Interpretation : Taken together, our findings demonstrate that a dietary condition that leads to an elevation of Hcy levels results in an exacerbation of all 3 major pathol. features of the AD phenotype: memory deficits, and Aβ and tau neuropathol.  They support the concept that this dietary lifestyle can act as a risk factor and actively contribute to the development of the disease.  Ann Neurol 2014;75:851-863.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZzOf0vxhNeLVg90H21EOLACvtfcHk0lilKElPaYyC8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2murjL&md5=0bceed9e1378a20bec8c843824e1664b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fana.24145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24145%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.-G.%26aulast%3DChu%26aufirst%3DJ.%26aulast%3DBarrero%26aufirst%3DC.%26aulast%3DMerali%26aufirst%3DS.%26aulast%3DPratic%25C3%25B2%26aufirst%3DD.%26atitle%3DHomocysteine%2520exacerbates%2520%25CE%25B2-amyloid%2520pathology%252C%2520tau%2520pathology%252C%2520and%2520cognitive%2520deficit%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%2520disease%2520with%2520plaques%2520and%2520tangles%26jtitle%3DAnn.%2520Neurol.%26date%3D2014%26volume%3D75%26spage%3D851%26epage%3D863%26doi%3D10.1002%2Fana.24145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yangbo Feng, HaJeung Park, Luke Bauer, Jae Cheon Ryu, <span class="NLM_string-name hlFld-ContribAuthor">Sung OK Yoon</span>. </span><span class="cited-content_cbyCitation_article-title">Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 24-29. <a href="https://doi.org/10.1021/acsmedchemlett.0c00533" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00533</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00533%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThiophene-Pyrazolourea%252BDerivatives%252Bas%252BPotent%25252C%252BOrally%252BBioavailable%25252C%252Band%252BIsoform-Selective%252BJNK3%252BInhibitors%26aulast%3DFeng%26aufirst%3DYangbo%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06102020%26date%3D30112020%26date%3D13122020%26volume%3D12%26issue%3D1%26spage%3D24%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">So  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Tomoko  Kayama</span>, <span class="hlFld-ContribAuthor ">Moeko  Noguchi-Shinohara</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Hamaguchi</span>, <span class="hlFld-ContribAuthor ">Masahito  Yamada</span>, <span class="hlFld-ContribAuthor ">Keiko  Abe</span>, <span class="hlFld-ContribAuthor ">Shoko  Kobayashi</span>. </span><span class="cited-content_cbyCitation_article-title">Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">npj Science of Food</span><span> <strong>2021,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41538-021-00084-5" title="DOI URL">https://doi.org/10.1038/s41538-021-00084-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41538-021-00084-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41538-021-00084-5%26sid%3Dliteratum%253Aachs%26jtitle%3Dnpj%2520Science%2520of%2520Food%26atitle%3DRosmarinic%252Bacid%252Bsuppresses%252Btau%252Bphosphorylation%252Band%252Bcognitive%252Bdecline%252Bby%252Bdownregulating%252Bthe%252BJNK%252Bsignaling%252Bpathway%26aulast%3DYamamoto%26aufirst%3DSo%26date%3D2021%26date%3D2021%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ekaterina E.  Stepanova</span>, <span class="hlFld-ContribAuthor ">Svetlana Yu  Balandina</span>, <span class="hlFld-ContribAuthor ">Vera A.  Drobkova</span>, <span class="hlFld-ContribAuthor ">Maksim V.  Dmitriev</span>, <span class="hlFld-ContribAuthor ">Irina V.  Mashevskaya</span>, <span class="hlFld-ContribAuthor ">Andrey N.  Maslivets</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, in vitro antibacterial activity against
              Mycobacterium tuberculosis
              , and reverse docking‐based target fishing of 1,4‐benzoxazin‐2‐one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2021,</strong> <em>354 </em>
                                    (2)
                                     , 2000199. <a href="https://doi.org/10.1002/ardp.202000199" title="DOI URL">https://doi.org/10.1002/ardp.202000199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000199%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%25252C%252Bin%252Bvitro%252Bantibacterial%252Bactivity%252Bagainst%252BMycobacterium%252Btuberculosis%252B%25252C%252Band%252Breverse%252Bdocking%2525E2%252580%252590based%252Btarget%252Bfishing%252Bof%252B1%25252C4%2525E2%252580%252590benzoxazin%2525E2%252580%2525902%2525E2%252580%252590one%252Bderivatives%26aulast%3DStepanova%26aufirst%3DEkaterina%2BE.%26date%3D2021%26date%3D2020%26volume%3D354%26issue%3D2%26spage%3D2000199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clara Alice  Musi</span>, <span class="hlFld-ContribAuthor ">Graziella  Agrò</span>, <span class="hlFld-ContribAuthor ">Francesco  Santarella</span>, <span class="hlFld-ContribAuthor ">Erika  Iervasi</span>, <span class="hlFld-ContribAuthor ">Tiziana  Borsello</span>. </span><span class="cited-content_cbyCitation_article-title">JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (10)
                                     , 2190. <a href="https://doi.org/10.3390/cells9102190" title="DOI URL">https://doi.org/10.3390/cells9102190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9102190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9102190%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DJNK3%252Bas%252BTherapeutic%252BTarget%252Band%252BBiomarker%252Bin%252BNeurodegenerative%252Band%252BNeurodevelopmental%252BBrain%252BDiseases%26aulast%3DMusi%26aufirst%3DClara%2BAlice%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D10%26spage%3D2190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline L.  Benn</span>, <span class="hlFld-ContribAuthor ">Lee A.  Dawson</span>. </span><span class="cited-content_cbyCitation_article-title">Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2020,</strong> <em>12 </em><a href="https://doi.org/10.3389/fnagi.2020.00242" title="DOI URL">https://doi.org/10.3389/fnagi.2020.00242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2020.00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2020.00242%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DClinically%252BPrecedented%252BProtein%252BKinases%25253A%252BRationale%252Bfor%252BTheir%252BUse%252Bin%252BNeurodegenerative%252BDisease%26aulast%3DBenn%26aufirst%3DCaroline%2BL.%26date%3D2020%26date%3D2020%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Dou</span>, <span class="hlFld-ContribAuthor ">Huixia  Huang</span>, <span class="hlFld-ContribAuthor ">Lan  Jiang</span>, <span class="hlFld-ContribAuthor ">Guiwang  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongwei  Jin</span>, <span class="hlFld-ContribAuthor ">Ning  Jiao</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>, <span class="hlFld-ContribAuthor ">Lihe  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>201 </em>, 112445. <a href="https://doi.org/10.1016/j.ejmech.2020.112445" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112445%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bmodification%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3%25252C4-dihydroquinoxalin-2%2525281H%252529-one%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252Bc-Jun%252BN-terminal%252Bkinase%252B3%252B%252528JNK3%252529%252Binhibitors%26aulast%3DDou%26aufirst%3DXiaodong%26date%3D2020%26volume%3D201%26spage%3D112445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Xia</span>, <span class="hlFld-ContribAuthor ">Shan  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Ding</span>, <span class="hlFld-ContribAuthor ">Song  Wu</span>, <span class="hlFld-ContribAuthor ">Xiang Simon  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">MUBD‐DecoyMaker 2.0: A Python GUI Application to Generate Maximal Unbiased Benchmarking Data Sets for Virtual Drug Screening. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2020,</strong> <em>39 </em>
                                    (4)
                                     , 1900151. <a href="https://doi.org/10.1002/minf.201900151" title="DOI URL">https://doi.org/10.1002/minf.201900151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201900151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201900151%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DMUBD%2525E2%252580%252590DecoyMaker%252B2.0%25253A%252BA%252BPython%252BGUI%252BApplication%252Bto%252BGenerate%252BMaximal%252BUnbiased%252BBenchmarking%252BData%252BSets%252Bfor%252BVirtual%252BDrug%252BScreening%26aulast%3DXia%26aufirst%3DJie%26date%3D2020%26volume%3D39%26issue%3D4%26spage%3D1900151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean M. F.  Custodio</span>, <span class="hlFld-ContribAuthor ">Andrea F.  Moura</span>, <span class="hlFld-ContribAuthor ">Manoel O.  de Moraes</span>, <span class="hlFld-ContribAuthor ">Caridad N.  Perez</span>, <span class="hlFld-ContribAuthor ">Hamilton B.  Napolitano</span>. </span><span class="cited-content_cbyCitation_article-title">On the
              in silico
              and
              in vitro
              anticancer activity of sulfonamide chalcones: potential JNKK3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (8)
                                     , 3294-3309. <a href="https://doi.org/10.1039/C9NJ05612B" title="DOI URL">https://doi.org/10.1039/C9NJ05612B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ05612B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ05612B%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DOn%252Bthe%252Bin%252Bsilico%252Band%252Bin%252Bvitro%252Banticancer%252Bactivity%252Bof%252Bsulfonamide%252Bchalcones%25253A%252Bpotential%252BJNKK3%252Binhibitors%26aulast%3DCustodio%26aufirst%3DJean%2BM.%2BF.%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D8%26spage%3D3294%26epage%3D3309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arindam  Chatterjee</span>. </span><span class="cited-content_cbyCitation_article-title">Computational methods and tools for sustainable and green approaches in drug discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 965-988. <a href="https://doi.org/10.1016/B978-0-12-817592-7.00027-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-817592-7.00027-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817592-7.00027-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817592-7.00027-7%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252Bmethods%252Band%252Btools%252Bfor%252Bsustainable%252Band%252Bgreen%252Bapproaches%252Bin%252Bdrug%252Bdiscovery%26aulast%3DChatterjee%26aufirst%3DArindam%26date%3D2020%26spage%3D965%26epage%3D988%26pub%3DElsevier%26atitle%3DGreen%252BApproaches%252Bin%252BMedicinal%252BChemistry%252Bfor%252BSustainable%252BDrug%252BDesign%26date%3D2020%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ekaterina E  Stepanova</span>, <span class="hlFld-ContribAuthor ">Maksim V  Dmitriev</span>, <span class="hlFld-ContribAuthor ">Andrey N  Maslivets</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1,4-benzothiazinones from acylpyruvic acids or furan-2,3-diones and
              o
              -aminothiophenol. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>16 </em>, 2322-2331. <a href="https://doi.org/10.3762/bjoc.16.193" title="DOI URL">https://doi.org/10.3762/bjoc.16.193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.16.193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.16.193%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B1%25252C4-benzothiazinones%252Bfrom%252Bacylpyruvic%252Bacids%252Bor%252Bfuran-2%25252C3-diones%252Band%252Bo%252B-aminothiophenol%26aulast%3DStepanova%26aufirst%3DEkaterina%2BE%26date%3D2020%26date%3D2020%26volume%3D16%26spage%3D2322%26epage%3D2331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youri  Oh</span>, <span class="hlFld-ContribAuthor ">Miyoung  Jang</span>, <span class="hlFld-ContribAuthor ">Hyunwook  Cho</span>, <span class="hlFld-ContribAuthor ">Songyi  Yang</span>, <span class="hlFld-ContribAuthor ">Daseul  Im</span>, <span class="hlFld-ContribAuthor ">Hyungwoo  Moon</span>, <span class="hlFld-ContribAuthor ">Jung-Mi  Hah</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1
              H-
              pyrazole derivatives as a novel selective inhibitor scaffold of JNK3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 372-376. <a href="https://doi.org/10.1080/14756366.2019.1705294" title="DOI URL">https://doi.org/10.1080/14756366.2019.1705294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1705294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1705294%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-alkyl-5-aryl-1-pyrimidyl-1%252BH-%252Bpyrazole%252Bderivatives%252Bas%252Ba%252Bnovel%252Bselective%252Binhibitor%252Bscaffold%252Bof%252BJNK3%26aulast%3DOh%26aufirst%3DYouri%26date%3D2020%26date%3D2019%26volume%3D35%26issue%3D1%26spage%3D372%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Hu  Teng</span>, <span class="hlFld-ContribAuthor ">Yan  Yao</span>, <span class="hlFld-ContribAuthor ">Wen-Xiu  Wei</span>, <span class="hlFld-ContribAuthor ">Hai-Tao  Tang</span>, <span class="hlFld-ContribAuthor ">Jia-Rong  Li</span>, <span class="hlFld-ContribAuthor ">Ying-Ming  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Direct C–H sulfenylation of quinoxalinones with thiols under visible-light-induced photocatalyst-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2019,</strong> <em>21 </em>
                                    (23)
                                     , 6241-6245. <a href="https://doi.org/10.1039/C9GC03045J" title="DOI URL">https://doi.org/10.1039/C9GC03045J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9GC03045J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9GC03045J%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DDirect%252BC%2525E2%252580%252593H%252Bsulfenylation%252Bof%252Bquinoxalinones%252Bwith%252Bthiols%252Bunder%252Bvisible-light-induced%252Bphotocatalyst-free%252Bconditions%26aulast%3DTeng%26aufirst%3DQing-Hu%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D23%26spage%3D6241%26epage%3D6245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of representative JNK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. JNK3 inhibitors identification. (A) General workflow. (B) Physicochemical properties distribution curves for all active ligands and decoys in JNK3 benchmarking data set. (C) Receiver operating characteristic (ROC) curves of the eight evaluated JNK3 docking models. (D) Enrichment factor (EF) results obtained for docking studies of unbiased benchmarking data set into JNK3 crystal complexes, including PDB entries: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMV">1PMV</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P33">2P33</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ZDU">2ZDU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CGF">3CGF</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FV8">3FV8</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTI">3TTI</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y46">4Y46</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Chemical structures of the seven identified JNK3 inhibitors. (B) Enzymatic activity and representative molecular properties of identified JNK3 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Synthesis of compounds <b>J30-8</b> and <b>J46</b>. ODPA = <i>o</i>-phenylenediamine. (B) Dose dependency inhibition of compounds <b>J30-8</b> and <b>J46</b> against JNKs. Mean values ± standard error (SE) of duplicate. (C) Kinome-wide selectivity for <b>J30-8</b> and <b>J46</b> represented on a kinome phylogenetic tree. Each inhibitor was screened against 398 kinases at 10 or 1 μM. Kinases more than 50% inhibitions are depicted. (D) IC<sub>50</sub> values of <b>J30-8</b> and <b>J46</b> against kinases. IC<sub>50</sub> values are reported as means ± SE of duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Protective effects of JNK3 inhibitors against Aβ<sub>25–35</sub>-induced cell death in SH-SY5Y cells. (B) Effects on cell proliferation of JNK3 inhibitors in SH-SY5Y cells. Data are presented as mean ± SE (<i>n</i> = 3). <sup>##</sup><i>p</i> < 0.01, Aβ<sub>25–35</sub> group compared to vehicle group; * <i>p</i> < 0.05, ** <i>p</i> < 0.01, test groups compared to the Aβ<sub>25–35</sub> group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Behavioral effects of <b>J30-8</b> in homozygous APPswe/PS1dE9 double-transgenic mice model. (A) Effect of compounds <b>J30-8</b> and <b>SP600125</b> on the weight of the mice. (B) Escape latency and (C) exploration distance in the positioning navigation experiments. (E) Representative searching swimming paths by rats in different groups and (E) total time of stay in the target quadrant (%) in the probe trials. (F) Swimming time to target quadrant and (G) swimming speed to target quadrant in the visual platform trails. (H) Acquisition latency and (I) retention latency during the step-through passive avoidance tasks. Data were presented as mean ± SD (<i>n</i> = 8). * <i>p</i> < 0.05, ** <i>p</i> < 0.01 vs vehicle group; <sup>#</sup><i>p</i> < 0.05, <sup>##</sup><i>p</i> < 0.01 vs <b>SP600125</b> (30 mg/kg) group. SP = <b>SP600125</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compounds <b>J30-8</b> and <b>SP600125</b> on the number of diffuse plaques, percent of diffuse plaques (A), number of fibrillar plaques, percent of fibrillar plaques (B) in cortex from mice in the indicated groups, and number of diffuse plaques, percent of diffuse plaques (C), number of fibrillar plaques, percent of fibrillar plaques (D) in hippocampus from mice in the indicated groups. The results are presented as mean ± SD (<i>n</i> = 6). Scale bar, 300 μm. ** <i>p</i> < 0.01 vs vehicle group; <sup>#</sup><i>p</i> < 0.05, <sup>##</sup><i>p</i> < 0.01 vs <b>SP600125</b> (30 mg/kg) group. SP = <b>SP600125</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of <b>J30-8</b> and <b>SP60015</b> treatments on the phosphorylation levels of JNK, APP, Tau protein, and the sAPPα, sAPPβ expressions in the cortex (A) and hippocampus (B) of mice from indicated groups. Representative bands are shown. Densitometric quantification of protein band optical densities for Phos-JNK expression (C), Phos-APP (Thr668) expression (D), Phos-Tau (Ser235) expression (E), Phos-Tau (Thr205) expression (F), sAPPα expression (G), and sAPPβ expression (H). The results are presented as mean ± SD (<i>n</i> = 8). * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 vs vehicle group. <sup>#</sup><i>p</i> < 0.05, <sup>##</sup><i>p</i> < 0.01, <sup>###</sup><i>p</i> < 0.001 vs <b>SP600125</b> (30 mg/kg) group. SP = <b>SP600125</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Plasma concentration–time profiles for <b>J30-8</b> (A) and <b>SP600125</b> (B) intraperitoneal administration (30 mg/kg) in homozygous APPswe/PS1dE9 double-transgenic mice (<i>n</i> = 6, respectively).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Predicted binding modes of compounds <b>J30-8</b> (A) and <b>J46</b> (B). Superimposition of the crystal structures of JNK3 (PDB IDs: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WHZ">4WHZ</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W">4W4W</a>, gray), JNK1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PZE">3PZE</a>, light blue), and JNK2 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7O">3E7O</a>, yellow) with compounds <b>J30-8</b> (C) and <b>J46</b> (D). Hydrogen bonds are represented by the yellow lines. HR I = hydrophobic region I. Images depicting the proposed binding modes were generated using PyMOL software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Superimposition of the binding modes of <b>J30-8</b> (pink) in JNK3 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WHZ">4WHZ</a>, gray) and <b>sunitinib</b> (yellow) in VEGFR (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AGD">4AGD</a>) with (A) or without (B) protein ribbons. Hydrogen bonds are represented by the yellow lines. HR I = hydrophobic region I. The images depict the proposed binding modes generated using PyMOL software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/medium/jm-2019-005377_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Protein–ligand contacts histogram <b>J30-8</b> (A) and <b>J46</b> (B) and corresponding 2D diagram <b>J30-8</b> (C) and <b>J46</b> (D) predicted through MD simulations; percentage suggests that for X% of the simulation time, the specific interaction is maintained.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00537/20190719/images/large/jm-2019-005377_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00537&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76504" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76504" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheltens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breteler, M. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisoni, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salloway, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Flier, W. M.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(15)01124-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2FS0140-6736%2815%2901124-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=26921134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFOls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=505-517&author=P.+Scheltensauthor=K.+Blennowauthor=M.+M.+B.+Bretelerauthor=B.+de+Strooperauthor=G.+B.+Frisoniauthor=S.+Sallowayauthor=W.+M.+Van+der+Flier&title=Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2815%2901124-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Scheltens, Philip; Blennow, Kaj; Breteler, Monique M. B.; de Strooper, Bart; Frisoni, Giovanni B.; Salloway, Stephen; Van der Flier, Wiesje Maria</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10043</span>),
    <span class="NLM_cas:pages">505-517</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Although the prevalence of dementia continues to increase worldwide, incidence in the western world might have decreased as a result of better vascular care and improved brain health.  Alzheimer's disease, the most prevalent cause of dementia, is still defined by the combined presence of amyloid and tau, but researchers are gradually moving away from the simple assumption of linear causality as proposed in the original amyloid hypothesis.  Age-related, protective, and disease-promoting factors probably interact with the core mechanisms of the disease.  Amyloid β42, and tau proteins are established core cerebrospinal biomarkers; novel candidate biomarkers include amyloid β oligomers and synaptic markers.  MRI and fluorodeoxyglucose PET are established imaging techniques for diagnosis of Alzheimer's disease.  Amyloid PET is gaining traction in the clin. arena, but validity and cost-effectiveness remain to be established.  Tau PET might offer new insights and be of great help in differential diagnosis and selection of patients for trials.  In the search for understanding the disease mechanism and keys to treatment, research is moving increasingly into the earliest phase of disease.  Preclin. Alzheimer's disease is defined as biomarker evidence of Alzheimer's pathol. changes in cognitively healthy individuals.  Patients with subjective cognitive decline have been identified as a useful population in whom to look for preclin. Alzheimer's disease.  Moderately pos. results for interventions targeting several lifestyle factors in non-demented elderly patients and moderately pos. interim results for lowering amyloid in pre-dementia Alzheimer's disease suggest that, ultimately, there will be a future in which specific anti-Alzheimer's therapy will be combined with lifestyle interventions targeting general brain health to jointly combat the disease.  In this Seminar, we discuss the main developments in Alzheimer's research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWZLFEpEZFe7Vg90H21EOLACvtfcHk0ljYJH-rzlW2nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFOls7c%253D&md5=4aca6ac6d79fb10ef1bab5348b31e24a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2815%2901124-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252815%252901124-1%26sid%3Dliteratum%253Aachs%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DBreteler%26aufirst%3DM.%2BM.%2BB.%26aulast%3Dde%2BStrooper%26aufirst%3DB.%26aulast%3DFrisoni%26aufirst%3DG.%2BB.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DVan%2Bder%2BFlier%26aufirst%3DW.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26spage%3D505%26epage%3D517%26doi%3D10.1016%2FS0140-6736%2815%2901124-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stopschinski, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M. I.</span></span> <span> </span><span class="NLM_article-title">The prion model for progression and diversity of neurodegenerative diseases</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">332</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(17)30037-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2FS1474-4422%2817%2930037-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=28238712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=323-332&author=B.+E.+Stopschinskiauthor=M.+I.+Diamond&title=The+prion+model+for+progression+and+diversity+of+neurodegenerative+diseases&doi=10.1016%2FS1474-4422%2817%2930037-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The prion model for progression and diversity of neurodegenerative diseases</span></div><div class="casAuthors">Stopschinski, Barbara E.; Diamond, Marc I.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-332</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The neuropathol. of different neurodegenerative diseases begins in different brain regions, and involves distinct brain networks.  Evidence indicates that transcellular propagation of protein aggregation, which is the basis of prion disease, might underlie the progression of pathol. in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.  The prion model predicts specific patterns of neuronal vulnerability and network involvement on the basis of the conformation of pathol. proteins.  Indeed, evidence indicates that self-propagating aggregate conformers, or so-called strains, are assocd. with distinct neuropathol. syndromes.  The extension of this hypothesis to our understanding of common neurodegenerative disorders can suggest new therapeutic approaches, such as immunotherapy and small mols., to block transcellular propagation, and new diagnostic tools to detect early evidence of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnR2DhaWpjBbVg90H21EOLACvtfcHk0ljYJH-rzlW2nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGkt7w%253D&md5=e42b6241cba73884d43777c0bfc85b50</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2817%2930037-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252817%252930037-6%26sid%3Dliteratum%253Aachs%26aulast%3DStopschinski%26aufirst%3DB.%2BE.%26aulast%3DDiamond%26aufirst%3DM.%2BI.%26atitle%3DThe%2520prion%2520model%2520for%2520progression%2520and%2520diversity%2520of%2520neurodegenerative%2520diseases%26jtitle%3DLancet%2520Neurol.%26date%3D2017%26volume%3D16%26spage%3D323%26epage%3D332%26doi%3D10.1016%2FS1474-4422%2817%2930037-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Alzheimer’s Disease
International</span>.  <i>World Alzheimer Report
2018</i>. <a href="http://ps://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf" class="extLink">ps://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf</a> (accessed
Mar 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=Alzheimer%E2%80%99s+Disease%0AInternational&title=World+Alzheimer+Report%0A2018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Alzheimer%2520Report%250A2018%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkin-Groner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaikin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalom, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weill, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsburg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, M.</span></span> <span> </span><span class="NLM_article-title">Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10700</span>– <span class="NLM_lpage">10715</span>, <span class="refDoi"> DOI: 10.1021/jm301411g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301411g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10700-10715&author=I.+Yanovskyauthor=E.+Finkin-Gronerauthor=A.+Zaikinauthor=L.+Lermanauthor=H.+Shalomauthor=S.+Zeeliauthor=T.+Weillauthor=I.+Ginsburgauthor=A.+Nudelmanauthor=M.+Weinstock&title=Carbamate+derivatives+of+indolines+as+cholinesterase+inhibitors+and+antioxidants+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301411g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamate Derivatives of Indolines as Cholinesterase Inhibitors and Antioxidants for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yanovsky, Inessa; Finkin-Groner, Efrat; Zaikin, Andrey; Lerman, Lena; Shalom, Hila; Zeeli, Shani; Weill, Tehilla; Ginsburg, Isaac; Nudelman, Abraham; Weinstock, Marta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10700-10715</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cascade of events that occurs in Alzheimer's disease involving oxidative stress and the redn. in cholinergic transmission can be better addressed by multifunctional drugs than cholinesterase inhibitors alone.  For this purpose, we prepd. a large no. of derivs. of indoline-3-propionic acids and esters.  They showed scavenging activity against different radicals in soln. and significant protection against cytotoxicity in cardiomyocytes and primary cultures of neuronal cells exposed to H2O2 species and serum deprivation at concns. ranging from 1 nM to 10 μM depending on the compd.  For most of the indoline-3-propionic acid derivs., introduction of N-methyl-N-Et or N-methyl-N-(4-methoxyphenyl) carbamate moieties at positions 4, 6, or 7 conferred both acetyl (AChE) and butyryl (BuChE) cholinesterase inhibitory activities at similar concns. to those that showed antioxidant activity.  The most potent AChE inhibitors were I.2HCl [3-(2-aminoethyl)indolin-4-yl ethyl(methyl)carbamate dihydrochloride] and II.HCl [3-(3-methoxy-3-oxopropyl)-4-[((4-methoxyphenyl)(methyl)carbamoyl)oxy]indolin-1-ium chloride] with IC50s of 0.4 and 1.2 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEMfB-21FGL7Vg90H21EOLACvtfcHk0lhcuUyBtnZkMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs73J&md5=139fc0296d7da235f3f3ae885165a8e2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm301411g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301411g%26sid%3Dliteratum%253Aachs%26aulast%3DYanovsky%26aufirst%3DI.%26aulast%3DFinkin-Groner%26aufirst%3DE.%26aulast%3DZaikin%26aufirst%3DA.%26aulast%3DLerman%26aufirst%3DL.%26aulast%3DShalom%26aufirst%3DH.%26aulast%3DZeeli%26aufirst%3DS.%26aulast%3DWeill%26aufirst%3DT.%26aulast%3DGinsburg%26aufirst%3DI.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DCarbamate%2520derivatives%2520of%2520indolines%2520as%2520cholinesterase%2520inhibitors%2520and%2520antioxidants%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10700%26epage%3D10715%26doi%3D10.1021%2Fjm301411g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trincavelli, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span> <span> </span><span class="NLM_article-title">Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9708</span>– <span class="NLM_lpage">9721</span>, <span class="refDoi"> DOI: 10.1021/jm3009458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9708-9721&author=E.+Simoniauthor=S.+Danieleauthor=G.+Bottegoniauthor=D.+Pizziraniauthor=M.+L.+Trincavelliauthor=L.+Goldoniauthor=G.+Tarozzoauthor=A.+Reggianiauthor=C.+Martiniauthor=D.+Piomelliauthor=C.+Melchiorreauthor=M.+Rosiniauthor=A.+Cavalli&title=Combining+galantamine+and+memantine+in+multitargeted%2C+new+chemical+entities+potentially+useful+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm3009458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer's Disease</span></div><div class="casAuthors">Simoni, Elena; Daniele, Simona; Bottegoni, Giovanni; Pizzirani, Daniela; Trincavelli, Maria L.; Goldoni, Luca; Tarozzo, Glauco; Reggiani, Angelo; Martini, Claudia; Piomelli, Daniele; Melchiorre, Carlo; Rosini, Michela; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9708-9721</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we report on a novel series of multitargeted compds. obtained by linking together galantamine and memantine.  The compds. were designed by taking advantage of the crystal structures of acetylcholinesterase (AChE) in complex with galantamine derivs.  Sixteen novel derivs. were synthesized, using spacers of different lengths and chem. compn.  The mols. were then tested as inhibitors of AChE and as binders of the N-methyl-d-aspartate (NMDA) receptor (NMDAR).  Some of the new compds. were nanomolar inhibitors of AChE and showed micromolar affinities for NMDAR.  All compds. were also tested for selectivity toward NMDAR contg. the 2B subunit (NR2B).  Some of the new derivs. showed a micromolar affinity for NR2B.  Finally, selected compds. were tested using a cell-based assay to measure their neuroprotective activity.  Three of them showed a remarkable neuroprotective profile, inhibiting the NMDA-induced neurotoxicity at subnanomolar concns. (e.g., 5, named memagal, IC50 = 0.28 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSQQfPMtkC0bVg90H21EOLACvtfcHk0lht8jUioKc0Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLjL&md5=2db81502732f6337c02f9a1a3afa84f3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm3009458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009458%26sid%3Dliteratum%253Aachs%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DDaniele%26aufirst%3DS.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DGoldoni%26aufirst%3DL.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DCombining%2520galantamine%2520and%2520memantine%2520in%2520multitargeted%252C%2520new%2520chemical%2520entities%2520potentially%2520useful%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9708%26epage%3D9721%26doi%3D10.1021%2Fjm3009458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span> <span> </span><span class="NLM_article-title">Lessons learned from alzheimer disease: clinical trials with negative outcomes</span>. <i>Clin. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1111/cts.12491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1111%2Fcts.12491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=28767185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A280%3ADC%252BC1cfjsVyqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=147-152&author=J.+Cummings&title=Lessons+learned+from+alzheimer+disease%3A+clinical+trials+with+negative+outcomes&doi=10.1111%2Fcts.12491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes</span></div><div class="casAuthors">Cummings Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and translational science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-152</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4EcVa2l0ofS86Js-BCLiifW6udTcc2eYHOw2FopyMCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfjsVyqtA%253D%253D&md5=6318eac19ef6e09ab99933284f55bf96</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fcts.12491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcts.12491%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%26atitle%3DLessons%2520learned%2520from%2520alzheimer%2520disease%253A%2520clinical%2520trials%2520with%2520negative%2520outcomes%26jtitle%3DClin.%2520Transl.%2520Sci.%26date%3D2018%26volume%3D11%26spage%3D147%26epage%3D152%26doi%3D10.1111%2Fcts.12491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geldmacher, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provenzano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McRae, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ieni, J. R.</span></span> <span> </span><span class="NLM_article-title">Donepezil is associated with delayed nursing home placement in patients with Alzheimer’s disease</span>. <i>J. Am. Geriatr. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">937</span>– <span class="NLM_lpage">944</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2389.2003.51306.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1046%2Fj.1365-2389.2003.51306.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=12834513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A280%3ADC%252BD3sznsFyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=937-944&author=D.+S.+Geldmacherauthor=G.+Provenzanoauthor=T.+McRaeauthor=V.+Masteyauthor=J.+R.+Ieni&title=Donepezil+is+associated+with+delayed+nursing+home+placement+in+patients+with+Alzheimer%E2%80%99s+disease&doi=10.1046%2Fj.1365-2389.2003.51306.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease</span></div><div class="casAuthors">Geldmacher David S; Provenzano George; McRae Thomas; Mastey Vera; Ieni John R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Geriatrics Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">937-44</span>
        ISSN:<span class="NLM_cas:issn">0002-8614</span>.
    </div><div class="casAbstract">OBJECTIVES:  To assess the relationship between donepezil treatment and time to nursing home placement (NHP) for patients with Alzheimer's disease (AD).  DESIGN:  Observational follow-up of patient NHP and vital status.  SETTING:  Community.  PARTICIPANTS:  Patients previously enrolled in one of three randomized, double-blind, placebo-controlled clinical trials of donepezil and two subsequent open-label studies (total N = 1,115); 671 patients provided complete data for analysis.  MEASUREMENTS:  Data were obtained through follow-up interviews with caregivers and chart reviews of patients with AD.  Comparison groups were defined by whether patients received an effective dose of donepezil (>/=5 mg/d; >/=80% compliance) for specific numbers of weeks during the double-blind or open-label trial phase, in both phases, or in neither.  Cox proportional hazards models were used to estimate risk ratios for NHP and survival curves from which median times to NHP were estimated for first dementia-related placement of longer than 2 weeks and permanent placement.  The models were adjusted for age, sex, baseline Mini-Mental State Examination score, whether the caregiver was a spouse, caregiver continuity, and use of other cholinesterase inhibitors after the clinical trials.  RESULTS:  Use of donepezil of 5 mg/d or more was associated with significant delays in NHP.  A cumulative dose-response relationship was observed between longer-term sustained donepezil use and delay of NHP.  When donepezil was taken at an effective dose for at least 9 to 12 months, conservative estimates of the time gained before NHP were 21.4 months for first dementia-related NHP and 17.5 months for permanent NHP.  CONCLUSION:  Use of donepezil by AD patients resulted in significant delays in NHP.  Long-term use of donepezil may help AD patients live longer in community settings, with consequent personal, social, and economic benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXmoyhFZauwfcsfMJQC1ZdfW6udTcc2eYHOw2FopyMCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sznsFyrsw%253D%253D&md5=ba06fb717bec801eb57215ea4d53185e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2389.2003.51306.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2389.2003.51306.x%26sid%3Dliteratum%253Aachs%26aulast%3DGeldmacher%26aufirst%3DD.%2BS.%26aulast%3DProvenzano%26aufirst%3DG.%26aulast%3DMcRae%26aufirst%3DT.%26aulast%3DMastey%26aufirst%3DV.%26aulast%3DIeni%26aufirst%3DJ.%2BR.%26atitle%3DDonepezil%2520is%2520associated%2520with%2520delayed%2520nursing%2520home%2520placement%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Am.%2520Geriatr.%2520Soc.%26date%3D2003%26volume%3D51%26spage%3D937%26epage%3D944%26doi%3D10.1046%2Fj.1365-2389.2003.51306.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilienfeld, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span> <span> </span><span class="NLM_article-title">A 5-month, randomized, placebo-controlled trial of galantamine in AD. The galantamine USA-10 study group</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2269</span>– <span class="NLM_lpage">2276</span>, <span class="refDoi"> DOI: 10.1212/WNL.54.12.2269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1212%2FWNL.54.12.2269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10881251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFSmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=2269-2276&author=P.+N.+Tariotauthor=P.+R.+Solomonauthor=J.+C.+Morrisauthor=P.+Kershawauthor=S.+Lilienfeldauthor=C.+Ding&title=A+5-month%2C+randomized%2C+placebo-controlled+trial+of+galantamine+in+AD.+The+galantamine+USA-10+study+group&doi=10.1212%2FWNL.54.12.2269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A 5-month, randomized, placebo-controlled trial of galantamine in AD</span></div><div class="casAuthors">Tariot, P. N.; Solomon, P. R.; Morris, J. C.; Kershaw, P.; Lilienfeld, S.; Ding, C.; Ahern, G.; Aronson, S.; Brenner, R.; Burke, W.; Cochran, J.; Cohen, S.; Cummins, H.; Drachman, D.; Duboff, E.; Farlow, M.; Ferris, S.; Forchetti, C.; Frey, J.; Grossberg, G.; Harrell, L.; Hoffstetter, M.; Holub, R.; Kaye, J.; Landbloom, R.; Levin, K.; Lindahl, L.; Londborg, P.; Lyketsos, C.; Maguire, G.; Mallya, G.; Merideth, C.; Mintzer, J.; Morris, J.; Newhouse, P.; Ng, K.; Plopper, M.; Porteinsson, A.; Probst, T.; Raskind, M.; Reichman, W.; Richardson, B.; Richter, R.; Ross, J.; Sadowsky, C.; Saur, D.; Sauter, M.; Scharre, D.; Schindler, R.; Schneider, L.; Scinto, L.; Siegal, A.; Smith, W.; Solomon, P.; Steinberg, A.; Stone, W.; Tariot, P. N.; Thein, S.; Van Dyck, C.; Visser, J.; Walshe, T., III; Weiner, M.; West, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2269-2276</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The efficacy and tolerability of galantamine, using a slow dose escalation schedule of up to 8 wk, were evaluated in 978 patients with mild to moderate AD.  The study consisted of a 5-mo multicenter, placebo-controlled, double-blind trial.  Following a 4-wk placebo run-in, patients were randomized to one of four treatment arms: placebo or galantamine escalated to final maintenance doses of 8, 16, or 24 mg/day.  Outcome measures included the cognitive subscale of the AD Assessment Scale (ADAS-cog), the Clinician's Interview-Based Impression of Change plus Caregiver Input (CIBIC-plus), the AD Cooperative Study Activities of Daily Living inventory, and the Neuropsychiatric Inventory.  Std. safety evaluations and adverse event monitoring were carried out.  After 5 mo, the galantamine-placebo differences on ADAS-cog were 3.3 points for the 16 mg/day group and 3.6 points for the 24 mg/day group (p < 0.001 vs. placebo, both doses).  Compared with placebo, the galantamine 16- and 24-mg/day groups also had a significantly better outcome on CIBIC-plus, activities of daily living, and behavioral symptoms.  Treatment discontinuations due to adverse events were low in all galantamine groups (6 to 10%) and comparable with the discontinuation rate in the placebo group (7%).  The incidence of adverse events in the galantamine groups, notably gastrointestinal symptoms, was low and most adverse events were mild.  Galantamine 16 and 24 mg/day significantly benefits the cognitive, functional, and behavioral symptoms of AD as compared with placebo.  Slow dose escalation appears to enhance the tolerability of galantamine, minimizing the incidence and severity of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn9bdC2XgNr7Vg90H21EOLACvtfcHk0lgxAG3_UTCfpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFSmsL8%253D&md5=1833030f74b7331699a45fbe3f750dcb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1212%2FWNL.54.12.2269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.54.12.2269%26sid%3Dliteratum%253Aachs%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DSolomon%26aufirst%3DP.%2BR.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DKershaw%26aufirst%3DP.%26aulast%3DLilienfeld%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DC.%26atitle%3DA%25205-month%252C%2520randomized%252C%2520placebo-controlled%2520trial%2520of%2520galantamine%2520in%2520AD.%2520The%2520galantamine%2520USA-10%2520study%2520group%26jtitle%3DNeurology%26date%3D2000%26volume%3D54%26spage%3D2269%26epage%3D2276%26doi%3D10.1212%2FWNL.54.12.2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span> <i>Clinical Trials in Alzheimer’s Disease.</i> <a href="https://www.ctad-alzheimer.com/" class="extLink">https://www.ctad-alzheimer.com/</a> (accessed Mar 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=M.+Geng&title=Clinical+Trials+in+Alzheimer%E2%80%99s+Disease."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DM.%26jtitle%3DClinical%2520Trials%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease.%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of c-Jun N-terminal kinases: an update</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1021/jm501212r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501212r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=72-95&author=P.+Kochauthor=M.+Gehringerauthor=S.+A.+Laufer&title=Inhibitors+of+c-Jun+N-terminal+kinases%3A+an+update&doi=10.1021%2Fjm501212r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of c-Jun N-Terminal Kinases: An Update</span></div><div class="casAuthors">Koch, Pierre; Gehringer, Matthias; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-95</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The c-Jun N-terminal kinases (JNKs) are serine/threonine kinases implicated in the pathogenesis of various diseases.  Recent advances in the development of novel inhibitors of JNKs will be reviewed.  Significant progress in the design of JNK inhibitors displaying selectivity vs. other kinases has been achieved within the past 4 years.  However, the development of isoform selective JNK inhibitors is still an open task.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_LzW9t04ImLVg90H21EOLACvtfcHk0lgxAG3_UTCfpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FN&md5=0d1c32e1463de951c8b47f35882f90ab</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm501212r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501212r%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DInhibitors%2520of%2520c-Jun%2520N-terminal%2520kinases%253A%2520an%2520update%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D72%26epage%3D95%26doi%3D10.1021%2Fjm501212r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tournier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimnual, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. J.</span></span> <span> </span><span class="NLM_article-title">Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">870</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1126/science.288.5467.870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1126%2Fscience.288.5467.870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10797012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFGisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2000&pages=870-874&author=C.+Tournierauthor=P.+Hessauthor=D.+D.+Yangauthor=J.+Xuauthor=T.+K.+Turnerauthor=A.+Nimnualauthor=D.+Bar-Sagiauthor=S.+N.+Jonesauthor=R.+A.+Flavellauthor=R.+J.+Davis&title=Requirement+of+JNK+for+stress-induced+activation+of+the+cytochrome+c-mediated+death+pathway&doi=10.1126%2Fscience.288.5467.870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway</span></div><div class="casAuthors">Tournier, Cathhy; Hess, Patricia; Yang, Derek D.; Xu, Jie; Turner, Tod K.; Nimnual, Anjaruwee; Bar-Sagi, Dafna; Jones, Stephen N.; Flavell, Richard A.; Davis, Roger J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">5467</span>),
    <span class="NLM_cas:pages">870-874</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The c-Jun NH2-terminal kinase (JNK) is activated when cells are exposed to UV radiation.  However, the functional consequence of JNK activation in UV-irradiated cells has not been established.  It is shown here that JNK is required for UV-induced apoptosis in primary murine embryonic fibroblasts.  Fibroblasts with simultaneous targeted disruptions of all the functional Jnk genes were protected against UV-stimulated apoptosis.  The absence of JNK caused a defect in the mitochondrial death signaling pathway, including the failure to release cytochrome c.  These data indicate that mitochondria are influenced by proapoptotic signal transduction through the JNK pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvUKbVwr9pErVg90H21EOLACvtfcHk0lgxAG3_UTCfpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFGisLg%253D&md5=919ddffe16984321cbc14d9bddc3dbe4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.288.5467.870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.288.5467.870%26sid%3Dliteratum%253Aachs%26aulast%3DTournier%26aufirst%3DC.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DD.%2BD.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTurner%26aufirst%3DT.%2BK.%26aulast%3DNimnual%26aufirst%3DA.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DS.%2BN.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26atitle%3DRequirement%2520of%2520JNK%2520for%2520stress-induced%2520activation%2520of%2520the%2520cytochrome%2520c-mediated%2520death%2520pathway%26jtitle%3DScience%26date%3D2000%26volume%3D288%26spage%3D870%26epage%3D874%26doi%3D10.1126%2Fscience.288.5467.870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cargnello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, P. P.</span></span> <span> </span><span class="NLM_article-title">Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">496</span>, <span class="refDoi"> DOI: 10.1128/MMBR.00013-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1128%2FMMBR.00013-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2012&pages=496&author=M.+Cargnelloauthor=P.+P.+Roux&title=Activation+and+function+of+the+MAPKs+and+their+substrates%2C+the+MAPK-activated+protein+kinases&doi=10.1128%2FMMBR.00013-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00013-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00013-12%26sid%3Dliteratum%253Aachs%26aulast%3DCargnello%26aufirst%3DM.%26aulast%3DRoux%26aufirst%3DP.%2BP.%26atitle%3DActivation%2520and%2520function%2520of%2520the%2520MAPKs%2520and%2520their%2520substrates%252C%2520the%2520MAPK-activated%2520protein%2520kinases%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2012%26volume%3D76%26spage%3D496%26doi%3D10.1128%2FMMBR.00013-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, E. T.</span></span> <span> </span><span class="NLM_article-title">Nuclear and cytosolic JNK signalling in neurons</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1038/nrn3729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1038%2Fnrn3729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=24739785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlagsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=285-299&author=E.+T.+Coffey&title=Nuclear+and+cytosolic+JNK+signalling+in+neurons&doi=10.1038%2Fnrn3729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear and cytosolic JNK signalling in neurons</span></div><div class="casAuthors">Coffey, Eleanor T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">285-299</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It has been over 20 years since JUN amino-terminal kinases (JNKs) were identified as protein kinases that are strongly activated by cellular stress and that have a key role in apoptosis.  Examn. of Jnk-knockout mice and characterization of JNK behavior in neuronal cells has further revealed the importance of the JNK family in the nervous system.  As well as regulating neuronal death, JNKs govern brain morphogenesis and axodendritic architecture during development, and regulate important neuron-specific functions such as synaptic plasticity and memory formation.  This Review examines the evidence that the spatial segregation of JNKs in neurons underlies their distinct functions and that compartment-specific targeting of JNKs may offer promising new therapeutic avenues for the treatment of diseases of the nervous system, such as stroke and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmWx_u9jXjdrVg90H21EOLACvtfcHk0ljdj2vpmlKdig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlagsLY%253D&md5=3663cf6a809ff8ff5e836bf37f82c69e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrn3729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3729%26sid%3Dliteratum%253Aachs%26aulast%3DCoffey%26aufirst%3DE.%2BT.%26atitle%3DNuclear%2520and%2520cytosolic%2520JNK%2520signalling%2520in%2520neurons%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2014%26volume%3D15%26spage%3D285%26epage%3D299%26doi%3D10.1038%2Fnrn3729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. J.</span></span> <span> </span><span class="NLM_article-title">Signal transduction by the JNK group of MAP kinases</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)00116-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2FS0092-8674%2800%2900116-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=11057897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns1Cltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2000&pages=239-252&author=R.+J.+Davis&title=Signal+transduction+by+the+JNK+group+of+MAP+kinases&doi=10.1016%2FS0092-8674%2800%2900116-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transduction by the JNK group of MAP kinases</span></div><div class="casAuthors">Davis, Roger J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-252</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 132 refs.  The purpose of this review is to summarize recent advances that have been made toward understanding the JNK signaling pathway.  It is now known that JNK is required for embryonic morphogenesis and that this signaling pathway contributes to the regulation of cell proliferation and apoptosis.  JNK also contributes to the function of some differentiated cells.  Thus, the JNK signal transduction pathway is implicated in multiple physiol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMPzQW8epuZ7Vg90H21EOLACvtfcHk0ljdj2vpmlKdig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns1Cltrk%253D&md5=eeb3712790a731b15d2676a94197057a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900116-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900116-1%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26atitle%3DSignal%2520transduction%2520by%2520the%2520JNK%2520group%2520of%2520MAP%2520kinases%26jtitle%3DCell%26date%3D2000%26volume%3D103%26spage%3D239%26epage%3D252%26doi%3D10.1016%2FS0092-8674%2800%2900116-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitmarsh, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavanagh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluss, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derijard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. J.</span></span> <span> </span><span class="NLM_article-title">Selective interaction of JNK protein kinase isoforms with transcription factors</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2760</span>– <span class="NLM_lpage">2770</span>, <span class="refDoi"> DOI: 10.1002/j.1460-2075.1996.tb00636.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1002%2Fj.1460-2075.1996.tb00636.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=8654373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADyaK28XjvVWitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=2760-2770&author=S.+Guptaauthor=T.+Barrettauthor=A.+J.+Whitmarshauthor=J.+Cavanaghauthor=H.+K.+Slussauthor=B.+Derijardauthor=R.+J.+Davis&title=Selective+interaction+of+JNK+protein+kinase+isoforms+with+transcription+factors&doi=10.1002%2Fj.1460-2075.1996.tb00636.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Selective interaction of JNK protein kinase isoforms with transcription factors</span></div><div class="casAuthors">Gupta, Shashi; Barret, Tamera; Whitmarsh, Alan J.; Cavanagh, Julie; Sluss, Hayla K.; Derijard, Benoit; Davis, Roger J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2760-2770</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The JNK protein kinase is a member of the MAP kinase group that is activated in response to dual phosphorylation on threonine and tyrosine.  Ten JNK isoforms were identified in human brain by mol. cloning.  These protein kinases correspond to alternatively spliced isoforms derived from the JNK1, JNK2 and JNK3 genes.  The protein kinase activity of these JNK isoforms was measured using the transcription factors ATF2, Elk-1 and members of the Jun family as substrates.  Treatment of cells with interleukin-1 (IL-1) caused activation of the JNK isoforms.  This activation was blocked by expression of the MAP kinase phosphatase MKP-1.  Comparison of the binding activity of the JNK isoforms demonstrated that the JNK proteins differ in their interaction with ATF2, Elk-1 and Jun transcription factors.  Individual members of the JNK group may therefore selectively target specific transcription factors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX1aO5n8MPFbVg90H21EOLACvtfcHk0ljdj2vpmlKdig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVWitbo%253D&md5=2947079a9a607c139115a34cf389d933</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1996.tb00636.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1996.tb00636.x%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DBarrett%26aufirst%3DT.%26aulast%3DWhitmarsh%26aufirst%3DA.%2BJ.%26aulast%3DCavanagh%26aufirst%3DJ.%26aulast%3DSluss%26aufirst%3DH.%2BK.%26aulast%3DDerijard%26aufirst%3DB.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26atitle%3DSelective%2520interaction%2520of%2520JNK%2520protein%2520kinase%2520isoforms%2520with%2520transcription%2520factors%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D2760%26epage%3D2770%26doi%3D10.1002%2Fj.1460-2075.1996.tb00636.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waetzig, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdegen, T.</span></span> <span> </span><span class="NLM_article-title">Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2005.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.tips.2005.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=16054242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslCgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=455-461&author=V.+Waetzigauthor=T.+Herdegen&title=Context-specific+inhibition+of+JNKs%3A+overcoming+the+dilemma+of+protection+and+damage&doi=10.1016%2Fj.tips.2005.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage</span></div><div class="casAuthors">Waetzig, Vicki; Herdegen, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The c-Jun N-terminal kinases (JNKs), which are essential regulators of physiol. and pathol. processes, are involved in several diseases including diabetes, atherosclerosis, stroke, and Parkinson's and Alzheimer's diseases.  Inhibition of JNKs suppresses pathol. features of these diseases but the many physiol. functions of these enzymes argue against the use of sustained, systemic, nonspecific inhibition in the treatment of these diseases.  For example, deletion of the gene that encodes JNK1 prevents insulin resistance but disrupts neuronal cytoarchitecture and initiates the pathol. of Alzheimer's disease.  Thus, it is not sufficient to inhibit selectively either JNKs or individual isoforms of JNK.  Instead, the aim is to inhibit the damaging actions of JNK.  This can be achieved using peptides that selectively target mol. domains of individual JNK signaling complexes (exclusively) that form under pathol. conditions.  To date, peptide inhibitors of JNK have been successful in protecting against ischemia-induced brain damage and insulin resistance following obesity.  In this review, we discuss novel pharmacol. strategies to inhibit JNK and the limitations of these strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUU8sMkwub97Vg90H21EOLACvtfcHk0lhs_JTfVVqPWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslCgsL0%253D&md5=e9b12c2b4258c0a7f71b871f5528a751</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DWaetzig%26aufirst%3DV.%26aulast%3DHerdegen%26aufirst%3DT.%26atitle%3DContext-specific%2520inhibition%2520of%2520JNKs%253A%2520overcoming%2520the%2520dilemma%2520of%2520protection%2520and%2520damage%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D455%26epage%3D461%26doi%3D10.1016%2Fj.tips.2005.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sclip, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forloni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borsello, T.</span></span> <span> </span><span class="NLM_article-title">JNK regulates APP cleavage and degradation in a model of Alzheimer’s disease</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">525</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2008.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.nbd.2008.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=19166938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVSjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=518-525&author=A.+Colomboauthor=A.+Bastoneauthor=C.+Ploiaauthor=A.+Sclipauthor=M.+Salmonaauthor=G.+Forloniauthor=T.+Borsello&title=JNK+regulates+APP+cleavage+and+degradation+in+a+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.nbd.2008.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">JNK regulates APP cleavage and degradation in a model of Alzheimer's disease</span></div><div class="casAuthors">Colombo, Alessio; Bastone, Antonio; Ploia, Cristina; Sclip, Alessandra; Salmona, Mario; Forloni, Gianluigi; Borsello, Tiziana</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">518-525</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Secretion of Amyloid-beta peptide (Aβ) circulating oligomers and their aggregate forms derived by processing of beta-amyloid precursor protein (APP) are a key event in Alzheimer's disease (AD).  We show that phosphorylation of APP on threonine 668 may play a role in APP metab. in H4-APPsw cell line, a degenerative AD model.  We proved that JNK plays a fundamental role in this phosphorylation since its specific inhibition, with the JNK inhibitor peptide (D-JNKI1), induced APP degrdn. and prevented APP phosphorylation at T668.  This results in a significant drop of βAPPs, Aβ fragments and Aβ circulating oligomers.  Moreover the D-JNKI1 treatment produced a switch in the APP metab., since the peptide reduced the rate of the amyloidogenic processing in favor of the non-amyloidogenic one.  All together our results suggest an important link between APP metab. and the JNK pathway and contribute to shed light on the mol. signalling pathway of this disease indicating JNK as an innovative target for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-j8BPYvgDB7Vg90H21EOLACvtfcHk0lhs_JTfVVqPWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVSjt74%253D&md5=7e7ba36777e13a3bf5430b8be9c1cc14</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2008.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2008.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DA.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DPloia%26aufirst%3DC.%26aulast%3DSclip%26aufirst%3DA.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DForloni%26aufirst%3DG.%26aulast%3DBorsello%26aufirst%3DT.%26atitle%3DJNK%2520regulates%2520APP%2520cleavage%2520and%2520degradation%2520in%2520a%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D33%26spage%3D518%26epage%3D525%26doi%3D10.1016%2Fj.nbd.2008.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Triaca, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sposato, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciotti, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelicci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruni, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupidi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maletta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feligioni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nistico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calissano, P.</span></span> <span> </span><span class="NLM_article-title">NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer’s disease</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1111/acel.12473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1111%2Facel.12473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=27076121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVSnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=661-672&author=V.+Triacaauthor=V.+Sposatoauthor=G.+Bolascoauthor=M.+T.+Ciottiauthor=P.+Pelicciauthor=A.+C.+Bruniauthor=C.+Cupidiauthor=R.+Malettaauthor=M.+Feligioniauthor=R.+Nisticoauthor=N.+Canuauthor=P.+Calissano&title=NGF+controls+APP+cleavage+by+downregulating+APP+phosphorylation+at+Thr668%3A+relevance+for+Alzheimer%E2%80%99s+disease&doi=10.1111%2Facel.12473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease</span></div><div class="casAuthors">Triaca, Viviana; Sposato, Valentina; Bolasco, Giulia; Ciotti, Maria Teresa; Pelicci, Piergiuseppe; Bruni, Amalia C.; Cupidi, Chiara; Maletta, Raffaele; Feligioni, Marco; Nistico, Robert; Canu, Nadia; Calissano, Pietro</div><div class="citationInfo"><span class="NLM_cas:title">Aging Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">661-672</span>CODEN:
                <span class="NLM_cas:coden">ACGECQ</span>;
        ISSN:<span class="NLM_cas:issn">1474-9718</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : NGF has been implicated in forebrain neuroprotection from amyloidogenesis and Alzheimer's disease (AD).  However, the underlying mol. mechanisms are still poorly understood.  Here, we investigated the role of NGF signalling in the metab. of amyloid precursor protein (APP) in forebrain neurons using primary cultures of septal neurons and acute septo-hippocampal brain slices.  In this study, we show that NGF controls the basal level of APP phosphorylation at Thr668 (T668) by downregulating the activity of the Ser/Thr kinase JNK(p54) through the Tyr kinase signalling adaptor SH2-contg. sequence C (ShcC).  We also found that the specific NGF receptor, Tyr kinase A (TrkA), which is known to bind to APP, fails to interact with the fraction of APP mols. phosphorylated at T668 (APPpT668).  Accordingly, the amt. of TrkA bound to APP is significantly reduced in the hippocampus of ShcC KO mice and of patients with AD in which elevated APPpT668 levels are detected.  NGF promotes TrkA binding to APP and APP trafficking to the Golgi, where APP-BACE interaction is hindered, finally resulting in reduced generation of sAPPβ, CTFβ and amyloid-beta (1-42).  These results demonstrate that NGF signalling directly controls basal APP phosphorylation, subcellular localization and BACE cleavage, and pave the way for novel approaches specifically targeting ShcC signalling and/or the APP-TrkA interaction in AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrETcaIiFrU_rVg90H21EOLACvtfcHk0lhs_JTfVVqPWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVSnsbs%253D&md5=9ea05402edaba1535ac435cc8d392b6a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Facel.12473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Facel.12473%26sid%3Dliteratum%253Aachs%26aulast%3DTriaca%26aufirst%3DV.%26aulast%3DSposato%26aufirst%3DV.%26aulast%3DBolasco%26aufirst%3DG.%26aulast%3DCiotti%26aufirst%3DM.%2BT.%26aulast%3DPelicci%26aufirst%3DP.%26aulast%3DBruni%26aufirst%3DA.%2BC.%26aulast%3DCupidi%26aufirst%3DC.%26aulast%3DMaletta%26aufirst%3DR.%26aulast%3DFeligioni%26aufirst%3DM.%26aulast%3DNistico%26aufirst%3DR.%26aulast%3DCanu%26aufirst%3DN.%26aulast%3DCalissano%26aufirst%3DP.%26atitle%3DNGF%2520controls%2520APP%2520cleavage%2520by%2520downregulating%2520APP%2520phosphorylation%2520at%2520Thr668%253A%2520relevance%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAging%2520Cell%26date%3D2016%26volume%3D15%26spage%3D661%26epage%3D672%26doi%3D10.1111%2Facel.12473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozer, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tep, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastorino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunwar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahara, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuszynski, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.</span></span> <span> </span><span class="NLM_article-title">JNK3 perpetuates metabolic stress induced by Abeta peptides</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2012.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.neuron.2012.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=22958823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSktrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=824-837&author=S.+O.+Yoonauthor=D.+J.+Parkauthor=J.+C.+Ryuauthor=H.+G.+Ozerauthor=C.+Tepauthor=Y.+J.+Shinauthor=T.+H.+Limauthor=L.+Pastorinoauthor=A.+J.+Kunwarauthor=J.+C.+Waltonauthor=A.+H.+Nagaharaauthor=K.+P.+Luauthor=R.+J.+Nelsonauthor=M.+H.+Tuszynskiauthor=K.+Huang&title=JNK3+perpetuates+metabolic+stress+induced+by+Abeta+peptides&doi=10.1016%2Fj.neuron.2012.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides</span></div><div class="casAuthors">Yoon, Sung Ok; Park, Dong Ju; Ryu, Jae Cheon; Ozer, Hatice Gulcin; Tep, Chhavy; Shin, Yong Jae; Lim, Tae Hee; Pastorino, Lucia; Kunwar, Ajaya J.; Walton, James C.; Nagahara, Alan H.; Lu, Kun Ping; Nelson, Randy J.; Tuszynski, Mark H.; Huang, Kun</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">824-837</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although Aβ peptides are causative agents in Alzheimer's disease (AD), the underlying mechanisms are still elusive.  We report that Aβ42 induces a translational block by activating AMPK, thereby inhibiting the mTOR pathway.  This translational block leads to widespread ER stress, which activates JNK3.  JNK3 in turn phosphorylates APP at T668, thereby facilitating its endocytosis and subsequent processing.  In support, pharmacol. blocking translation results in a significant increase in Aβ42 in a JNK3-dependent manner.  Thus, JNK3 activation, which is increased in human AD cases and a familial AD (FAD) mouse model, is integral to perpetuating Aβ42 prodn.  Concomitantly, deletion of JNK3 from FAD mice results in a dramatic redn. in Aβ42 levels and overall plaque loads and increased neuronal no. and improved cognition.  This reveals AD as a metabolic disease that is under tight control by JNK3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOAk5iFWtmHLVg90H21EOLACvtfcHk0lh9sHeuUW-MpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSktrrI&md5=d54d63193d35184d8f8ef14e0631c03e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2012.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2012.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DS.%2BO.%26aulast%3DPark%26aufirst%3DD.%2BJ.%26aulast%3DRyu%26aufirst%3DJ.%2BC.%26aulast%3DOzer%26aufirst%3DH.%2BG.%26aulast%3DTep%26aufirst%3DC.%26aulast%3DShin%26aufirst%3DY.%2BJ.%26aulast%3DLim%26aufirst%3DT.%2BH.%26aulast%3DPastorino%26aufirst%3DL.%26aulast%3DKunwar%26aufirst%3DA.%2BJ.%26aulast%3DWalton%26aufirst%3DJ.%2BC.%26aulast%3DNagahara%26aufirst%3DA.%2BH.%26aulast%3DLu%26aufirst%3DK.%2BP.%26aulast%3DNelson%26aufirst%3DR.%2BJ.%26aulast%3DTuszynski%26aufirst%3DM.%2BH.%26aulast%3DHuang%26aufirst%3DK.%26atitle%3DJNK3%2520perpetuates%2520metabolic%2520stress%2520induced%2520by%2520Abeta%2520peptides%26jtitle%3DNeuron%26date%3D2012%26volume%3D75%26spage%3D824%26epage%3D837%26doi%3D10.1016%2Fj.neuron.2012.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillozet-Bongaarts, A.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cryns, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binder, L. I.</span></span> <span> </span><span class="NLM_article-title">Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1005</span>– <span class="NLM_lpage">1014</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.03784.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1111%2Fj.1471-4159.2006.03784.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=16606369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVOntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2006&pages=1005-1014&author=A.%0AL.+Guillozet-Bongaartsauthor=M.+E.+Cahillauthor=V.+L.+Crynsauthor=M.+R.+Reynoldsauthor=R.+W.+Berryauthor=L.+I.+Binder&title=Pseudophosphorylation+of+tau+at+serine+422+inhibits+caspase+cleavage%3A+in+vitro+evidence+and+implications+for+tangle+formation+in+vivo&doi=10.1111%2Fj.1471-4159.2006.03784.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo</span></div><div class="casAuthors">Guillozet-Bongaarts, Angela L.; Cahill, Michael E.; Cryns, Vincent L.; Reynolds, Matthew R.; Berry, Robert W.; Binder, Lester I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1005-1014</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The tangles of Alzheimer's disease (AD) are comprised of the tau protein displaying numerous alterations, including phosphorylation at serine 422 (S422) and truncation at aspartic acid 421 (D421).  Truncation at the latter site appears to result from activation of caspases, a class of proteases that cleave specifically at aspartic acid residues.  It has been proposed that phosphorylation at or near caspase cleavage sites could regulate the ability of the protease to cleave at those sites.  Here, we use tau pseudophosphorylated at S422 (S422E) to examine the effects of tau phosphorylation on its cleavage by caspase 3.  We find that S422E tau is more resistant to proteolysis by caspase 3 than non-pseudophosphorylated tau.  Addnl., we use antibodies directed against the phosphorylation site and against the truncation epitope to assess the presence of these epitopes in neurofibrillary tangles in the aged human brain.  We show that phosphorylation precedes truncation during tangle maturation.  Moreover, the distribution of the two epitopes suggests that a significant length of time (perhaps as much as two decades) elapses between S422 phosphorylation and cleavage at D421.  We further conclude that tau phosphorylation at S422 may be a protective mechanism that inhibits cleavage in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8FRMpyiZv4bVg90H21EOLACvtfcHk0lh9sHeuUW-MpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVOntro%253D&md5=6124e371597607c8482e7e046e782b3e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03784.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03784.x%26sid%3Dliteratum%253Aachs%26aulast%3DGuillozet-Bongaarts%26aufirst%3DA.%2BL.%26aulast%3DCahill%26aufirst%3DM.%2BE.%26aulast%3DCryns%26aufirst%3DV.%2BL.%26aulast%3DReynolds%26aufirst%3DM.%2BR.%26aulast%3DBerry%26aufirst%3DR.%2BW.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26atitle%3DPseudophosphorylation%2520of%2520tau%2520at%2520serine%2520422%2520inhibits%2520caspase%2520cleavage%253A%2520in%2520vitro%2520evidence%2520and%2520implications%2520for%2520tangle%2520formation%2520in%2520vivo%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D97%26spage%3D1005%26epage%3D1014%26doi%3D10.1111%2Fj.1471-4159.2006.03784.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagalwar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillozet-Bongaarts, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binder, L. I.</span></span> <span> </span><span class="NLM_article-title">Formation of phospho-SAPK/JNK is an early event in granules in the hippocampus Alzheimer disease</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1097/01.jnen.0000229236.98124.d8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1097%2F01.jnen.0000229236.98124.d8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=16772869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A280%3ADC%252BD28zlvVClsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2006&pages=455-464&author=S.+Lagalwarauthor=A.+L.+Guillozet-Bongaartsauthor=R.+W.+Berryauthor=L.+I.+Binder&title=Formation+of+phospho-SAPK%2FJNK+is+an+early+event+in+granules+in+the+hippocampus+Alzheimer+disease&doi=10.1097%2F01.jnen.0000229236.98124.d8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease</span></div><div class="casAuthors">Lagalwar Sarita; Guillozet-Bongaarts Angela L; Berry Robert W; Binder Lester I</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuropathology and experimental neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">455-64</span>
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    </div><div class="casAbstract">The mitogen-activated protein (MAP) kinase SAPK/JNK phosphorylates tau protein at many of its proline-directed serine/threonine residues in vitro and is a likely candidate kinase to phosphorylate the pathologically relevant S422 site on tau.  Since phosphorylation of tau, particularly at S422, is a relatively early marker of AD and seems to precede tangle formation, it appears likely that an early form of activated SAPK/JNK might be detected by immunohistochemical means around the time that tau begins to aggregate into tangles.  We report here that an antibody to phospho-SAPK/JNK (p-SAPK/JNK) reacts with several types of lesions including granular bodies in limbic areas; NFTs in limbic cortex and temporal neocortex; occasional neuritic plaques in temporal neocortex; and select axons in the hippocampus, entorhinal cortex, and inferior temporal cortex.  In order to characterize the appearance of granular p-SAPK/JNK and determine if it appears early in disease, we employed an immunohistochemical study of postmortem limbic tissue from 20 cases ranging from Braak stages I-VI.  By co-staining with anti-tau antibodies specific to different molecular events that occur during tangle evolution, we were able to identify the appearance of p-SAPK/JNK in early Braak stages with an increased elevation during the limbic stages of AD and during the early stages of the formation of individual hippocampal tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSV9hlaR5K7dsScOqQTSkOffW6udTcc2eZ5Lu5JTx4ux7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zlvVClsw%253D%253D&md5=7b8c3821d7c871d1ca28560d94554b5c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1097%2F01.jnen.0000229236.98124.d8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.jnen.0000229236.98124.d8%26sid%3Dliteratum%253Aachs%26aulast%3DLagalwar%26aufirst%3DS.%26aulast%3DGuillozet-Bongaarts%26aufirst%3DA.%2BL.%26aulast%3DBerry%26aufirst%3DR.%2BW.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26atitle%3DFormation%2520of%2520phospho-SAPK%252FJNK%2520is%2520an%2520early%2520event%2520in%2520granules%2520in%2520the%2520hippocampus%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2006%26volume%3D65%26spage%3D455%26epage%3D464%26doi%3D10.1097%2F01.jnen.0000229236.98124.d8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1002/ana.24361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1002%2Fana.24361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=25611954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlt1WqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2015&pages=637-654&author=Q.+Zhouauthor=M.+Wangauthor=Y.+Duauthor=W.+Zhangauthor=M.+Baiauthor=Z.+Zhangauthor=Z.+Liauthor=J.+Miao&title=Inhibition+of+c-Jun+N-terminal+kinase+activation+reverses+Alzheimer+disease+phenotypes+in+APPswe%2FPS1dE9+mice&doi=10.1002%2Fana.24361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice</span></div><div class="casAuthors">Zhou, Qiong; Wang, Man; Du, Ying; Zhang, Wei; Bai, Miao; Zhang, Zhuo; Li, Zhuyi; Miao, Jianting</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">637-654</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : Growing evidence indicates that the activation of c-Jun N-terminal kinase (JNK) is implicated in the multiple major pathol. features of Alzheimer disease (AD).  However, whether specific inhibition of JNK activation could prevent disease progression in adult transgenic AD models at moderate stage remains unknown.  Here we first investigated the potential disease-modifying therapeutic effect of systemic administration of SP600125, a small-mol. JNK-specific inhibitor, in middle-aged APPswe/PS1dE9 mice.  Methods : Using behavioral, histol., and biochem. methods, outcomes of SP600125 treatment on neuropathol. and cognitive deficits were studied in APPswe/PS1dE9 mice.  Results : Compared with vehicle-treated APPswe/PS1dE9 mice, chronic treatment of SP600125 for 12 wk potently inhibited JNK activation, which resulted in a marked improvement of behavioral measures of cognitive deficits and a dramatic redn. in amyloid plaque burden, β-amyloid prodn., tau hyperphosphorylation, inflammatory responses, and synaptic loss in these transgenic animals.  In particular, we found that SP600125 treatment strongly promoted nonamyloidogenic amyloid precursor protein (APP) processing and inhibited amyloidogenic APP processing via regulating APP-cleavage secretase expression (ie, ADAM10, BACE1, and PS1) in APPswe/PS1dE9 mice.  Interpretation : Our findings demonstrate that chronic SP600125 treatment is powerfully effective in slowing down disease progression by markedly reducing multiple pathol. features and ameliorating cognitive deficits assocd. with AD.  This study highlights the concept that active JNK actually contributes to the development of the disease, and provides crit. preclin. evidence that specific inhibition of JNK activation by SP600125 treatment may be a novel promising disease-modifying therapeutic strategy for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOwnT-t3qHXbVg90H21EOLACvtfcHk0lh9sHeuUW-MpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlt1WqtLc%253D&md5=0f6ce5cdf905ffc7aea5cb38d90de401</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fana.24361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24361%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBai%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMiao%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520c-Jun%2520N-terminal%2520kinase%2520activation%2520reverses%2520Alzheimer%2520disease%2520phenotypes%2520in%2520APPswe%252FPS1dE9%2520mice%26jtitle%3DAnn.%2520Neurol.%26date%3D2015%26volume%3D77%26spage%3D637%26epage%3D654%26doi%3D10.1002%2Fana.24361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crocker, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lograsso, P.</span></span> <span> </span><span class="NLM_article-title">JNK inhibition protects dopamine neurons and provides behavioral improvement in a rat 6-hydroxydopamine model of Parkinson’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1021/cn1001107</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn1001107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFalsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=207-212&author=C.+E.+Crockerauthor=S.+Khanauthor=M.+D.+Cameronauthor=H.+A.+Robertsonauthor=G.+S.+Robertsonauthor=P.+Lograsso&title=JNK+inhibition+protects+dopamine+neurons+and+provides+behavioral+improvement+in+a+rat+6-hydroxydopamine+model+of+Parkinson%E2%80%99s+disease&doi=10.1021%2Fcn1001107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-Hydroxydopamine Model of Parkinson's Disease</span></div><div class="casAuthors">Crocker, Candice E.; Khan, Susan; Cameron, Michael D.; Robertson, Harold A.; Robertson, George S.; LoGrasso, Philip</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">207-212</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) results from the loss of dopamine neurons located in the substantia nigra pars compacta (SNpc) that project to the striatum.  A therapeutic has yet to be identified that halts this neurodegenerative process, and as such, development of a brain penetrant small mol. neuroprotective agent would represent a significant advancement in the treatment of the disease.  To fill this void, we developed an aminopyrimidine JNK inhibitor (SR-3306) that reduced the loss of dopaminergic cell bodies in the SNpc and their terminals in the striatum produced by unilateral injection of 6-hydroxydopamine (6-OHDA) into the nigrostriatal pathway.  Administration of SR-3306 [10 mg/kg/day (s.c.) for 14 days] increased the no. of tyrosine hydroxylase immunoreactive (TH+) neurons in the SNpc by 6-fold and reduced the loss of the TH+ terminals in the striatum relative to the corresponding side of 6-OHDA-lesioned rats that received only vehicle (p < 0.05).  In addn., SR-3306 [10 mg/kg/day (s.c.) for 14 days] decreased d-amphetamine-induced circling by 87% compared to 6-OHDA-lesioned animals given vehicle.  Steady-state brain levels of SR-3306 at day 14 were 347 nM, which was approx. 2-fold higher than the cell-based IC50 for this compd.  Finally, immunohistochem. staining for phospho-c-jun (p-c-jun) revealed that SR-3306 [10 mg/kg/day (s.c.) for 14 days] produced a 2.3-fold redn. of the no. of immunoreactive neurons in the SNpc relative to vehicle treated rats.  Collectively, these data suggest that orally bioavailable JNK inhibitors may be useful neuroprotective agents for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ZXdX36RxpLVg90H21EOLACvtfcHk0lghXNzjihgzAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFalsbo%253D&md5=3254d7fb8fe2ffbc8be28d22a5b0d650</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcn1001107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1001107%26sid%3Dliteratum%253Aachs%26aulast%3DCrocker%26aufirst%3DC.%2BE.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DRobertson%26aufirst%3DH.%2BA.%26aulast%3DRobertson%26aufirst%3DG.%2BS.%26aulast%3DLograsso%26aufirst%3DP.%26atitle%3DJNK%2520inhibition%2520protects%2520dopamine%2520neurons%2520and%2520provides%2520behavioral%2520improvement%2520in%2520a%2520rat%25206-hydroxydopamine%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D207%26epage%3D212%26doi%3D10.1021%2Fcn1001107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. G.</span></span> <span> </span><span class="NLM_article-title">Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1373</span>– <span class="NLM_lpage">1383</span>, <span class="refDoi"> DOI: 10.1517/13543784.14.11.1373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1517%2F13543784.14.11.1373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=16255677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGqsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1373-1383&author=G.+Y.+Zhangauthor=Q.+G.+Zhang&title=Agents+targeting+c-Jun+N-terminal+kinase+pathway+as+potential+neuroprotectants&doi=10.1517%2F13543784.14.11.1373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants</span></div><div class="casAuthors">Zhang, Guang-Yi; Zhang, Quan-Guang</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1373-1383</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  C-Jun N-terminal kinase (JNK) plays an integral role in neuronal death in multiple cell lines following a wide variety of stimuli and in a no. of physiol. functions that may be involved in human disease, including CNS diseases.  In the past decades, many researchers in this field have found and reinforced the concept that prolonged activation of JNK signaling can induce neuronal cell death by both a transcriptional induction of death-promoting genes and modulation of the mitochondrial apoptosis pathways.  Data are emerging to extend the understanding of the JNK signaling and confirm the possibility that targeting JNK signaling may offer an effective therapy for pathol. conditions in the near future.  This review will focus on the pro-apoptotic role of JNK signaling and updated pharmacol. inhibitors of this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquWjsT9BECMrVg90H21EOLACvtfcHk0lghXNzjihgzAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGqsrnN&md5=4b8775a51ae9a318693e2e36d9fb38ff</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.11.1373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.11.1373%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%2BY.%26aulast%3DZhang%26aufirst%3DQ.%2BG.%26atitle%3DAgents%2520targeting%2520c-Jun%2520N-terminal%2520kinase%2520pathway%2520as%2520potential%2520neuroprotectants%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D1373%26epage%3D1383%26doi%3D10.1517%2F13543784.14.11.1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span> <span> </span><span class="NLM_article-title">JNK inhibitor SP600125 attenuates paraquat-induced acute lung injury: an in vivo and in vitro study</span>. <i>Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1319</span>– <span class="NLM_lpage">1330</span>, <span class="refDoi"> DOI: 10.1007/s10753-017-0575-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1007%2Fs10753-017-0575-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=28474156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFait7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2017&pages=1319-1330&author=H.+Shenauthor=N.+Wuauthor=Y.+Wangauthor=X.+Hanauthor=Q.+Zhengauthor=X.+Caiauthor=H.+Zhangauthor=M.+Zhao&title=JNK+inhibitor+SP600125+attenuates+paraquat-induced+acute+lung+injury%3A+an+in+vivo+and+in+vitro+study&doi=10.1007%2Fs10753-017-0575-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">JNK Inhibitor SP600125 Attenuates Paraquat-Induced Acute Lung Injury: an In Vivo and In Vitro Study</span></div><div class="casAuthors">Shen, Haitao; Wu, Na; Wang, Yu; Han, Xinfei; Zheng, Qiang; Cai, Xue; Zhang, Honglei; Zhao, Min</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1319-1330</span>CODEN:
                <span class="NLM_cas:coden">INFLD4</span>;
        ISSN:<span class="NLM_cas:issn">0360-3997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Acute lung injury (ALI) is a major complication soon after paraquat poisoning and rapidly progresses with high mortality.  However, the specific mechanism underlying paraquat-induced ALI is still unclear.  In this study, the mechanism underlying the protective effects of SP600125 on paraquat-induced ALI was investigated according to oxidative stress, inflammation, and apoptosis.  The rats were randomly assigned into the control group (CON), the paraquat poisoning group (PQ), and the PQ + SP600125 group (SP).  A549 cells were divided into the Con group, Pq group, and Sp group.  H&E staining and detection of lung wet/dry ratio were employed to evaluate lung injury.  Annexin V-PI staining was done to evaluate A549 cell apoptosis.  Dihydroethidium fluorescence was used to measure reactive oxygen species (ROS) in the lungs and A549 cells.  ELISA was performed to detect TNF-α and IL-6 in the supernatant of bronchoalveolar lavage fluid (BALF) and A549 cells.  RT-qPCR was done to measure the mRNA (mRNA) expression of TNF-α and IL-6 in the lungs and A549 cells.  Western blotting assay was performed to detect the protein expression of phospho-JNK, total JNK, and cleaved caspase-3.  Electrophoretic mobility shift assay was employed to detect the DNA binding activities of AP-1 and P-p65.  JNK inhibitor SP600125 reduced JNK phosphorylation, downregulated cleaved caspase-3 protein level, decreased AP-1 transcriptional activity and ROS level, and reduced the transcription and expression of TNF-α and IL-6, which improved ALI and cell apoptosis after paraquat poisoning.  Our results indicate that JNK/AP-1 mediates ALI as well as oxidative stress and inflammation deterioration secondary to paraquat poisoning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp61hG43Jlvx7Vg90H21EOLACvtfcHk0lghXNzjihgzAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFait7Y%253D&md5=9f83f1279e08c875c2ede1b3f1f4cc45</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10753-017-0575-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10753-017-0575-8%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DM.%26atitle%3DJNK%2520inhibitor%2520SP600125%2520attenuates%2520paraquat-induced%2520acute%2520lung%2520injury%253A%2520an%2520in%2520vivo%2520and%2520in%2520vitro%2520study%26jtitle%3DInflammation%26date%3D2017%26volume%3D40%26spage%3D1319%26epage%3D1330%26doi%3D10.1007%2Fs10753-017-0575-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, D.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lograsso, P.</span></span> <span> </span><span class="NLM_article-title">Small molecule c-Jun-N-terminal kinase (JNK) inhibitors protect dopaminergic neurons in a model of Parkinson’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.1021/cn100109k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100109k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFalsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=198-206&author=J.+W.+Chambersauthor=A.+Pachoriauthor=S.+Howardauthor=M.+Gannoauthor=D.+Hansenauthor=T.+Kameneckaauthor=X.+Songauthor=D.+Duckettauthor=W.+Chenauthor=Y.+Y.+Lingauthor=L.+Cherryauthor=M.+D.+Cameronauthor=L.+Linauthor=C.+H.+Ruizauthor=P.+Lograsso&title=Small+molecule+c-Jun-N-terminal+kinase+%28JNK%29+inhibitors+protect+dopaminergic+neurons+in+a+model+of+Parkinson%E2%80%99s+disease&doi=10.1021%2Fcn100109k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson's Disease</span></div><div class="casAuthors">Chambers, Jeremy W.; Pachori, Alok; Howard, Shannon; Ganno, Michelle; Hansen, Donald; Kamenecka, Ted; Song, Xinyi; Duckett, Derek; Chen, Weimin; Ling, Yuan Yuan; Cherry, Lisa; Cameron, Michael D.; Lin, Li; Ruiz, Claudia H.; LoGrasso, Philip</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">198-206</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are currently no drugs to treat neurodegeneration in Parkinson's disease (PD), and all existing medications only treat symptoms, lose efficacy over time, and produce untoward side effects.  In the current work, we report the first highly selective, orally bioavailable c-jun-N-terminal kinase (JNK) inhibitor for protection of dopaminergic neurons in vitro and in vivo.  At 300 nM, this compd. showed statistically significant protection of primary dopaminergic neurons exposed to 1-methyl-4-phenylpyridinium (MPP+), had pharmacokinetic properties in rodents consistent with twice daily (b.i.d.) dosing, and was orally efficacious at 30 mg/kg in a mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson's disease.  Moreover, a dose-dependent target modulation of c-jun phosphorylation served as a biomarker for demonstrating on-target inhibition of JNK as the mechanism of action for this compd.  Collectively, these results suggest that this JNK inhibitor could be a promising therapeutic neuroprotective agent in the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr64E9S-UR66bVg90H21EOLACvtfcHk0liD1GwOKgkXxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFalsb0%253D&md5=b68177290319f0922a59743440d557e7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcn100109k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100109k%26sid%3Dliteratum%253Aachs%26aulast%3DChambers%26aufirst%3DJ.%2BW.%26aulast%3DPachori%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DGanno%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DD.%26aulast%3DKamenecka%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DDuckett%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLing%26aufirst%3DY.%2BY.%26aulast%3DCherry%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DRuiz%26aufirst%3DC.%2BH.%26aulast%3DLograsso%26aufirst%3DP.%26atitle%3DSmall%2520molecule%2520c-Jun-N-terminal%2520kinase%2520%2528JNK%2529%2520inhibitors%2520protect%2520dopaminergic%2520neurons%2520in%2520a%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D198%26epage%3D206%26doi%3D10.1021%2Fcn100109k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graczyk, P. P.</span></span> <span> </span><span class="NLM_article-title">JNK inhibitors as anti-inflammatory and neuroprotective agents</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.4155/fmc.13.34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.4155%2Ffmc.13.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=23573972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsF2nsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=539-551&author=P.+P.+Graczyk&title=JNK+inhibitors+as+anti-inflammatory+and+neuroprotective+agents&doi=10.4155%2Ffmc.13.34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">JNK inhibitors as anti-inflammatory and neuroprotective agents</span></div><div class="casAuthors">Graczyk, Piotr P.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">539-551</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  JNK is involved in a broad range of physiol. processes.  Several inflammatory and neurodegenerative diseases, such as multiple sclerosis, Alzheimer's and Parkinson's disease have been linked with the dysregulated JNK pathway.  Research on disease models using the relevant knockout mice has highlighted the importance of specific JNK isoforms in particular disorders and has stimulated further efforts in the drug-discovery area.  However, most of the exptl. evidence for the efficacy of JNK inhibition in animal models is from studies using JNK inhibitors, which are not isoform selective.  Some of the more recent compds. exhibit good oral bioavailability, CNS penetration and selectivity against the rest of the kinome.  Efforts to design isoform-selective inhibitors have produced a no. of examples with various selectivity profiles.  This article presents recent progress in this area and comment on the role of isoform selectivity for efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqFxJRbS2D57Vg90H21EOLACvtfcHk0liD1GwOKgkXxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsF2nsL0%253D&md5=5b60481d1f6347aab1c3f0ead1c8eede</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.34%26sid%3Dliteratum%253Aachs%26aulast%3DGraczyk%26aufirst%3DP.%2BP.%26atitle%3DJNK%2520inhibitors%2520as%2520anti-inflammatory%2520and%2520neuroprotective%2520agents%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D539%26epage%3D551%26doi%3D10.4155%2Ffmc.13.34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leisten, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motiwala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagwat, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. W.</span></span> <span> </span><span class="NLM_article-title">SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">13681</span>– <span class="NLM_lpage">13686</span>, <span class="refDoi"> DOI: 10.1073/pnas.251194298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1073%2Fpnas.251194298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=11717429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVynsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=13681-13686&author=B.+L.+Bennettauthor=D.+T.+Sasakiauthor=B.+W.+Murrayauthor=E.+C.+O%E2%80%99Learyauthor=S.+T.+Sakataauthor=W.+Xuauthor=J.+C.+Leistenauthor=A.+Motiwalaauthor=S.+Pierceauthor=Y.+Satohauthor=S.+S.+Bhagwatauthor=A.+M.+Manningauthor=D.+W.+Anderson&title=SP600125%2C+an+anthrapyrazolone+inhibitor+of+Jun+N-terminal+kinase&doi=10.1073%2Fpnas.251194298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase</span></div><div class="casAuthors">Bennett, Brydon L.; Sasaki, Dennis T.; Murray, Brion W.; O'Leary, Eoin C.; Sakata, Steve T.; Xu, Weiming; Leisten, Jim C.; Motiwala, Aparna; Pierce, Steve; Satoh, Yoshitaka; Bhagwat, Shripad S.; Manning, Anthony M.; Anderson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13681-13686</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Jun N-terminal kinase (JNK) is a stress-activated protein kinase that can be induced by inflammatory cytokines, bacterial endotoxin, osmotic shock, UV radiation, and hypoxia.  We report the identification of an anthrapyrazolone series with significant inhibition of JNK1, -2, and -3 (Ki = 0.19 μM).  SP600125 is a reversible ATP-competitive inhibitor with >20-fold selectivity vs. a range of kinases and enzymes tested.  In cells, SP600125 dose-dependently inhibited the phosphorylation of c-Jun, the expression of inflammatory genes COX-2, IL-2, IFN-γ, TNF-α, and prevented the activation and differentiation of primary human CD4 cell cultures.  In animal studies, SP600125 blocked (bacterial) lipopolysaccharide-induced expression of tumor necrosis factor-α and inhibited anti-CD3-induced apoptosis of CD4+ CD8+ thymocytes.  Our study supports targeting JNK as an important strategy in inflammatory disease, apoptotic cell death, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3oaSuth8djbVg90H21EOLACvtfcHk0liD1GwOKgkXxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVynsbg%253D&md5=011499f96b13981c568d06120ba0a740</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.251194298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.251194298%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DB.%2BL.%26aulast%3DSasaki%26aufirst%3DD.%2BT.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DE.%2BC.%26aulast%3DSakata%26aufirst%3DS.%2BT.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLeisten%26aufirst%3DJ.%2BC.%26aulast%3DMotiwala%26aufirst%3DA.%26aulast%3DPierce%26aufirst%3DS.%26aulast%3DSatoh%26aufirst%3DY.%26aulast%3DBhagwat%26aufirst%3DS.%2BS.%26aulast%3DManning%26aufirst%3DA.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BW.%26atitle%3DSP600125%252C%2520an%2520anthrapyrazolone%2520inhibitor%2520of%2520Jun%2520N-terminal%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D13681%26epage%3D13686%26doi%3D10.1073%2Fpnas.251194298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedi, K. L.</span></span> <span> </span><span class="NLM_article-title">SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats</span>. <i>Pharmacol. Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2010.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.pbb.2010.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=20600246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2010&pages=386-394&author=N.+Sharmaauthor=R.+Deshmukhauthor=K.+L.+Bedi&title=SP600125%2C+a+competitive+inhibitor+of+JNK+attenuates+streptozotocin+induced+neurocognitive+deficit+and+oxidative+stress+in+rats&doi=10.1016%2Fj.pbb.2010.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats</span></div><div class="casAuthors">Sharma, Nidhi; Deshmukh, Rahul; Bedi, K. L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">386-394</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activated JNK has been reported to be located in nucleus in mild cases of Alzheimer's disease (AD), but is exclusively in cytoplasm in more advanced stages of AD and implicated in its pathogenesis, suggesting that activation and re-distribution of JNK correlate with the progress of AD.  The present study was designed to investigate the role of JNK in intracerebroventricular streptozotocin (i.c.v. STZ) induced cognitive impairment and oxidative stress.  Streptozotocin has been obsd. to impair learning and memory, increase oxidative-nitritive stress, induce cholinergic hypofunction and neuronal damage in rat brain.  Chronic treatment with SP600125 from day 10 to 28 following i.c.v. STZ injections significantly improved spatial memory, attenuate oxidative-nitritive stress.  In addn., significant increase in acetylcholinesterase activity and lactate dehydrogenase (LDH) levels was obsd. in the present model indicating cholinergic hypofunction and increase in neuronal cell damage.  Whereas, SP600125 treatment significantly restored acetylcholinesterase activity and reduced LDH levels indicating restorative capacity of SP600125 with respect to cholinergic functions and preventing the neuronal damage.  In line with previous report, the current study also supports the potential of JNK inhibition as a possible therapeutic strategy to ameliorate neurodegenerative disorders assocd. with oxidative stress and cognitive impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSQpQLt3UsHrVg90H21EOLACvtfcHk0lhWOMzWUhQk_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtLjE&md5=573872186130882faeccef35ec52039e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2010.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2010.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DDeshmukh%26aufirst%3DR.%26aulast%3DBedi%26aufirst%3DK.%2BL.%26atitle%3DSP600125%252C%2520a%2520competitive%2520inhibitor%2520of%2520JNK%2520attenuates%2520streptozotocin%2520induced%2520neurocognitive%2520deficit%2520and%2520oxidative%2520stress%2520in%2520rats%26jtitle%3DPharmacol.%2520Biochem.%2520Behav.%26date%3D2010%26volume%3D96%26spage%3D386%26epage%3D394%26doi%3D10.1016%2Fj.pbb.2010.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W. X.</span></span> <span> </span><span class="NLM_article-title">SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrest</span>. <i>Pharmazie</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">942</span>– <span class="NLM_lpage">946</span>, <span class="refDoi"> DOI: 10.1691/ph.2012.1849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1691%2Fph.2012.1849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=23210245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVOi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=942-946&author=J.+Y.+Liauthor=J.+Y.+Huangauthor=B.+Xingauthor=K.+W.+Renauthor=M.+Liauthor=D.+Weiauthor=P.+Y.+Guauthor=G.+Chenauthor=B.+Guauthor=G.+F.+Zhangauthor=W.+X.+Hu&title=SP600125%2C+a+JNK+inhibitor%2C+suppresses+growth+of+JNK-inactive+glioblastoma+cells+through+cell-cycle+G2%2FM+phase+arrest&doi=10.1691%2Fph.2012.1849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrest</span></div><div class="casAuthors">Li, J. Y.; Huang, J. Y.; Xing, B.; Ren, K. W.; Li, M.; Wei, D.; Gu, P. Y.; Chen, G.; Gu, B.; Zhang, G. F.; Hu, W. X.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmazie</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">942-946</span>CODEN:
                <span class="NLM_cas:coden">PHARAT</span>;
        ISSN:<span class="NLM_cas:issn">0031-7144</span>.
    
            (<span class="NLM_cas:orgname">Govi-Verlag Pharmazeutischer Verlag GmbH</span>)
        </div><div class="casAbstract">SP600125 is a well studied inhibitor of c-Jun N-terminal kinase (JNK).  Its direct biochem. effects on JNK-inactive tumor cells are usually ignored.  In this study, we investigated the effects of SP600125 on JNK-inactive U251 human glioblastoma cells.  Our results demonstrate that, 20 μM or more SP600125 can induce significant cell growth inhibition and cell-cycle G2/M phase arrest in U251 cells.  Interestingly, we also found that SP600125 can stop the duplicated chromosomes from sepg. into two cells and the karyokinesis progression.  Our study opened up a new perspective for further studies involved in JNK inhibitors or anti-glioma therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmEKvzwbPPjLVg90H21EOLACvtfcHk0lhWOMzWUhQk_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVOi&md5=450e7f37a1a75cef6ecbacc3a72f9a8c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1691%2Fph.2012.1849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1691%252Fph.2012.1849%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BY.%26aulast%3DHuang%26aufirst%3DJ.%2BY.%26aulast%3DXing%26aufirst%3DB.%26aulast%3DRen%26aufirst%3DK.%2BW.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DP.%2BY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DG.%2BF.%26aulast%3DHu%26aufirst%3DW.%2BX.%26atitle%3DSP600125%252C%2520a%2520JNK%2520inhibitor%252C%2520suppresses%2520growth%2520of%2520JNK-inactive%2520glioblastoma%2520cells%2520through%2520cell-cycle%2520G2%252FM%2520phase%2520arrest%26jtitle%3DPharmazie%26date%3D2012%26volume%3D67%26spage%3D942%26epage%3D946%26doi%3D10.1691%2Fph.2012.1849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anand, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruthi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, P. P.</span></span> <span> </span><span class="NLM_article-title">The specific, reversible JNK inhibitor SP600125 improves survivability and attenuates neuronal cell death in experimental cerebral malaria (ECM)</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1959</span>– <span class="NLM_lpage">1966</span>, <span class="refDoi"> DOI: 10.1007/s00436-013-3352-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1007%2Fs00436-013-3352-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=23455938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A280%3ADC%252BC3svislWgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2013&pages=1959-1966&author=S.+S.+Anandauthor=M.+Maruthiauthor=P.+P.+Babu&title=The+specific%2C+reversible+JNK+inhibitor+SP600125+improves+survivability+and+attenuates+neuronal+cell+death+in+experimental+cerebral+malaria+%28ECM%29&doi=10.1007%2Fs00436-013-3352-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The specific, reversible JNK inhibitor SP600125 improves survivability and attenuates neuronal cell death in experimental cerebral malaria (ECM)</span></div><div class="casAuthors">Anand Sripada Santosh; Maruthi Mulaka; Babu Phanithi Prakash</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1959-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cerebral malaria (CM) is the most severe complication of Plasmodium falciparum in humans and major cause of death.  SP600125 is a specific, small molecule inhibitor of JNK that prevents the phosphorylation of c-Jun and blocks the expression of proinflammatory cytokines and attenuates neuronal apoptosis in several neurodegenerative disorders.  We evaluated the effect of SP600125 treatment on the survival of Plasmodium berghei ANKA (PbA)-infected C57BL/6J mice.  Administration of SP600125 improved survival in PbA-infected C57BL6J mice but has no effect on parasitemia.  Further, SP600125 administration resulted in attenuation of neuronal cell death along with inhibition of proinflammatory mediators TNF-α and COX-2 and proapoptotic mediators p-c-Jun and active caspase 3 in PbA-infected mice.  The promising findings of this study make SP600125 a potential agent for supportive therapy to alleviate inflammation and neuronal cell death associated with CM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7MlQKb0V41cScOqQTSkOffW6udTcc2eZokpMty-KUCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svislWgsQ%253D%253D&md5=09f4bee1fd760200645930b57943c100</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00436-013-3352-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-013-3352-0%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DS.%2BS.%26aulast%3DMaruthi%26aufirst%3DM.%26aulast%3DBabu%26aufirst%3DP.%2BP.%26atitle%3DThe%2520specific%252C%2520reversible%2520JNK%2520inhibitor%2520SP600125%2520improves%2520survivability%2520and%2520attenuates%2520neuronal%2520cell%2520death%2520in%2520experimental%2520cerebral%2520malaria%2520%2528ECM%2529%26jtitle%3DParasitol.%2520Res.%26date%3D2013%26volume%3D112%26spage%3D1959%26epage%3D1966%26doi%3D10.1007%2Fs00436-013-3352-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halazy, S.</span></span> <span> </span><span class="NLM_article-title">Designing heterocyclic selective kinase inhibitors: from concept to new drug candidates</span>. <i>ARKIVOC</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_fpage">496</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.3998/ark.5550190.0007.734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.3998%2Fark.5550190.0007.734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1eqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=496-508&author=S.+Halazy&title=Designing+heterocyclic+selective+kinase+inhibitors%3A+from+concept+to+new+drug+candidates&doi=10.3998%2Fark.5550190.0007.734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Designing heterocyclic selective kinase inhibitors: from concept to new drug candidates</span></div><div class="casAuthors">Halazy, Serge</div><div class="citationInfo"><span class="NLM_cas:title">ARKIVOC (Gainesville, FL, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">496-508</span>CODEN:
                <span class="NLM_cas:coden">AGFUAR</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Arkat USA Inc.</span>)
        </div><div class="casAbstract">Kinases represent one of the most popular and promising target class in drug discovery.  Success in finding new therapeutics will depend on the validation of the kinase chosen with respect to the disease of interest, and on the ability of chemists to design and synthesize inhibitors which are selective for this particular kinase.  One of the most powerful validation tool for kinases is the Analog-Sensitive Kinase Allele (ASKA) technol., where chemists and biologists have engineered modified kinases and inhibitors by generating functionally active kinase mutants which are specifically inhibited by a chem. modified inhibitor, thus allowing to study specific responses in knock-in animals.  The design of selective, ATP competitive kinase inhibitors has been successfully achieved by combining different technologies like computational chem., structure-based design and combinatorial chem. as illustrated by the discovery of AS602801, a potent and selective JNK inhibitor with therapeutic potential in MS and fibrosis.  The exploration of non ATP-competitive inhibitors is also very promising, as illustrated by the case of MEK inhibitors which show strong interest as anti-cancer agents.  In the future, the rationale design of selective kinase inhibitors will move to the design of compds. that will induce a selective perturbation of cell regulation, where kinases play a crit. role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaVzLpUfqHObVg90H21EOLACvtfcHk0lhE7L6V9sXBHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1eqtbY%253D&md5=c3d6d5846564619e75877588d0131bda</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3998%2Fark.5550190.0007.734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3998%252Fark.5550190.0007.734%26sid%3Dliteratum%253Aachs%26aulast%3DHalazy%26aufirst%3DS.%26atitle%3DDesigning%2520heterocyclic%2520selective%2520kinase%2520inhibitors%253A%2520from%2520concept%2520to%2520new%2520drug%2520candidates%26jtitle%3DARKIVOC%26date%3D2006%26spage%3D496%26epage%3D508%26doi%3D10.3998%2Fark.5550190.0007.734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tos, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotteland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osteen, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruner-Tran, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nataraja, S. G.</span></span> <span> </span><span class="NLM_article-title">Bentamapimod (JNK inhibitor AS602801) induces regression of endometriotic lesions in animal models</span>. <i>Reprod. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1177/1933719115600553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1177%2F1933719115600553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=26335175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVensrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=11-23&author=S.+S.+Palmerauthor=M.+Altanauthor=D.+Denisauthor=E.+G.+Tosauthor=J.+P.+Gottelandauthor=K.+G.+Osteenauthor=K.+L.+Bruner-Tranauthor=S.+G.+Nataraja&title=Bentamapimod+%28JNK+inhibitor+AS602801%29+induces+regression+of+endometriotic+lesions+in+animal+models&doi=10.1177%2F1933719115600553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Bentamapimod (JNK inhibitor AS602801) induces regression of endometriotic lesions in animal models</span></div><div class="casAuthors">Palmer, Stephen S.; Altan, Melis; Denis, Deborah; Tos, Enrico Gillio; Gotteland, Jean-Pierre; Osteen, Kevin G.; Bruner-Tran, Kaylon L.; Nataraja, Selvaraj G.</div><div class="citationInfo"><span class="NLM_cas:title">Reproductive Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-23</span>CODEN:
                <span class="NLM_cas:coden">RSECC3</span>;
        ISSN:<span class="NLM_cas:issn">1933-7191</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Endometriosis is an estrogen (ER)-dependent gynecol. disease caused by the growth of endometrial tissue at extrauterine sites.  Current endocrine therapies address the estrogenic aspect of disease and offer some relief from pain but are assocd. with significant side effects.  Immune dysfunction is also widely believed to be an underlying contributor to the pathogenesis of this disease.  This study evaluated an inhibitor of c-Jun N-terminal kinase, bentamapimod (AS602801), which interrupts immune pathways, in 2 rodent endometriosis models.  Treatment of nude mice bearing xenografts biopsied from women with endometriosis (BWE) with 30 mg/kg AS602801 caused 29% regression of lesion.  Medroxyprogesterone acetate (MPA) or progesterone (PR) alone did not cause regression of BWE lesions, but combining 10 mg/kg AS602801 with MPA caused 38% lesion regression.  In human endometrial organ cultures (from healthy women), treatment with AS602801 or MPA reduced matrix metalloproteinase-3 (MMP-3) release into culture medium.  In organ cultures established with BWE, PR or MPA failed to inhibit MMP-3 secretion, whereas AS602801 alone or MPA + AS602801 suppressed MMP-3 prodn.  In an autologous rat endometriosis model, AS602801 caused 48% regression of lesions compared to GnRH antagonist Antide (84%).  AS602801 reduced inflammatory cytokines in endometriotic lesions, while levels of cytokines in ipsilateral horns were unaffected.  Furthermore, AS602801 enhanced natural killer cell activity, without apparent neg. effects on uterus.  These results indicate that bentamapimod induced regression of endometriotic lesions in endometriosis rodent animal models without suppressing ER action. c-Jun N-terminal kinase inhibition mediated a comprehensive redn. in cytokine secretion and moreover was able to overcome PR resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5FGFNcm6HpLVg90H21EOLACvtfcHk0lhE7L6V9sXBHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVensrY%253D&md5=f8604d4855f38f0a3888a59cf27f463e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1177%2F1933719115600553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1933719115600553%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DS.%2BS.%26aulast%3DAltan%26aufirst%3DM.%26aulast%3DDenis%26aufirst%3DD.%26aulast%3DTos%26aufirst%3DE.%2BG.%26aulast%3DGotteland%26aufirst%3DJ.%2BP.%26aulast%3DOsteen%26aufirst%3DK.%2BG.%26aulast%3DBruner-Tran%26aufirst%3DK.%2BL.%26aulast%3DNataraja%26aufirst%3DS.%2BG.%26atitle%3DBentamapimod%2520%2528JNK%2520inhibitor%2520AS602801%2529%2520induces%2520regression%2520of%2520endometriotic%2520lesions%2520in%2520animal%2520models%26jtitle%3DReprod.%2520Sci.%26date%3D2016%26volume%3D23%26spage%3D11%26epage%3D23%26doi%3D10.1177%2F1933719115600553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span>NCT01630252.
JNK ClinicalTrials.gov. <a href="https://clinicaltrials.gov/" class="extLink">https://clinicaltrials.gov/</a> (accessed Mar 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=NCT01630252.%0AJNK+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2F+%28accessed+Mar+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krenitsky, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadolny, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clareen, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgraf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Sidocky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapienza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahmanyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muir, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celeridad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachowitzer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moghaddam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatsenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benish, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodine, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blease, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cathers, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1438</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.bmcl.2011.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=22244937" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1433-1438&author=V.+P.+Krenitskyauthor=L.+Nadolnyauthor=M.+Delgadoauthor=L.+Ayalaauthor=S.+S.+Clareenauthor=R.+Hilgrafauthor=R.+Albersauthor=S.+Hegdeauthor=N.+D%E2%80%99Sidockyauthor=J.+Sapienzaauthor=J.+Wrightauthor=M.+McCarrickauthor=S.+Bahmanyarauthor=P.+Chamberlainauthor=S.+L.+Delkerauthor=J.+Muirauthor=D.+Giegelauthor=L.+Xuauthor=M.+Celeridadauthor=J.+Lachowitzerauthor=B.+Bennettauthor=M.+Moghaddamauthor=O.+Khatsenkoauthor=J.+Katzauthor=R.+Fanauthor=A.+Baiauthor=Y.+Tangauthor=M.+A.+Shirleyauthor=B.+Benishauthor=T.+Bodineauthor=K.+Bleaseauthor=H.+Raymonauthor=B.+E.+Cathersauthor=Y.+Satoh&title=Discovery+of+CC-930%2C+an+orally+active+anti-fibrotic+JNK+inhibitor&doi=10.1016%2Fj.bmcl.2011.12.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DKrenitsky%26aufirst%3DV.%2BP.%26aulast%3DNadolny%26aufirst%3DL.%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DAyala%26aufirst%3DL.%26aulast%3DClareen%26aufirst%3DS.%2BS.%26aulast%3DHilgraf%26aufirst%3DR.%26aulast%3DAlbers%26aufirst%3DR.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Sidocky%26aufirst%3DN.%26aulast%3DSapienza%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DMcCarrick%26aufirst%3DM.%26aulast%3DBahmanyar%26aufirst%3DS.%26aulast%3DChamberlain%26aufirst%3DP.%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DMuir%26aufirst%3DJ.%26aulast%3DGiegel%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DCeleridad%26aufirst%3DM.%26aulast%3DLachowitzer%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DB.%26aulast%3DMoghaddam%26aufirst%3DM.%26aulast%3DKhatsenko%26aufirst%3DO.%26aulast%3DKatz%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DR.%26aulast%3DBai%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DShirley%26aufirst%3DM.%2BA.%26aulast%3DBenish%26aufirst%3DB.%26aulast%3DBodine%26aufirst%3DT.%26aulast%3DBlease%26aufirst%3DK.%26aulast%3DRaymon%26aufirst%3DH.%26aulast%3DCathers%26aufirst%3DB.%2BE.%26aulast%3DSatoh%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520CC-930%252C%2520an%2520orally%2520active%2520anti-fibrotic%2520JNK%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1433%26epage%3D1438%26doi%3D10.1016%2Fj.bmcl.2011.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span>NCT01466725,
NCT01203943. JNK ClinicalTrials.gov. <a href="https://clinicaltrials.gov/" class="extLink">https://clinicaltrials.gov/</a> (accessed Mar 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=NCT01466725%2C%0ANCT01203943.+JNK+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2F+%28accessed+Mar+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoGrasso, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of highly potent and isoform selective JNK3 inhibitors: SAR studies on aminopyrazole derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10013</span>– <span class="NLM_lpage">10030</span>, <span class="refDoi"> DOI: 10.1021/jm501256y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501256y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWns7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10013-10030&author=K.+Zhengauthor=S.+Iqbalauthor=P.+Hernandezauthor=H.+Parkauthor=P.+V.+LoGrassoauthor=Y.+Feng&title=Design+and+synthesis+of+highly+potent+and+isoform+selective+JNK3+inhibitors%3A+SAR+studies+on+aminopyrazole+derivatives&doi=10.1021%2Fjm501256y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole Derivatives</span></div><div class="casAuthors">Zheng, Ke; Iqbal, Sarah; Hernandez, Pamela; Park, HaJeung; LoGrasso, Philip V.; Feng, Yangbo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10013-10030</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The c-jun N-terminal kinase 3 (JNK3) is expressed primarily in the brain.  Numerous reports have shown that inhibition of JNK3 is a promising strategy for treatment of neurodegeneration.  The optimization of aminopyrazole-based JNK3 inhibitors with improved potency, isoform selectivity, and pharmacol. properties by structure-activity relationship (SAR) studies utilizing biochem. and cell-based assays, and structure-based drug design is reported.  These inhibitors had high selectivity over JNK1 and p38α, minimal cytotoxicity, potent inhibition of 6-OHDA-induced mitochondrial membrane potential dissipation and ROS generation, and good drug metab. and pharmacokinetic (DMPK) properties for iv dosing. 26n was profiled against 464 kinases and was found to be highly selective hitting only seven kinases with >80% inhibition at 10 μM.  Moreover, 26n showed good soly., good brain penetration, and good DMPK properties.  Finally, the crystal structure of 26k in complex with JNK3 was solved at 1.8 Å to explore the binding mode of aminopyrazole based JNK3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLNAzFBTMXr7Vg90H21EOLACvtfcHk0liCY2o0Zj9Lug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWns7fJ&md5=fd826c83f112d7270ef669b74e6ef6f0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm501256y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501256y%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DIqbal%26aufirst%3DS.%26aulast%3DHernandez%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DFeng%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520highly%2520potent%2520and%2520isoform%2520selective%2520JNK3%2520inhibitors%253A%2520SAR%2520studies%2520on%2520aminopyrazole%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10013%26epage%3D10030%26doi%3D10.1021%2Fjm501256y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Messoussi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feneyrolles, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deroide, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayde-Cazals, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheve, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hijfte, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauvel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougrin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasri, A.</span></span> <span> </span><span class="NLM_article-title">Recent progress in the design, study, and development of c-jun N-terminal kinase inhibitors as anticancer agents</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1443</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2014.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.chembiol.2014.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=25442375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOrtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1433-1443&author=A.+Messoussiauthor=C.+Feneyrollesauthor=A.+Brosauthor=A.+Deroideauthor=B.+Dayde-Cazalsauthor=G.+Cheveauthor=N.+Van+Hijfteauthor=B.+Fauvelauthor=K.+Bougrinauthor=A.+Yasri&title=Recent+progress+in+the+design%2C+study%2C+and+development+of+c-jun+N-terminal+kinase+inhibitors+as+anticancer+agents&doi=10.1016%2Fj.chembiol.2014.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Design, Study, and Development of c-Jun N-Terminal Kinase Inhibitors as Anticancer Agents</span></div><div class="casAuthors">Messoussi, Abdellah; Feneyrolles, Clemence; Bros, Aurelie; Deroide, Arthur; Dayde-Cazals, Benedicte; Cheve, Gwenael; Van Hijfte, Nathalie; Fauvel, Benedicte; Bougrin, Khalid; Yasri, Aziz</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1433-1443</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The c-Jun N-terminal kinase (JNK) family, with its three members JNK1, JNK2, and JNK3, is a subfamily of mitogen-activated protein kinases.  Involved in many aspects of cellular processes, JNK has been also assocd. with pathol. states such as neurodegenerative diseases, inflammation, and cancers.  In oncol., each isoform plays a distinct role depending on the context of the targeted tissue/organ, the tumor stage, and, most likely, the signaling pathway activated upstream.  Consequently, the current challenge in finding new successful anti-JNK therapies is to design isoform-selective inhibitors of the JNKs.  In this review, a particular focus is given to the JNK inhibitors that have been developed thus far when examg. 3D structures of various JNK-inhibitor complexes.  Using current data regarding structure-activity relationships and medicinal chem. approaches, our objective is to provide a better understanding of the design and development of selective JNK inhibitors in the present and future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3mHBbGq0JBrVg90H21EOLACvtfcHk0liCY2o0Zj9Lug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOrtLzI&md5=3efe4c042059334f46ae5725e811c32d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DMessoussi%26aufirst%3DA.%26aulast%3DFeneyrolles%26aufirst%3DC.%26aulast%3DBros%26aufirst%3DA.%26aulast%3DDeroide%26aufirst%3DA.%26aulast%3DDayde-Cazals%26aufirst%3DB.%26aulast%3DCheve%26aufirst%3DG.%26aulast%3DVan%2BHijfte%26aufirst%3DN.%26aulast%3DFauvel%26aufirst%3DB.%26aulast%3DBougrin%26aufirst%3DK.%26aulast%3DYasri%26aufirst%3DA.%26atitle%3DRecent%2520progress%2520in%2520the%2520design%252C%2520study%252C%2520and%2520development%2520of%2520c-jun%2520N-terminal%2520kinase%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D1433%26epage%3D1443%26doi%3D10.1016%2Fj.chembiol.2014.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muth, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doring, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druckes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothbauer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Tetra-substituted pyridinylimidazoles as dual inhibitors of p38alpha mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.1021/jm501557a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501557a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=443-456&author=F.+Muthauthor=M.+Guntherauthor=S.+M.+Bauerauthor=E.+Doringauthor=S.+Fischerauthor=J.+Maierauthor=P.+Druckesauthor=J.+Kopplerauthor=J.+Trappeauthor=U.+Rothbauerauthor=P.+Kochauthor=S.+A.+Laufer&title=Tetra-substituted+pyridinylimidazoles+as+dual+inhibitors+of+p38alpha+mitogen-activated+protein+kinase+and+c-Jun+N-terminal+kinase+3+for+potential+treatment+of+neurodegenerative+diseases&doi=10.1021%2Fjm501557a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases</span></div><div class="casAuthors">Muth, Felix; Guenther, Marcel; Bauer, Silke M.; Doering, Eva; Fischer, Sabine; Maier, Julia; Drueckes, Peter; Koeppler, Juergen; Trappe, Joerg; Rothbauer, Ulrich; Koch, Pierre; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">443-456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tetra-substituted imidazoles were designed as dual inhibitors of c-Jun N-terminal kinase (JNK) 3 and p38α mitogen-activated protein (MAP) kinase.  A library of 45 derivs. was prepd. and evaluated in a kinase activity assay for their ability to inhibit both kinases, JNK3 and p38α MAP kinase.  Dual inhibitors with IC50 values down to the low double-digit nanomolar range at both enzymes were identified.  The best balanced dual JNK3/p38α MAP kinase inhibitors are I (IC50: JNK3, 18 nM; p38α, 30 nM) and II (IC50: JNK3, 26 nM; p38α, 34 nM) featuring both excellent soly. and metabolic stability.  They may serve as useful tool compds. for preclin. proof-of-principle studies in order to validate the synergistic role of both kinases in the progression of Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNwp_1AD67j7Vg90H21EOLACvtfcHk0liCY2o0Zj9Lug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FJ&md5=3b17ce2ed0396efcee28302d6f6910e7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm501557a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501557a%26sid%3Dliteratum%253Aachs%26aulast%3DMuth%26aufirst%3DF.%26aulast%3DGunther%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DDoring%26aufirst%3DE.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DMaier%26aufirst%3DJ.%26aulast%3DDruckes%26aufirst%3DP.%26aulast%3DKoppler%26aufirst%3DJ.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DRothbauer%26aufirst%3DU.%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DTetra-substituted%2520pyridinylimidazoles%2520as%2520dual%2520inhibitors%2520of%2520p38alpha%2520mitogen-activated%2520protein%2520kinase%2520and%2520c-Jun%2520N-terminal%2520kinase%25203%2520for%2520potential%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D443%26epage%3D456%26doi%3D10.1021%2Fjm501557a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarza, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, M. J.</span></span> <span> </span><span class="NLM_article-title">c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer’s disease</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">321</span>, <span class="refDoi"> DOI: 10.3389/fphar.2015.00321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.3389%2Ffphar.2015.00321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=26793112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=321&author=R.+Yarzaauthor=S.+Velaauthor=M.+Solasauthor=M.+J.+Ramirez&title=c-Jun+N-terminal+kinase+%28JNK%29+signaling+as+a+therapeutic+target+for+Alzheimer%E2%80%99s+disease&doi=10.3389%2Ffphar.2015.00321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer's disease</span></div><div class="casAuthors">Yarza, Ramon; Vela, Silvia; Solas, Maite; Ramirez, Maria J.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">321/1-321/12</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">C-Jun N-terminal kinases (JNKs) are a family of protein kinases that play a central role in stress signaling pathways implicated in gene expression, neuronal plasticity, regeneration, cell death, and regulation of cellular senescence.  It has been shown that there is a JNK pathway activation after exposure to different stressing factors, including cytokines, growth factors, oxidative stress, unfolded protein response signals or Aβ peptides.  Altogether, JNKs have become a focus of screening strategies searching for new therapeutic approaches to diabetes, cancer or liver diseases.  In addn., activation of JNK has been identified as a key element responsible for the regulation of apoptosis signals and therefore, it is crit. for pathol. cell death assocd. with neurodegenerative diseases and, among them, with Alzheimer's disease (AD).  In addn., in vitro and in vivo studies have reported alterations of JNK pathways potentially assocd. with pathogenesis and neuronal death in AD.  JNK's, particularly JNK3, not only enhance Aβ prodn., moreover it plays a key role in the maturation and development of neurofibrillary tangles.  This review aims to explain the rationale behind testing therapies based on inhibition of JNK signaling for AD in terms of current knowledge about the pathophysiol. of the disease.  Keeping in mind that JNK3 is specifically expressed in the brain and activated by stress-stimuli, it is possible to hypothesize that inhibition of JNK3 might be considered as a potential target for treating neurodegenerative mechanisms assocd. with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL1r26YWz0XrVg90H21EOLACvtfcHk0lhFZP8X3vmbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSiug%253D%253D&md5=bb9c3d594b4414dca03e66af69f231ee</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2015.00321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2015.00321%26sid%3Dliteratum%253Aachs%26aulast%3DYarza%26aufirst%3DR.%26aulast%3DVela%26aufirst%3DS.%26aulast%3DSolas%26aufirst%3DM.%26aulast%3DRamirez%26aufirst%3DM.%2BJ.%26atitle%3Dc-Jun%2520N-terminal%2520kinase%2520%2528JNK%2529%2520signaling%2520as%2520a%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Pharmacol.%26date%3D2015%26volume%3D6%26spage%3D321%26doi%3D10.3389%2Ffphar.2015.00321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antoniou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falconi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borsello, T.</span></span> <span> </span><span class="NLM_article-title">JNK3 as a therapeutic target for neurodegenerative diseases</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.3233/JAD-2011-091567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.3233%2FJAD-2011-091567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=21321401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFyrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=633-642&author=X.+Antoniouauthor=M.+Falconiauthor=D.+Di+Marinoauthor=T.+Borsello&title=JNK3+as+a+therapeutic+target+for+neurodegenerative+diseases&doi=10.3233%2FJAD-2011-091567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">JNK3 as a Therapeutic Target for Neurodegenerative Diseases</span></div><div class="casAuthors">Antoniou, Xanthi; Falconi, Mattia; Di Marino, Daniele; Borsello, Tiziana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">633-642</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  C-Jun N-terminal kinases (JNKs) and in particular JNK3 the neuronal specific isoform, have been recognized as important enzymes in the pathol. of diverse neurol. disorders.  Indeed, several efforts have been made to design drugs that inhibit JNK signaling.  The success that characterized the new generation of cell permeable peptides raise the hope in the field of neurodegeneration for new therapeutic routes.  However, in order to design new and more efficient therapeutical approaches careful re-examn. of current knowledge is required.  Scaffold proteins are key endogenous regulators of JNK signaling: they can modulate spatial and temporal activation of the JNK signaling and can thus provide the basis for the design of more specific inhibitors.  This review focuses on delineating the role of scaffold proteins on the regulation of JNK signaling in neurons.  Furthermore the possibility to design a new JNK3 cell permeable peptide inhibitor by targeting the β-arrestin-JNK3 interaction is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWEl6zvv3NKLVg90H21EOLACvtfcHk0lhFZP8X3vmbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFyrsr8%253D&md5=cb087071a51bf1f91c70bfacec7dddae</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-091567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-091567%26sid%3Dliteratum%253Aachs%26aulast%3DAntoniou%26aufirst%3DX.%26aulast%3DFalconi%26aufirst%3DM.%26aulast%3DDi%2BMarino%26aufirst%3DD.%26aulast%3DBorsello%26aufirst%3DT.%26atitle%3DJNK3%2520as%2520a%2520therapeutic%2520target%2520for%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D24%26spage%3D633%26epage%3D642%26doi%3D10.3233%2FJAD-2011-091567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiwaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaniwa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekiguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirasawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, K.</span></span> <span> </span><span class="NLM_article-title">Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">396</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.ejmech.2015.04.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=25912672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslarurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2015&pages=396-404&author=I.+Nakanishiauthor=K.+Murataauthor=N.+Nagataauthor=M.+Kuronoauthor=T.+Kinoshitaauthor=M.+Yasueauthor=T.+Miyazakiauthor=Y.+Takeiauthor=S.+Nakamuraauthor=A.+Sakuraiauthor=N.+Iwamotoauthor=K.+Nishiwakiauthor=T.+Nakaniwaauthor=Y.+Sekiguchiauthor=A.+Hirasawaauthor=G.+Tsujimotoauthor=K.+Kitaura&title=Identification+of+protein+kinase+CK2+inhibitors+using+solvent+dipole+ordering+virtual+screening&doi=10.1016%2Fj.ejmech.2015.04.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening</span></div><div class="casAuthors">Nakanishi, Isao; Murata, Katsumi; Nagata, Naoya; Kurono, Masakuni; Kinoshita, Takayoshi; Yasue, Misato; Miyazaki, Takako; Takei, Yoshinori; Nakamura, Shinya; Sakurai, Atsushi; Iwamoto, Nobuko; Nishiwaki, Keiji; Nakaniwa, Tetsuko; Sekiguchi, Yusuke; Hirasawa, Akira; Tsujimoto, Gozoh; Kitaura, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">396-404</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Novel protein kinase CK2 inhibitors were identified using the solvent dipole ordering virtual screening method.  A total of 26 compds. categorized in 15 distinct scaffold classes inhibited greater than 50% of enzyme activity at 50 μM, and eight exhibited IC50 values less than 10 μM.  Most of the identified compds. are lead-like and dissimilar to known inhibitors.  The crystal structures of two of the CK2 complexes revealed the high accuracy of the predicted binding modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr09zbCwMAnoLVg90H21EOLACvtfcHk0lhFZP8X3vmbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslarurs%253D&md5=c6ac78194f5ab517aa271567753c7508</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DI.%26aulast%3DMurata%26aufirst%3DK.%26aulast%3DNagata%26aufirst%3DN.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DYasue%26aufirst%3DM.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DTakei%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DIwamoto%26aufirst%3DN.%26aulast%3DNishiwaki%26aufirst%3DK.%26aulast%3DNakaniwa%26aufirst%3DT.%26aulast%3DSekiguchi%26aufirst%3DY.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DKitaura%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520protein%2520kinase%2520CK2%2520inhibitors%2520using%2520solvent%2520dipole%2520ordering%2520virtual%2520screening%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D96%26spage%3D396%26epage%3D404%26doi%3D10.1016%2Fj.ejmech.2015.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilchmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcaida, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boss, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonczy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymond, J. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a selective Aurora A kinase inhibitor by virtual screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7188</span>– <span class="NLM_lpage">7211</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFersrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7188-7211&author=F.+Kilchmannauthor=M.+J.+Marcaidaauthor=S.+Kotakauthor=T.+Schickauthor=S.+D.+Bossauthor=M.+Awaleauthor=P.+Gonczyauthor=J.+L.+Reymond&title=Discovery+of+a+selective+Aurora+A+kinase+inhibitor+by+virtual+screening&doi=10.1021%2Facs.jmedchem.6b00709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening</span></div><div class="casAuthors">Kilchmann, Falco; Marcaida, Maria J.; Kotak, Sachin; Schick, Thomas; Boss, Silvan D.; Awale, Mahendra; Gonczy, Pierre; Reymond, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7188-7211</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here we report the discovery of a selective inhibitor of Aurora A, a key regulator of cell division and potential anticancer target.  We used the atom category extended ligand overlap score (xLOS), a 3D ligand-based virtual screening method recently developed in our group, to select 437 shape and pharmacophore analogs of ref. kinase inhibitors.  Biochem. screening uncovered two inhibitor series with scaffolds unprecedented among kinase inhibitors.  One of them was successfully optimized by structure-based design to a potent Aurora A inhibitor (IC50 = 2 nM) with very high kinome selectivity for Aurora kinases.  This inhibitor locks Aurora A in an inactive conformation and disrupts binding to its activator protein TPX2, which impairs Aurora A localization at the mitotic spindle and induces cell division defects.  This phenotype can be rescued by inhibitor-resistant Aurora A mutants.  The inhibitor furthermore does not induce Aurora B specific effects in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQCO8boEwSO7Vg90H21EOLACvtfcHk0ljk3-DXRZtXAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFersrjP&md5=0928f42cef599fb5d7a26bdafeb79d3e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00709%26sid%3Dliteratum%253Aachs%26aulast%3DKilchmann%26aufirst%3DF.%26aulast%3DMarcaida%26aufirst%3DM.%2BJ.%26aulast%3DKotak%26aufirst%3DS.%26aulast%3DSchick%26aufirst%3DT.%26aulast%3DBoss%26aufirst%3DS.%2BD.%26aulast%3DAwale%26aufirst%3DM.%26aulast%3DGonczy%26aufirst%3DP.%26aulast%3DReymond%26aufirst%3DJ.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520Aurora%2520A%2520kinase%2520inhibitor%2520by%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7188%26epage%3D7211%26doi%3D10.1021%2Facs.jmedchem.6b00709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.ejmech.2017.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=28231524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=275-286&author=T.+Wangauthor=Z.+Yangauthor=Y.+Zhangauthor=W.+Yanauthor=F.+Wangauthor=L.+Heauthor=Y.+Zhouauthor=L.+Chen&title=Discovery+of+novel+CDK8+inhibitors+using+multiple+crystal+structures+in+docking-based+virtual+screening&doi=10.1016%2Fj.ejmech.2017.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening</span></div><div class="casAuthors">Wang, Taijin; Yang, Zhuang; Zhang, Yongguang; Yan, Wei; Wang, Fang; He, Linhong; Zhou, Yuanyuan; Chen, Lijuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">275-286</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The cyclin dependent kinase CDK8, along with Med12 and Med13, form the kinase module of the Mediator complex.  CDK8 expression assocs. with the activation of β-catenin in colon and gastric cancers.  Herein, we applied docking-based virtual screening (VS) using the multiple crystal structures to identify several potent CDK8 inhibitors.  The appropriate use of multiple crystal structures obtained a better enrichment of CDK8 conformations to cope with the protein flexibility.  Later on, the 2D similarity search was used to find the derivs. of the high inhibitory CDK8 inhibitors we discovered by VS.  Finally, we measured the dose response behaviors, the IC50 values of compd. W-34, W-37, W-8, WS-2 are 6.5 nM, 36 nM, 93 nM, 9 nM, resp.  These novel leads provided good starting points to design and synthesis a series of highly selective and potent CDK8 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3tNFP1H7AnbVg90H21EOLACvtfcHk0ljk3-DXRZtXAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGjsrs%253D&md5=bb1500bb9d7f805f5f81f2c51b4198a9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520novel%2520CDK8%2520inhibitors%2520using%2520multiple%2520crystal%2520structures%2520in%2520docking-based%2520virtual%2520screening%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D129%26spage%3D275%26epage%3D286%26doi%3D10.1016%2Fj.ejmech.2017.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. S.</span></span> <span> </span><span class="NLM_article-title">An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1450</span>, <span class="refDoi"> DOI: 10.1021/ci500062f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500062f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVektLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=1433-1450&author=J.+Xiaauthor=H.+Jinauthor=Z.+Liuauthor=L.+Zhangauthor=X.+S.+Wang&title=An+unbiased+method+to+build+benchmarking+sets+for+ligand-based+virtual+screening+and+its+application+to+GPCRs&doi=10.1021%2Fci500062f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">An Unbiased Method To Build Benchmarking Sets for Ligand-Based Virtual Screening and its Application To GPCRs</span></div><div class="casAuthors">Xia, Jie; Jin, Hongwei; Liu, Zhenming; Zhang, Liangren; Wang, Xiang Simon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1433-1450</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benchmarking data sets have become common in recent years for the purpose of virtual screening, though the main focus had been placed on the structure-based virtual screening (SBVS) approaches.  Due to the lack of crystal structures, there is great need for unbiased benchmarking sets to evaluate various ligand-based virtual screening (LBVS) methods for important drug targets such as G protein-coupled receptors (GPCRs).  To date these ready-to-apply data sets for LBVS are fairly limited, and the direct usage of benchmarking sets designed for SBVS could bring the biases to the evaluation of LBVS.  Herein, we propose an unbiased method to build benchmarking sets for LBVS and validate it on a multitude of GPCRs targets.  To be more specific, our methods can (1) ensure chem. diversity of ligands, (2) maintain the physicochem. similarity between ligands and decoys, (3) make the decoys dissimilar in chem. topol. to all ligands to avoid false negatives, and (4) maximize spatial random distribution of ligands and decoys.  We evaluated the quality of our Unbiased Ligand Set (ULS) and Unbiased Decoy Set (UDS) using three common LBVS approaches, with Leave-One-Out (LOO) Cross-Validation (CV) and a metric of av. AUC of the ROC curves.  Our method has greatly reduced the "artificial enrichment" and "analog bias" of a published GPCRs benchmarking set, i.e., GPCR Ligand Library (GLL)/GPCR Decoy Database (GDD).  In addn., we addressed an important issue about the ratio of decoys per ligand and found that for a range of 30 to 100 it does not affect the quality of the benchmarking set, so we kept the original ratio of 39 from the GLL/GDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreeqZHc9Xi0LVg90H21EOLACvtfcHk0ljk3-DXRZtXAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVektLY%253D&md5=aa1b9d3f990859e9335e163f6e8f9052</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fci500062f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500062f%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%2BS.%26atitle%3DAn%2520unbiased%2520method%2520to%2520build%2520benchmarking%2520sets%2520for%2520ligand-based%2520virtual%2520screening%2520and%2520its%2520application%2520to%2520GPCRs%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D1433%26epage%3D1450%26doi%3D10.1021%2Fci500062f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balius, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroz, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algaa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span> <span> </span><span class="NLM_article-title">Ultra-large library docking for discovering new chemotypes</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>566</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-0917-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1038%2Fs41586-019-0917-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=30728502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmt1yns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=566&publication_year=2019&pages=224-229&author=J.+Lyuauthor=S.+Wangauthor=T.+E.+Baliusauthor=I.+Singhauthor=A.+Levitauthor=Y.+S.+Morozauthor=M.+J.+O%E2%80%99Mearaauthor=T.+Cheauthor=E.+Algaaauthor=K.+Tolmachovaauthor=A.+A.+Tolmachevauthor=B.+K.+Shoichetauthor=B.+L.+Rothauthor=J.+J.+Irwin&title=Ultra-large+library+docking+for+discovering+new+chemotypes&doi=10.1038%2Fs41586-019-0917-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ultra-large library docking for discovering new chemotypes</span></div><div class="casAuthors">Lyu, Jiankun; Wang, Sheng; Balius, Trent E.; Singh, Isha; Levit, Anat; Moroz, Yurii S.; O'Meara, Matthew J.; Che, Tao; Algaa, Enkhjargal; Tolmachova, Kateryna; Tolmachev, Andrey A.; Shoichet, Brian K.; Roth, Bryan L.; Irwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">566</span>
        (<span class="NLM_cas:issue">7743</span>),
    <span class="NLM_cas:pages">224-229</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite intense interest in expanding chem. space, libraries contg. hundreds-of-millions to billions of diverse mols. have remained inaccessible.  Here we investigate structure-based docking of 170 million make-on-demand compds. from 130 well-characterized reactions.  The resulting library is diverse, representing over 10.7 million scaffolds that are otherwise unavailable.  For each compd. in the library, docking against AmpC β-lactamase (AmpC) and the D4 dopamine receptor were simulated.  From the top-ranking mols., 44 and 549 compds. were synthesized and tested for interactions with AmpC and the D4 dopamine receptor, resp.  We found a phenolate inhibitor of AmpC, which revealed a group of inhibitors without known precedent.  This mol. was optimized to 77 nM, which places it among the most potent non-covalent AmpC inhibitors known.  Crystal structures of this and other AmpC inhibitors confirmed the docking predictions.  Against the D4 dopamine receptor, hit rates fell almost monotonically with docking score, and a hit-rate vs. score curve predicted that the library contained 453,000 ligands for the D4 dopamine receptor.  Of 81 new chemotypes discovered, 30 showed submicromolar activity, including a 180-pM subtype-selective agonist of the D4 dopamine receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc_Nuo9pc-Z7Vg90H21EOLACvtfcHk0ljk3-DXRZtXAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmt1yns70%253D&md5=589fb81ef11f9cbec645b9a3818648d1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-0917-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-0917-9%26sid%3Dliteratum%253Aachs%26aulast%3DLyu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBalius%26aufirst%3DT.%2BE.%26aulast%3DSingh%26aufirst%3DI.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DMoroz%26aufirst%3DY.%2BS.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%2BJ.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DAlgaa%26aufirst%3DE.%26aulast%3DTolmachova%26aufirst%3DK.%26aulast%3DTolmachev%26aufirst%3DA.%2BA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26atitle%3DUltra-large%2520library%2520docking%2520for%2520discovering%2520new%2520chemotypes%26jtitle%3DNature%26date%3D2019%26volume%3D566%26spage%3D224%26epage%3D229%26doi%3D10.1038%2Fs41586-019-0917-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0ljKJkvL4KG7-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egan, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, J. J.</span></span> <span> </span><span class="NLM_article-title">Prediction of drug absorption using multivariate statistics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3867</span>– <span class="NLM_lpage">3877</span>, <span class="refDoi"> DOI: 10.1021/jm000292e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000292e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3867-3877&author=W.+J.+Eganauthor=K.+M.+Merzauthor=J.+J.+Baldwin&title=Prediction+of+drug+absorption+using+multivariate+statistics&doi=10.1021%2Fjm000292e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Drug Absorption Using Multivariate Statistics</span></div><div class="casAuthors">Egan, William J.; Merz, Kenneth M. Jr.; Baldwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3867-3877</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Literature data on compds. both well- and poorly-absorbed in humans were used to build a statistical pattern recognition model of passive intestinal absorption.  Robust outlier detection was utilized to analyze the well-absorbed compds., some of which were intermingled with the poorly-absorbed compds. in the model space.  Outliers were identified as being actively transported.  The descriptors chosen for inclusion in the model were PSA and AlogP98, based on consideration of the phys. processes involved in membrane permeability and the interrelationships and redundancies between available descriptors.  These descriptors are quite straightforward for a medicinal chemist to interpret, enhancing the utility of the model.  Mol. wt., while often used in passive absorption models, was shown to be superfluous, as it is already a component of both PSA and AlogP98.  Extensive validation of the model on hundreds of known orally delivered drugs, "drug-like" mols., and Pharmacopeia, Inc. compds., which had been assayed for Caco-2 cell permeability, demonstrated a good rate of successful predictions (74-92%, depending on the dataset and exact criterion used).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbZF9e_GNz8LVg90H21EOLACvtfcHk0ljKJkvL4KG7-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitLk%253D&md5=44f909ad1fd6187840921e7f07497b4e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm000292e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000292e%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DW.%2BJ.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520drug%2520absorption%2520using%2520multivariate%2520statistics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3867%26epage%3D3877%26doi%3D10.1021%2Fjm000292e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andreichikov, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitirimova, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraeva, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gein, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plakhina, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voronova, L. A.</span></span> <span> </span><span class="NLM_article-title">3-Phenacyl-2-quinoxalones and 3-phenacylidene-3,4-dihydro-2-quinoxalones</span>. <i>Khim. Geterotsikl. Soedin.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1007/BF00470572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1007%2FBF00470572" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1978&pages=407-410&author=Y.+S.+Andreichikovauthor=S.+G.+Pitirimovaauthor=R.+F.+Saraevaauthor=V.+L.+Geinauthor=G.+D.+Plakhinaauthor=L.+A.+Voronova&title=3-Phenacyl-2-quinoxalones+and+3-phenacylidene-3%2C4-dihydro-2-quinoxalones&doi=10.1007%2FBF00470572"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2FBF00470572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00470572%26sid%3Dliteratum%253Aachs%26aulast%3DAndreichikov%26aufirst%3DY.%2BS.%26aulast%3DPitirimova%26aufirst%3DS.%2BG.%26aulast%3DSaraeva%26aufirst%3DR.%2BF.%26aulast%3DGein%26aufirst%3DV.%2BL.%26aulast%3DPlakhina%26aufirst%3DG.%2BD.%26aulast%3DVoronova%26aufirst%3DL.%2BA.%26atitle%3D3-Phenacyl-2-quinoxalones%2520and%25203-phenacylidene-3%252C4-dihydro-2-quinoxalones%26jtitle%3DKhim.%2520Geterotsikl.%2520Soedin.%26date%3D1978%26volume%3D3%26spage%3D407%26epage%3D410%26doi%3D10.1007%2FBF00470572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaminskyy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Hartog, G. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtyra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelyukh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gzella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bast, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesyk, R.</span></span> <span> </span><span class="NLM_article-title">Antifibrotic and anticancer action of 5-ene amino/iminothiazolidinones</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.ejmech.2016.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=26896707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28Xislyqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2016&pages=180-195&author=D.+Kaminskyyauthor=G.+J.+M.+den+Hartogauthor=M.+Wojtyraauthor=M.+Lelyukhauthor=A.+Gzellaauthor=A.+Bastauthor=R.+Lesyk&title=Antifibrotic+and+anticancer+action+of+5-ene+amino%2Fiminothiazolidinones&doi=10.1016%2Fj.ejmech.2016.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Antifibrotic and anticancer action of 5-ene amino/iminothiazolidinones</span></div><div class="casAuthors">Kaminskyy, Danylo; den Hartog, Gertjan J. M.; Wojtyra, Magdalena; Lelyukh, Maryan; Gzella, Andrzej; Bast, Aalt; Lesyk, Roman</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">180-195</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Here we describe the synthesis and the antifibrotic and anticancer activity detn. of amino(imino)thiazolidinone derivs.  An efficient one-pot three-component reaction which involved [2 + 3]-cyclocondensation and Knoevenagel condensation was used for the synthesis of 5-ene-2-amino(imino)-4-thiazolidinones.  Following amino-imino tautomerism, the compd. structures were confirmed by X-ray anal.  Comparison of SRB assays on fibroblasts and cancer cells revealed that compds. which significantly reduced the viability of fibroblasts did not possess an anticancer effect.  A series of thiazolidinone derivs. as interesting candidates for further testing has been identified.  Among the tested compds. 2-{3-furan-2-ylmethyl-2-[(2-methyl-3-phenylallylidene)hydrazono]-thiazolidin-4-one-5-yl}-N-(3-trifluoromethylphenyl)-acetamide, N-(2-methoxyphenyl)-2-[5-(4-oxothiazolidin-2-ylideneamino)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetamide, 3-[3-allyl-4-oxo-2-(thiazol-2-ylimino)thiazolidin-5-ylidene]-1,3-dihydroindol-2-one, and 5(Z)-(thiophen-2-ylmethylene)-4-(4-chlorophenylamino)thiazol-2(5H)-one possessed high antifibrotic activity levels, had a similar effect as Pirfenidone, and did not scavenge superoxide radicals.  Their antifibrotic potential was confirmed using the xCelligence system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn9EH9so_baLVg90H21EOLACvtfcHk0ljKJkvL4KG7-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xislyqsbo%253D&md5=ec9388a3e08c29a5ae23375b7aca275c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DKaminskyy%26aufirst%3DD.%26aulast%3Dden%2BHartog%26aufirst%3DG.%2BJ.%2BM.%26aulast%3DWojtyra%26aufirst%3DM.%26aulast%3DLelyukh%26aufirst%3DM.%26aulast%3DGzella%26aufirst%3DA.%26aulast%3DBast%26aufirst%3DA.%26aulast%3DLesyk%26aufirst%3DR.%26atitle%3DAntifibrotic%2520and%2520anticancer%2520action%2520of%25205-ene%2520amino%252Fiminothiazolidinones%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D112%26spage%3D180%26epage%3D195%26doi%3D10.1016%2Fj.ejmech.2016.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. X.</span></span> <span> </span><span class="NLM_article-title">C-glycosylflavones alleviate tau phosphorylation and amyloid neurotoxicity through GSK3beta inhibition</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">912</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00059</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00059" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC28XotlCnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=912-923&author=Z.+Liangauthor=B.+Zhangauthor=W.+W.+Suauthor=P.+G.+Williamsauthor=Q.+X.+Li&title=C-glycosylflavones+alleviate+tau+phosphorylation+and+amyloid+neurotoxicity+through+GSK3beta+inhibition&doi=10.1021%2Facschemneuro.6b00059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">C-Glycosylflavones Alleviate Tau Phosphorylation and Amyloid Neurotoxicity through GSK3β Inhibition</span></div><div class="casAuthors">Liang, Zhibin; Zhang, Bei; Su, Wei Wen; Williams, Philip G.; Li, Qing X.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">912-923</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common brain disorder worldwide.  Aberrant tau hyperphosphorylation and accumulation play crit. roles in the formation of neurofibrillary tangles highly assocd. with neuronal dysfunction and cognitive impairment in AD pathogenesis.  Glycogen synthase kinase-3β (GSK3β) is a key kinase responsible for tau hyperphosphorylation.  Selective inhibition of GSK3β is a promising strategy in AD therapy.  Corn silks (CS, Zea mays L.) have been traditionally used as a medicinal herb and recently noted for their potentially cognitive benefits.  However, the neuroprotective components of CS and their mol. mechanism have received little attention to date.  As part of our effort screening phytochems. against a broad panel of kinases targeting AD tauopathy, we found inhibition of GSK3β by CS exts.  Subsequent bioassay-guided fractionation led to the isolation and identification of two 6-C-glycosylflavones, isoorientin (1) and 3'-methoxymaysin (2), with selective inhibition against GSK3β in vitro.  Enzyme kinetics and mol. docking studies demonstrated that 1 specifically inhibited GSK3β via an ATP noncompetitive mechanism, acting as a substrate competitive inhibitor of GSK3β.  Further in vitro cellular studies demonstrated that 1 effectively attenuated tau phosphorylation mediated by GSK3β and was neuroprotective against β-amyloid-induced tau hyperphosphorylation and neurotoxicity in SH-SY5Y cells.  The C-glycosylflavones represent new lead candidates with a novel mechanism of action for the development of AD phytopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoULrY7iLLHRLVg90H21EOLACvtfcHk0li3sO3EK6L6OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotlCnsbk%253D&md5=de0a55c2cad16ac52d8335757a8628fd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00059%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DW.%2BW.%26aulast%3DWilliams%26aufirst%3DP.%2BG.%26aulast%3DLi%26aufirst%3DQ.%2BX.%26atitle%3DC-glycosylflavones%2520alleviate%2520tau%2520phosphorylation%2520and%2520amyloid%2520neurotoxicity%2520through%2520GSK3beta%2520inhibition%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D912%26epage%3D923%26doi%3D10.1021%2Facschemneuro.6b00059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mora, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoGrasso, P.</span></span> <span> </span><span class="NLM_article-title">Structural basis and biological consequences for JNK2/3 isoform selective aminopyrazoles</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">8047</span> <span class="refDoi"> DOI: 10.1038/srep08047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1038%2Fsrep08047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=25623238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKjurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&author=H.+Parkauthor=S.+Iqbalauthor=P.+Hernandezauthor=R.+Moraauthor=K.+Zhengauthor=Y.+Fengauthor=P.+LoGrasso&title=Structural+basis+and+biological+consequences+for+JNK2%2F3+isoform+selective+aminopyrazoles&doi=10.1038%2Fsrep08047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and Biological Consequences for JNK2/3 Isoform Selective Aminopyrazoles</span></div><div class="casAuthors">Park, Ha Jeung; Iqbal, Sarah; Hernandez, Pamela; Mora, Rudy; Zheng, Ke; Feng, Yangbo; LoGrasso, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8047</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Three JNK isoforms, JNK1, JNK2, and JNK3 have been reported and unique biol. function has been ascribed to each.  It is unknown if selective inhibition of these isoforms would confer therapeutic or safety benefit.  To probe JNK isoform function we designed JNK2/3 inhibitors that have >30-fold selectivity over JNK1.  Utilizing site-directed mutagenesis and x-ray crystallog. we identified L144 in JNK3 as a key residue for selectivity.  To test whether JNK2/3 selective inhibitors protect human dopaminergic neurons against neurotoxin-induced mitochondrial dysfunction, we monitored reactive oxygen species (ROS) generation and mitochondrial membrane potential (MMP).  The results showed that JNK2/3 selective inhibitors protected against 6-hydroxydopamine-induced ROS generation and MMP depolarization.  These results suggest that it was possible to develop JNK2/3 selective inhibitors and that residues in hydrophobic pocket I were responsible for selectivity.  Moreover, the findings also suggest that inhibition of JNK2/3 likely contributed to protecting mitochondrial function and prevented ultimate cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppecXktwxC9LVg90H21EOLACvtfcHk0li3sO3EK6L6OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKjurrE&md5=f895abe1774b76fd5e24be52c7860d4c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fsrep08047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep08047%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%26aulast%3DIqbal%26aufirst%3DS.%26aulast%3DHernandez%26aufirst%3DP.%26aulast%3DMora%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DLoGrasso%26aufirst%3DP.%26atitle%3DStructural%2520basis%2520and%2520biological%2520consequences%2520for%2520JNK2%252F3%2520isoform%2520selective%2520aminopyrazoles%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26doi%3D10.1038%2Fsrep08047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashwell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gero, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcombe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ready, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowsell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toader, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasbinder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabludoff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureas</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5130</span>– <span class="NLM_lpage">5142</span>, <span class="refDoi"> DOI: 10.1021/jm300025r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300025r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVWgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5130-5142&author=V.+Ozaauthor=S.+Ashwellauthor=L.+Almeidaauthor=P.+Brassilauthor=J.+Breedauthor=C.+Dengauthor=T.+Geroauthor=M.+Grondineauthor=C.+Hornauthor=S.+Ioannidisauthor=D.+Liuauthor=P.+Lyneauthor=N.+Newcombeauthor=M.+Passauthor=J.+Readauthor=S.+Readyauthor=S.+Rowsellauthor=M.+Suauthor=D.+Toaderauthor=M.+Vasbinderauthor=D.+Yuauthor=Y.+Yuauthor=Y.+Xueauthor=S.+Zabludoffauthor=J.+Janetka&title=Discovery+of+checkpoint+kinase+inhibitor+%28S%29-5-%283-fluorophenyl%29-N-%28piperidin-3-yl%29-3-ureidothiophene-2-carboxamide+%28AZD7762%29+by+structure-based+design+and+optimization+of+thiophenecarboxamide+ureas&doi=10.1021%2Fjm300025r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Checkpoint Kinase Inhibitor (S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by Structure-Based Design and Optimization of Thiophenecarboxamide Ureas</span></div><div class="casAuthors">Oza, Vibha; Ashwell, Susan; Almeida, Lynsie; Brassil, Patrick; Breed, Jason; Deng, Chun; Gero, Thomas; Grondine, Michael; Horn, Candice; Ioannidis, Stephanos; Liu, Dongfang; Lyne, Paul; Newcombe, Nicholas; Pass, Martin; Read, Jon; Ready, Shannon; Rowsell, Sian; Su, Mei; Toader, Dorin; Vasbinder, Melissa; Yu, Dingwei; Yu, Yan; Xue, Yafeng; Zabludoff, Sonya; Janetka, James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5130-5142</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Checkpoint kinases CHK1 and CHK2 are activated in response to DNA damage that results in cell cycle arrest, allowing sufficient time for DNA repair.  Agents that lead to abrogation of such checkpoints have potential to increase the efficacy of such compds. as chemo- and radiotherapies.  Thiophenecarboxamide ureas (TCUs) were identified as inhibitors of CHK1 by high throughput screening.  A structure-based approach is described using crystal structures of JNK1 and CHK1 in complex with 1 and 2 and of the CHK1-3b complex.  The ribose binding pocket of CHK1 was targeted to generate inhibitors with excellent cellular potency and selectivity over CDK1and IKKβ, key features lacking from the initial compds.  Optimization of 3b resulted in the identification of a regioisomeric 3-TCU lead 12a.  Optimization of 12a led to the discovery of the clin. candidate 4 (AZD7762, I), which strongly potentiates the efficacy of a variety of DNA-damaging agents in preclin. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra8G75JTejhbVg90H21EOLACvtfcHk0li3sO3EK6L6OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVWgtbc%253D&md5=f2880b57af6d1def8f91d3ee694e0182</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm300025r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300025r%26sid%3Dliteratum%253Aachs%26aulast%3DOza%26aufirst%3DV.%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DBrassil%26aufirst%3DP.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DGero%26aufirst%3DT.%26aulast%3DGrondine%26aufirst%3DM.%26aulast%3DHorn%26aufirst%3DC.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLyne%26aufirst%3DP.%26aulast%3DNewcombe%26aufirst%3DN.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DReady%26aufirst%3DS.%26aulast%3DRowsell%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DToader%26aufirst%3DD.%26aulast%3DVasbinder%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DJanetka%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520checkpoint%2520kinase%2520inhibitor%2520%2528S%2529-5-%25283-fluorophenyl%2529-N-%2528piperidin-3-yl%2529-3-ureidothiophene-2-carboxamide%2520%2528AZD7762%2529%2520by%2520structure-based%2520design%2520and%2520optimization%2520of%2520thiophenecarboxamide%2520ureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5130%26epage%3D5142%26doi%3D10.1021%2Fjm300025r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villasenor, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsing, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>383</i></span>,  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.08.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.jmb.2008.08.086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=18801372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1egtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2008&pages=885-893&author=D.+Shawauthor=S.+M.+Wangauthor=A.+G.+Villasenorauthor=S.+Tsingauthor=D.+Walterauthor=M.+F.+Brownerauthor=J.+Barnettauthor=A.+Kuglstatter&title=The+crystal+structure+of+JNK2+reveals+conformational+flexibility+in+the+MAP+kinase+insert+and+indicates+its+involvement+in+the+regulation+of+catalytic+activity&doi=10.1016%2Fj.jmb.2008.08.086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The Crystal Structure of JNK2 Reveals Conformational Flexibility in the MAP Kinase Insert and Indicates Its Involvement in the Regulation of Catalytic Activity</span></div><div class="casAuthors">Shaw, David; Wang, Sandra M.; Villasenor, Armando G.; Tsing, Stan; Walter, David; Browner, Michelle F.; Barnett, Jim; Kuglstatter, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">885-893</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">C-Jun N-terminal kinase (JNK) 2 is a member of the mitogen-activated protein (MAP) kinase group of signaling proteins.  MAP kinases share a common sequence insertion called "MAP kinase insert", which, for ERK2, has been shown to interact with regulatory proteins and, for p38α, has been proposed to be involved in the regulation of catalytic activity.  We have detd. the crystal structure of human JNK2 complexed with an indazole inhibitor by applying a high-throughput protein engineering and surface-site mutagenesis approach.  A novel conformation of the activation loop is obsd., which is not compatible with its phosphorylation by upstream kinases.  This activation inhibitory conformation of JNK2 is stabilized by the MAP kinase insert that interacts with the activation loop in an induced-fit manner.  We therefore suggest that the MAP kinase insert of JNK2 plays a role in the regulation of JNK2 activation, possibly by interacting with intracellular binding partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquRAOL6mYaC7Vg90H21EOLACvtfcHk0lh3yPCZKWr8FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1egtLnM&md5=a2dbcbe2d4bc8146cd8ef48f9162c268</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.08.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.08.086%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%2BM.%26aulast%3DVillasenor%26aufirst%3DA.%2BG.%26aulast%3DTsing%26aufirst%3DS.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DBrowner%26aufirst%3DM.%2BF.%26aulast%3DBarnett%26aufirst%3DJ.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DThe%2520crystal%2520structure%2520of%2520JNK2%2520reveals%2520conformational%2520flexibility%2520in%2520the%2520MAP%2520kinase%2520insert%2520and%2520indicates%2520its%2520involvement%2520in%2520the%2520regulation%2520of%2520catalytic%2520activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D383%26spage%3D885%26epage%3D893%26doi%3D10.1016%2Fj.jmb.2008.08.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span> <span> </span><span class="NLM_article-title">Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">18281</span>– <span class="NLM_lpage">18289</span>, <span class="refDoi"> DOI: 10.1073/pnas.1207759109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1073%2Fpnas.1207759109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=22988103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslymtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=18281-18289&author=M.+McTigueauthor=B.+W.+Murrayauthor=J.+H.+Chenauthor=Y.+L.+Dengauthor=J.+Solowiejauthor=R.+S.+Kania&title=Molecular+conformations%2C+interactions%2C+and+properties+associated+with+drug+efficiency+and+clinical+performance+among+VEGFR+TK+inhibitors&doi=10.1073%2Fpnas.1207759109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors</span></div><div class="casAuthors">McTigue, Michele; Murray, Brion William; Chen, Jeffrey H.; Deng, Ya-Li; Solowiej, James; Kania, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18281-18289, S18281/1-S18281/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Analyses of compds. in clin. development have shown that ligand efficient-mols. with privileged phys. properties and low dose are less likely to fail in the various stages of clin. testing, have fewer postapproval withdrawals, and are less likely to receive black box safety warnings.  However, detailed side-by-side examn. of mol. interactions and properties within single drug classes are lacking.  As a class, VEGF receptor tyrosine kinase inhibitors (VEGFR TKIs) have changed the landscape of how cancer is treated, particularly in clear cell renal cell carcinoma, which is molecularly linked to the VEGF signaling axis.  Despite the clear role of the mol. target, member mols. of this validated drug class exhibit distinct clin. efficacy and safety profiles in comparable renal cell carcinoma clin. studies.  The first head-to-head randomized phase III comparative study between active VEGFR TKIs has confirmed significant differences in clin. performance.  To elucidate how fundamental drug potency-efficiency is achieved and impacts differentiation within the VEGFR TKI class, we detd. potencies, time dependence, selectivities, and X-ray structures of the drug-kinase complexes using a VEGFR2 TK construct inclusive of the important juxtamembrane domain.  Collectively, the studies elucidate unique drug-kinase interactions that are dependent on distinct juxtamembrane domain conformations, resulting in significant potency and ligand efficiency differences.  The identified structural trends are consistent with in vitro measurements, which translate well to clin. performance, underscoring a principle that may be broadly applicable to prospective drug design for optimal in vivo performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsIUWiD4sXtbVg90H21EOLACvtfcHk0lh3yPCZKWr8FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslymtb3I&md5=4a5ec677298a8c924c0f9557ca688a79</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1207759109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1207759109%26sid%3Dliteratum%253Aachs%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26atitle%3DMolecular%2520conformations%252C%2520interactions%252C%2520and%2520properties%2520associated%2520with%2520drug%2520efficiency%2520and%2520clinical%2520performance%2520among%2520VEGFR%2520TK%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D18281%26epage%3D18289%26doi%3D10.1073%2Fpnas.1207759109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of new GSK-3beta inhibitors through structure-based virtual screening</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.11.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.bmcl.2017.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=29208522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgs7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=160-166&author=X.+Douauthor=L.+Jiangauthor=Y.+Wangauthor=H.+Jinauthor=Z.+Liuauthor=L.+Zhang&title=Discovery+of+new+GSK-3beta+inhibitors+through+structure-based+virtual+screening&doi=10.1016%2Fj.bmcl.2017.11.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new GSK-3β inhibitors through structure-based virtual screening</span></div><div class="casAuthors">Dou, Xiaodong; Jiang, Lan; Wang, Yanxing; Jin, Hongwei; Liu, Zhenming; Zhang, Liangren</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">160-166</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3β (GSK-3β) is an attractive therapeutic target for human diseases, such as diabetes, cancer, neurodegenerative diseases, and inflammation.  Thus, structure-based virtual screening was performed to identify novel scaffolds of GSK-3β inhibitors, and we obsd. that conserved water mols. of GSK-3β were suitable for virtual screening.  We found 14 hits and D1 (IC50 of 0.71 μM) were identified.  Furthermore, the neuroprotection activity of D1-D3 was validated on a cellular level. 2D similarity searches were used to find derivs. of high inhibitory compds. and an enriched structure-activity relationship suggested that these skeletons were worthy of study as potent GSK-3β inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Poir6nudnbVg90H21EOLACvtfcHk0lh3yPCZKWr8FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgs7bN&md5=9c972f8578594d2965a038304c72f251</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DDou%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520new%2520GSK-3beta%2520inhibitors%2520through%2520structure-based%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D160%26epage%3D166%26doi%3D10.1016%2Fj.bmcl.2017.11.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowotka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutowo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cibrian-Uhalte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magarinos, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadatos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span> <span> </span><span class="NLM_article-title">The ChEMBL database in 2017</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">D945</span>– <span class="NLM_lpage">D954</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw1074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1093%2Fnar%2Fgkw1074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=27899562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D945-D954&author=A.+Gaultonauthor=A.+Herseyauthor=M.+Nowotkaauthor=A.+P.+Bentoauthor=J.+Chambersauthor=D.+Mendezauthor=P.+Mutowoauthor=F.+Atkinsonauthor=L.+J.+Bellisauthor=E.+Cibrian-Uhalteauthor=M.+Daviesauthor=N.+Dedmanauthor=A.+Karlssonauthor=M.+P.+Magarinosauthor=J.+P.+Overingtonauthor=G.+Papadatosauthor=I.+Smitauthor=A.+R.+Leach&title=The+ChEMBL+database+in+2017&doi=10.1093%2Fnar%2Fgkw1074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The ChEMBL database in 2017</span></div><div class="casAuthors">Gaulton, Anna; Hersey, Anne; Nowotka, Micha-l; Bento, A. Patricia; Chambers, Jon; Mendez, David; Mutowo, Prudence; Atkinson, Francis; Bellis, Louisa J.; Cibrian-Uhalte, Elena; Davies, Mark; Dedman, Nathan; Karlsson, Anneli; Magarinos, Maria Paula; Overington, John P.; Papadatos, George; Smit, Ines; Leach, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D945-D954</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an open large-scale bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012 and 2014 Nucleic Acids Research Database Issues.  Since then, alongside the continued extn. of data from the medicinal chem. literature, new sources of bioactivity data have also been added to the database.  These include: deposited data sets from neglected disease screening; crop protection data; drug metab. and disposition data and bioactivity data from patents.  A no. of improvements and new features have also been incorporated.  These include the annotation of assays and targets using ontologies, the inclusion of targets and indications for clin. candidates, addn. of metabolic pathways for drugs and calcn. of structural alerts.  The ChEMBL data can be accessed via a web-interface, RDF distribution, data downloads and RESTful web-services.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB0IuNShSHIrVg90H21EOLACvtfcHk0lhq2DDpM4oZDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D&md5=1dcbb641f8c2d11410663f97505a4911</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1074%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DNowotka%26aufirst%3DM.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DMendez%26aufirst%3DD.%26aulast%3DMutowo%26aufirst%3DP.%26aulast%3DAtkinson%26aufirst%3DF.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DCibrian-Uhalte%26aufirst%3DE.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DDedman%26aufirst%3DN.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DMagarinos%26aufirst%3DM.%2BP.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DPapadatos%26aufirst%3DG.%26aulast%3DSmit%26aufirst%3DI.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26atitle%3DThe%2520ChEMBL%2520database%2520in%25202017%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26spage%3DD945%26epage%3DD954%26doi%3D10.1093%2Fnar%2Fgkw1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mysinger, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolstad, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R. G.</span></span> <span> </span><span class="NLM_article-title">ZINC: a free tool to discover chemistry for biology</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1757</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1021/ci3001277</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci3001277" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFGnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1757-1768&author=J.+J.+Irwinauthor=T.+Sterlingauthor=M.+M.+Mysingerauthor=E.+S.+Bolstadauthor=R.+G.+Coleman&title=ZINC%3A+a+free+tool+to+discover+chemistry+for+biology&doi=10.1021%2Fci3001277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">ZINC: A Free Tool to Discover Chemistry for Biology</span></div><div class="casAuthors">Irwin, John J.; Sterling, Teague; Mysinger, Michael M.; Bolstad, Erin S.; Coleman, Ryan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1757-1768</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ZINC is a free public resource for ligand discovery.  The database contains over twenty million com. available mols. in biol. relevant representations that may be downloaded in popular ready-to-dock formats and subsets.  The Web site also enables searches by structure, biol. activity, phys. property, vendor, catalog no., name, and CAS no.  Small custom subsets may be created, edited, shared, docked, downloaded, and conveyed to a vendor for purchase.  The database is maintained and curated for a high purchasing success rate and is freely available at zinc.docking.org.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotyhntxgvRpbVg90H21EOLACvtfcHk0lhq2DDpM4oZDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFGnsrg%253D&md5=97f2ede64afc6b5e3ea2f279e38e32a0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fci3001277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3001277%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DSterling%26aufirst%3DT.%26aulast%3DMysinger%26aufirst%3DM.%2BM.%26aulast%3DBolstad%26aufirst%3DE.%2BS.%26aulast%3DColeman%26aufirst%3DR.%2BG.%26atitle%3DZINC%253A%2520a%2520free%2520tool%2520to%2520discover%2520chemistry%2520for%2520biology%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1757%26epage%3D1768%26doi%3D10.1021%2Fci3001277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span> <i>LigPrep</i>, version 2.3; <span class="NLM_publisher-name">Schrodinger,
LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+LigPrep%2C+version+2.3%3B+Schrodinger%2C%0ALLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchrodinger%252C%250ALLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span> <i>Epic</i>,
version 3.2; <span class="NLM_publisher-name">Schrodinger,
LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Epic%2C%0Aversion+3.2%3B+Schrodinger%2C%0ALLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DEpic%26pub%3DSchrodinger%252C%250ALLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lhq2DDpM4oZDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairley, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flemington, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopcroft, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsay, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Gallay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, B.</span></span> <span> </span><span class="NLM_article-title">Structure-guided discovery of potent and selective inhibitors of ERK1/2 from a modestly active and promiscuous chemical start point</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3438</span>– <span class="NLM_lpage">3450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00267</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00267" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1Gls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3438-3450&author=R.+A.+Wardauthor=P.+Bethelauthor=C.+Cookauthor=E.+Daviesauthor=J.+E.+Debreczeniauthor=G.+Fairleyauthor=L.+Feronauthor=V.+Flemingtonauthor=M.+A.+Grahamauthor=R.+Greenwoodauthor=N.+Griffinauthor=L.+Hansonauthor=P.+Hopcroftauthor=T.+D.+Howardauthor=J.+Hudsonauthor=M.+Jamesauthor=C.+D.+Jonesauthor=C.+R.+Jonesauthor=S.+Lamontauthor=R.+Lewisauthor=N.+Lindsayauthor=K.+Robertsauthor=I.+Simpsonauthor=S.+St-Gallayauthor=S.+Swallowauthor=J.+Tangauthor=M.+Tongeauthor=Z.+Wangauthor=B.+Zhai&title=Structure-guided+discovery+of+potent+and+selective+inhibitors+of+ERK1%2F2+from+a+modestly+active+and+promiscuous+chemical+start+point&doi=10.1021%2Facs.jmedchem.7b00267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point</span></div><div class="casAuthors">Ward, Richard A.; Bethel, Paul; Cook, Calum; Davies, Emma; Debreczeni, Judit E.; Fairley, Gary; Feron, Lyman; Flemington, Vikki; Graham, Mark A.; Greenwood, Ryan; Griffin, Nicola; Hanson, Lyndsey; Hopcroft, Philip; Howard, Tina D.; Hudson, Julian; James, Michael; Jones, Clifford D.; Jones, Christopher R.; Lamont, Scott; Lewis, Richard; Lindsay, Nicola; Roberts, Karen; Simpson, Iain; St-Gallay, Steve; Swallow, Steve; Tang, Jia; Tonge, Michael; Wang, Zhenhua; Zhai, Baochang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3438-3450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are a no. of small-mol. inhibitors targeting the RAS/RAF/MEK/ERK signaling pathway that have either been approved or are in clin. development for oncol. across a range of disease indications.  The inhibition of ERK1/2 is of significant current interest, as cell lines with acquired resistance to BRAF and MEK inhibitors have been shown to maintain sensitivity to ERK1/2 inhibition in preclin. models.  This article reports on authors' recent work to identify novel, potent, and selective reversible ERK1/2 inhibitors from a low-mol.-wt., modestly active, and highly promiscuous chem. start point, compd. I.  To guide and inform the evolution of this series, inhibitor binding mode information from X-ray crystal structures was crit. in the rapid exploration of this template to compd. II, which was active when tested in in vivo antitumor efficacy expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokuJLRaK0sLLVg90H21EOLACvtfcHk0lh0zEBLpscSww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1Gls7c%253D&md5=2ab5cd30f6a9c887a9a21010b492cb34</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00267%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DBethel%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DE.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DFairley%26aufirst%3DG.%26aulast%3DFeron%26aufirst%3DL.%26aulast%3DFlemington%26aufirst%3DV.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DGriffin%26aufirst%3DN.%26aulast%3DHanson%26aufirst%3DL.%26aulast%3DHopcroft%26aufirst%3DP.%26aulast%3DHoward%26aufirst%3DT.%2BD.%26aulast%3DHudson%26aufirst%3DJ.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DJones%26aufirst%3DC.%2BR.%26aulast%3DLamont%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DLindsay%26aufirst%3DN.%26aulast%3DRoberts%26aufirst%3DK.%26aulast%3DSimpson%26aufirst%3DI.%26aulast%3DSt-Gallay%26aufirst%3DS.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DTonge%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhai%26aufirst%3DB.%26atitle%3DStructure-guided%2520discovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520ERK1%252F2%2520from%2520a%2520modestly%2520active%2520and%2520promiscuous%2520chemical%2520start%2520point%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3438%26epage%3D3450%26doi%3D10.1021%2Facs.jmedchem.7b00267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L. H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of LX2343 derivatives as neuroprotective agents for the treatment of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">633</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1016%2Fj.ejmech.2017.12.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=29339255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVensrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2018&pages=622-633&author=G.+L.+Sunauthor=J.+W.+Wangauthor=X.+D.+Guoauthor=M.+Leiauthor=Y.+N.+Zhangauthor=X.+C.+Wangauthor=X.+Shenauthor=L.+H.+Hu&title=Design%2C+synthesis+and+biological+evaluation+of+LX2343+derivatives+as+neuroprotective+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2017.12.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of LX2343 derivatives as neuroprotective agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Sun, Guanglong; Wang, Junwei; Guo, Xiaodan; Lei, Min; Zhang, Yinan; Wang, Xiachang; Shen, Xu; Hu, Lihong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">622-633</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of LX2343 derivs. were designed, synthesized and evaluated as neuroprotective agents for Alzheimer's disease (AD) in vitro.  Most of the compds. displayed potent neuroprotective activities.  Esp. for compd. 2-(N-(5-chloro-2-methoxyphenyl)phenylsulfonamido)-N-((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)acetamide, exhibited a remarkable EC50 value of 0.22 μM and further investigation demonstrated that this compd. can significantly reduce Aβ prodn. and increase Aβ clearance, and alleviate Tau hyperphosphorylation.  Most importantly, this compd. could ameliorate learning and memory impairments in APP/PS1 transgenic mice.  The present study evidently showed that compd. 2-(N-(5-chloro-2-methoxyphenyl)phenylsulfonamido)-N-((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)acetamide is a potent neuroprotective agent and might serve as a promising lead candidate for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0WARoMg_Av7Vg90H21EOLACvtfcHk0lh0zEBLpscSww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVensrk%253D&md5=faac9af0289d5514c60f690437f3abfe</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.080%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DG.%2BL.%26aulast%3DWang%26aufirst%3DJ.%2BW.%26aulast%3DGuo%26aufirst%3DX.%2BD.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%2BN.%26aulast%3DWang%26aufirst%3DX.%2BC.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%2BH.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520LX2343%2520derivatives%2520as%2520neuroprotective%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D145%26spage%3D622%26epage%3D633%26doi%3D10.1016%2Fj.ejmech.2017.12.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praticò, D.</span></span> <span> </span><span class="NLM_article-title">Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">863</span>, <span class="refDoi"> DOI: 10.1002/ana.24145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=10.1002%2Fana.24145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=24644038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2murjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=851-863&author=J.-G.+Liauthor=J.+Chuauthor=C.+Barreroauthor=S.+Meraliauthor=D.+Pratic%C3%B2&title=Homocysteine+exacerbates+%CE%B2-amyloid+pathology%2C+tau+pathology%2C+and+cognitive+deficit+in+a+mouse+model+of+Alzheimer+disease+with+plaques+and+tangles&doi=10.1002%2Fana.24145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles</span></div><div class="casAuthors">Li, Jian-Guo; Chu, Jin; Barrero, Carlos; Merali, Salim; Pratico, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">851-863</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective : High level of homocysteine (Hcy) is a recognized risk factor for developing Alzheimer disease (AD).  However, the mechanisms involved are unknown.  Previously, it was shown that high Hcy increases brain β-amyloid (Aβ) levels in amyloid precursor protein transgenic mice, but no data are available on the effect that it may have on the other main pathol. features of AD such as tau.  Methods : 3xTg mice with diet-induced high Hcy were compared with mice having normal Hcy.  Neuronal cells were incubated with and without Hcy.  Results : Diet-induced high Hcy resulted in an exacerbation of the entire AD-like phenotype of the 3xTg mice.  In particular, we found that compared with controls, mice with high Hcy developed significant memory and learning deficits, and had elevated Aβ levels and deposition, which was mediated by an activation of the γ-secretase pathway.  In addn., the same mice had a significant increase in the insol. fraction of tau and its phosphorylation at specific epitopes, which was mediated by the cdk5 pathway.  In vitro studies confirmed these observations and provided evidence that the effects of Hcy on Aβ and tau are independent from each other.  Interpretation : Taken together, our findings demonstrate that a dietary condition that leads to an elevation of Hcy levels results in an exacerbation of all 3 major pathol. features of the AD phenotype: memory deficits, and Aβ and tau neuropathol.  They support the concept that this dietary lifestyle can act as a risk factor and actively contribute to the development of the disease.  Ann Neurol 2014;75:851-863.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZzOf0vxhNeLVg90H21EOLACvtfcHk0lirdMnCf03sQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2murjL&md5=0bceed9e1378a20bec8c843824e1664b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fana.24145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24145%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.-G.%26aulast%3DChu%26aufirst%3DJ.%26aulast%3DBarrero%26aufirst%3DC.%26aulast%3DMerali%26aufirst%3DS.%26aulast%3DPratic%25C3%25B2%26aufirst%3DD.%26atitle%3DHomocysteine%2520exacerbates%2520%25CE%25B2-amyloid%2520pathology%252C%2520tau%2520pathology%252C%2520and%2520cognitive%2520deficit%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%2520disease%2520with%2520plaques%2520and%2520tangles%26jtitle%3DAnn.%2520Neurol.%26date%3D2014%26volume%3D75%26spage%3D851%26epage%3D863%26doi%3D10.1002%2Fana.24145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMV','PDB','1PMV'); return false;">PDB: 1PMV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P33" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P33','PDB','2P33'); return false;">PDB: 2P33</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ZDU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ZDU','PDB','2ZDU'); return false;">PDB: 2ZDU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CGF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CGF','PDB','3CGF'); return false;">PDB: 3CGF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FV8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FV8','PDB','3FV8'); return false;">PDB: 3FV8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTI','PDB','3TTI'); return false;">PDB: 3TTI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4W','PDB','4W4W'); return false;">PDB: 4W4W</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y46" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y46','PDB','4Y46'); return false;">PDB: 4Y46</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WHZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WHZ','PDB','4WHZ'); return false;">PDB: 4WHZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PZE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PZE','PDB','3PZE'); return false;">PDB: 3PZE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7O','PDB','3E7O'); return false;">PDB: 3E7O</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AGD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AGD','PDB','4AGD'); return false;">PDB: 4AGD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1JNK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1JNK','PDB','1JNK'); return false;">PDB: 1JNK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMN','PDB','1PMN'); return false;">PDB: 1PMN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMU','PDB','1PMU'); return false;">PDB: 1PMU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2O0U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2O0U','PDB','2O0U'); return false;">PDB: 2O0U</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2R9S" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2R9S','PDB','2R9S'); return false;">PDB: 2R9S</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ZDT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ZDT','PDB','2ZDT'); return false;">PDB: 2ZDT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CGO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CGO','PDB','3CGO'); return false;">PDB: 3CGO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KVX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KVX','PDB','3KVX'); return false;">PDB: 3KVX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OXI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OXI','PDB','3OXI'); return false;">PDB: 3OXI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PTG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PTG','PDB','3PTG'); return false;">PDB: 3PTG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TTJ','PDB','3TTJ'); return false;">PDB: 3TTJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KKE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KKE','PDB','4KKE'); return false;">PDB: 4KKE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KKH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KKH','PDB','4KKH'); return false;">PDB: 4KKH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4V','PDB','4W4V'); return false;">PDB: 4W4V</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4X','PDB','4W4X'); return false;">PDB: 4W4X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4Y" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4W4Y','PDB','4W4Y'); return false;">PDB: 4W4Y</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X21" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X21','PDB','4X21'); return false;">PDB: 4X21</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y5H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y5H','PDB','4Y5H'); return false;">PDB: 4Y5H</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z9L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z9L','PDB','4Z9L'); return false;">PDB: 4Z9L</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TT','PDB','3TT'); return false;">PDB: 3TT</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i44"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00537">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_15827"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00537">10.1021/acs.jmedchem.9b00537</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Selected active ligands of JNK3 (Figure S1); dose dependency curves (Figure S2); concentration–activity relationship (Figure S3); plasma concentration–time profiles (Figure S4); 2D binding modes (Figure S5); RMSD of protein and ligand (Figure S6); selected JNK3 crystal structures (Table S1); original RMSD values (Table S2); original Gscore values (Table S3); enrichment factor results (Table S4); Gscore and inhibition rate (Table S5); kinases panel selectivity (Table S6); and spectra of compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of tested compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_002.csv">CSV</a>)</p></li><li><p class="inline">Molecular formula strings of benchmarking data set (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_001.pdf">jm9b00537_si_001.pdf (986.9 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_002.csv">jm9b00537_si_002.csv (6.84 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00537/suppl_file/jm9b00537_si_003.csv">jm9b00537_si_003.csv (76.21 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00537&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-14%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00537" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00537" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                13MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aefcd4c8a21d6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
